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Abstract 
 
Introduction: The assessment of lung function in young children is crucial to the diagnosis, 
treatment and management of respiratory disease. Since measuring lung function in this age group 
can be challenging, specific lung function tests for this age group have been developed. Of these 
tests, the Forced Oscillation Technique (FOT) is a non-invasive method of measuring respiratory 
impedance (Zrs), requiring minimal cooperation from the patient. Whilst highly feasible in young 
children, conventional FOT measurements have inherent limits in both the clinical application and 
interpretation of the test. The conventional FOT has shown to be more useful at detecting 
differences in lung function between patient groups rather than following disease progression in 
individuals. This may, in part, be explained by the Zrs reference data that were developed using a 
commercial FOT device with a reported systematic bias in the estimation of Zrs. In addition to this, 
the calculation of Zrs as an average over several breathing cycles may account for the limited 
clinical utility of the conventional FOT. It can be hypothesised that accounting for the well-
established intrabreath changes of Zrs during normal breathing in both health and disease will 
enhance the diagnostic value of the FOT.  
 
Aims: This thesis aims to improve the clinical utility of Zrs measurements in preschool-aged 
children through the development of a novel, custom-made FOT device tracking the intrabreath 
changes of Zrs. This will be achieved through three distinct studies; firstly the development of 
reference ranges for the conventional Zrs measurements using a gold-standard FOT device and 
examining the definition of “healthy” in preschool-aged children. Secondly, the feasibility of 
intrabreath Zrs measurements will be examined and e reference ranges developed for a preschool-
aged population. Lastly, the diagnostic power of the intrabreath FOT measurements will be 
examined in preschool-aged children with airway obstruction.  
 
Methodology: Children 3-6 years of age were recruited. Children were classified into one of six 
health groups based on a modified International Study of Asthma and Allergies in Childhood 
(ISAAC) questionnaire. Custom-made FOT equipment consisting of a loudspeaker and a wave-tube 
were used to measure Zrs. Two distinct types of Zrs measurements were made; firstly, the 
conventional FOT employed a multi-frequency 4-36 Hz measurement from which the Zrs spectra 
were ensemble averaged. Secondly, single-frequency (10 Hz) measurements were obtained to track 
the intrabreath changes in Zrs at every 0.1 s. Summary statistics and FOT variables are presented as 
either mean ± SD or median (25th; 75th percentile). Reference ranges were developed using mixed-
II 
 
effect linear regression and z-scores were calculated. The diagnostic power of within-breath Zrs 
measurements were investigated using Receiver Operator Characteristic analysis.   
 
Results: A total of 494 children contributed 587 acceptable conventional FOT measurements, a 
feasibility of 85.5%. Comparison of z-scores between healthy children and the five health groups 
revealed no significant difference between healthy children, children with early-life wheeze and 
children born preterm. The lack of significant differences validated a more inclusive approach to 
defining healthy by combining the conventional Zrs data of children with early-life wheeze and 
born preterm with the healthy children, increasing the reference dataset by 22.3%.  
 
Intrabreath Zrs measurements were successfully obtained in 517 children (86.7% feasibility). The 
intrabreath FOT outcome variables were significantly associated with height, whereas the volume 
dependence of resistance (R) (∆R) and reactance (X) (∆X) were not associated with height, weight, 
sex and age. Normative intrabreath Zrs reference values and z-scores were developed based on 200 
healthy children. An upper limit of normal of 1.96 hPa.s.L-1 for ΔR and the lower limit of normal of 
-0.54 hPa.s.L-1 were defined for ΔX.  
Having demonstrated the feasibility of intrabreath Zrs measurements, the diagnostic power of these 
measurements was investigated. FOT was employed in 26 children with acute wheeze and 75 healthy 
children. The conventional FOT outcome variables of resistance (Rrs) and reactance (Xrs) were not 
statistically significant between groups. In contrast, the intrabreath changes in Rrs and Xrs (ΔR and 
ΔX) were significantly different in the children with acute wheeze compared to healthy children. 
Furthermore, the largest area under the curve was observed for ΔR (0.95) and a cut-off value for ΔR 
of 1.42 hPa.s.L-1 detected airway obstruction with a sensitivity of 92% and specificity of 89% in 
children with acute wheeze.   
Conclusions: As the main result of this thesis, a novel lung function test was developed, tested and 
introduced into clinical practice. Measurements of Zrs using a novel FOT device are highly feasible 
in preschool-aged children 3-6 years of age. Whilst measurements of conventional FOT have limited 
clinical utility in children with acute wheeze, the intrabreath tracking of Zrs finding the zero-flow 
points significantly improves the diagnostic power of the FOT in preschool-aged children with acute 
wheeze. Development of normative reference data, z-scores and cut-off limits for detecting airway 
obstruction provide further improvement in the clinical application and interpretation of FOT 
measurements in preschool-aged children. 
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Introduction and Thesis Structure 
 
Measurements of lung function have long been established as part of the routine clinical assessment 
in both children and adults with respiratory disease. Whilst technological advances have seen more 
sophisticated techniques developed, the physiological principles of these tests have been established 
for many decades. Despite this, measuring lung function in young children 3-6 years of age presents 
major challenges in both the diagnosis, management and treatment of respiratory diseases in this 
age group.   
 
The preschool years are a unique period in which the respiratory system undergoes a significant 
amount of development 1. These years, represent a window of opportunity in which possible 
changes in lung development during the early years of life can be detected. In recognition of this, 
lung function tests specifically designed for preschool-aged children have been developed. While 
there is sufficient evidence for the use of these tests, the clinical utility in young children with 
wheeze and asthma requires further investigation.   
 
Over seven chapters, this thesis examines the measurement and utility of the Forced Oscillation 
Technique (FOT) in preschool-aged children. Prior to exploring the wonderful world of FOT, a 
literature review of the techniques used to measure lung function in preschool-aged children are 
described in Chapter 1. The physiological basis, testing requirements and clinical utility of these 
tests in preschool-aged children with wheeze and asthma is provided. As highlighted in the review, 
FOT is an attractive measure of lung function in this age group, as it requires no active breathing 
manoeuvre. Chapter 1 explores the key concepts in both the application and interpretation of FOT 
measurements in young children in addition to the clinical utility of these measurements in 
preschool-aged children with wheeze and asthma. Chapter 2, states the aims and hypothesis of this 
thesis.  Chapter 3 outlines a detailed description of the study participants, methodology and 
statistical analysis contributing to the results of this thesis. Chapter’s 4, 5 and 6 are the individual 
results of this thesis and include two publications and one manuscript under review. To avoid 
repetition, the methodology applied in each of the results chapters is not described. Rather, I direct 
the reader to Chapter 3 to review the methodology and to the appendices for reference to the 
manuscript associated with that Chapter. Finally, the findings of this thesis are discussed in Chapter 
7, focussing on the implications of the findings reported in this thesis and how this has contributed 
to advancing the measurement of FOT in preschool-aged children with airway obstruction. 
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Chapter 1  
 
Literature Review 
 
1.1 Measurements of lung function in preschool-aged children 
 
Wheeze, a heterogeneous symptom that presents as a whistling sound occurs in one in three 
preschool-aged children and is most commonly associated with lower respiratory illness 2,3. With 
wheeze a common symptom in this age group, wheeze and asthma exacerbation account for 50% of 
hospital admissions in children under six years of age 4. The long-term impact of early-life wheeze 
on lung function has been investigated in longitudinal birth cohort studies. From these studies it is 
well-established that in the presence of early-life wheeze, infant lung function is reduced, with 
deficits in lung function tracking into childhood and continuing into adolescence 2,5-7. Whilst the 
majority of children outgrow their symptoms, Martinez and colleagues 2 have reported that 22.5% 
of children diagnosed with late-onset wheeze develop asthma by six years of age with the likelihood 
of an asthma diagnosis even higher (46%) in young children with persistent wheeze.   
 
It is well-established that both wheeze and asthma are multi-factorial disorders. Therefore, it would 
be simplistic to argue that patterns of reduced lung function in this age group are due to wheeze 
only. With several phenotypic classifications and limited clinical utility in longitudinal 
symptomology the diagnosis of wheeze and asthma in this age group can present a challenge. Aside 
from this, longitudinal studies highlight the importance of measuring lung function during the 
preschool years to detect possible deficits in lung function that may have lifelong consequences. For 
these reasons, lung function measurements in preschool-aged children with wheeze and asthma will 
be the focus of this review.  
Measuring lung function during the preschool years represents challenges unique to this age group. 
Preschool-aged children are less likely to sit still for prolonged periods of time, have a shorter 
attention span and require staff who are expertly trained in engaging with young children. In 
recognition of these challenges, a number of lung function tests have been developed specifically for 
use in children 3-6 years of age. Whilst the majority of these lung function measurements remain in 
the research setting (the interrupter technique, specific airway resistance and multiple breath 
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washout), both spirometry and the FOT can be measured as part of the routine clinical care of 
preschool-aged children with suspected or known respiratory disease.  
 
1.1.1 Measurements of forced expiration 
 
Spirometry 
 
Spirometry, a measure of forced expiration is the most utilised lung function test in older children 
and adults. The measurement is based on achieving expiratory flow limitation (where the increasing 
transpulmonary pressure cannot increase the flow any further) and where the flow is independent of 
effort 8. This is achieved by reaching a high lung volume (total lung capacity) resulting in a sharp 
rise in the plural pressure which is also transmitted to the alveoli. This associated rise coincides 
with an increased transmural pressure in the bronchi, decreasing the size of the lumen. These two 
opposing forces reach a dynamic equilibrium resulting in flow limitation. It is the relationship 
between flow and volume during a forced expiration that results in the characteristic flow-volume 
curve used to diagnose healthy, obstructive, restrictive and mixed lung disease.  
 
Performing the forced expiratory manoeuvre is complex, especially for young children and it is 
important to remember when interpreting spirometry that young children cannot simply be treated 
as small adults. Therefore, the outcome variables frequently used in older children and adult lung 
function testing (i.e. FEV1 and FEV1/FVC) may not be reliable, suggesting that spirometry 
acceptability criteria and outcome measures should differ for preschool-aged children 6,8-10. 
Previous studies measuring spirometry in preschool-aged children suggest that FEV0.5 or FEV0.75 
may be more useful outcome measures in this age group 11-15 however, the consensus on which 
outcome variable to use is not clear. Furthermore, the deep inspiration required for the spirometry 
manoeuvre has been reported to alter the bronchial tone resulting in bronchodilation in the children 
with recurrent wheeze 16 leading to interpretation problems of the data in asthmatic children.   
 
The feasibility of spirometry is variable with studies reporting acceptable and repeatable measures 
in 55%-85% of preschool-aged children 17. This variability may be attributed to the complex 
breathing manoeuvre and high level of co-operation required from the child to perform acceptable 
and repeatable measurements according to the American Thoracic Society and the European 
Respiratory Society (ATS/ERS) guidelines 8. Highly experienced staff trained in measuring 
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spirometry in young children is recommended and a considerable amount of training sessions with 
the child over several visits to improve testing feasibility. It is also important to note that even if 
young children are able to cooperate to perform the test, FEV1 is often invalid as for young children 
performing the forced expiration the lung will mostly have emptied after one second 15. This makes 
spirometry insensitive to detecting early lung disease, the main interest of lung function tests in 
young children with wheeze and asthma 17,18. 
 
Computer games have helped to facilitate spirometry technique in young children and to 
differentiate spirometry patterns between healthy children and those with moderate to severe asthma 
12. In this study by Violzni and colleagues 12, a diagnosis of asthma and its severity (mild, moderate 
or severe) were based on the Global Initiative for Asthma (GINA) guidelines. Whilst the GINA 
guidelines are not recommended for use in children under six years of age these same findings were 
reported in young children who had spirometry measured during an acute episode of viral wheeze 
or asthma, a diagnosis of which was made based on International guidelines appropriate to this age 
group 19,20. Spirometry can differentiate young healthy children from children with asthma however, 
the consensus on which spirometry outcome variable is most sensitive to detect these differences is 
not clear. Konstantinou and colleagues 21 reported the utility of FEV0.5 to differentiate children with 
acute viral wheeze or asthma from healthy children. In comparison, Neve and colleagues have also 
reported that the FEV0.75/FVC ratio correlated with uncontrolled wheeze in preschool-aged children 
rather than FEV1 or the FEV1/FVC ratio 22. Whereas, Busi et al. 15 reported that FEV0.75 
discriminated healthy children from children with asthma. These studies highlight the 
inconsistencies in the reporting of spirometry outcome variables in young children. Whilst, the 
utility of spirometry in preschool-aged children has improved through the development of reference 
values for children as young as three years of age 23, these do not include reference values for 
FEV0.5. It is important to note that the literature describing the utility of spirometry in asthmatic or 
wheezing preschool-aged children has focused on symptomatic periods. The utility of spirometry in 
tracking longitudinal changes in lung function or managing disease progress during asymptomatic 
periods is not established in this age group.  
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1.1.2 Measurements of lung volume and ventilation inhomogeneity 
 
Multiple breath washout 
The multiple breath washout technique (MBW) is a method to measure the gas mixing abilities of the 
lungs, which reflects the ventilation distribution using an inert gas such as Nitrogen (N2), Helium 
(He) or sulfurhexaflouride (SF6) 
24. This technique measures the changes in the exhaled concentration 
of the gas with changes in tidal flow continuously over multiple breathing cycles during tidal 
breathing, making it attractive for use in preschool-aged children 24. The functional residual capacity 
(FRC) and the lung clearance index (LCI), the cumulative expired volume required to clear the inert 
gas from the lungs divided by the FRC are the most commonly reported outcome measures. Advances 
in MBW analysis has seen the introduction of the normalised phase III slope analysis which 
distinguishes ventilation inhomogeneity arising from convection dependent homogeneity (Scond) or 
diffusion limitation inhomogeneity (Sacin). The correct calculation of these outcome measures requires 
a stable tidal breathing pattern and larger tidal volumes, which are unlikely to be achieved in 
preschool-aged children.  
MBW measurements using N2 are becoming increasingly popular as the washout gas, 100% oxygen 
is readily available and cheap to purchase 25. Prior to the washout phase of the measurement 
commencing, a stable breathing pattern (a minimum of five breaths) must be achieved. As illustrated 
in Figure 1.1, oxygen is then switched-in during the expiratory phase of the breath and with each 
breath the alveolar concentration of N2 is decreased until it reaches 1/40 of the starting concentration 
24. The washout-phase occurs faster in healthy individuals compared to those with respiratory disease. 
Whilst the use of oxygen has been shown to alter the breathing pattern of infants 26,27, this is not the 
case in young children 25,28.  
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The ATS/ERS consensus statement recommends a repeatable testing session to be a minimum of 
three measurements with an FRC within 25% which, the ATS/ERS reports can be difficult to achieve 
in young children 24. This statement is supported by a study of young children naïve to MBW, where 
only 24% of children were able to meet ATS/ERS repeatability criteria in a time frame (20 minutes) 
that mimicked a clinical setting 30. The low feasibility of the MBW in young children can be increased 
by using a facemask instead of a mouthpiece; however, the change in the interface results in errors in 
the dead space correction and further interpretation problems (i.e. nasal vs oral breathing). An 
additional barrier to the feasibility of MBW, is the time taken to meet the end of test criteria which, 
can be lengthy in young children. To minimise this and to assist in achieving a stable tidal breathing 
pattern many laboratories use distraction techniques, such as a movie during testing. In an attempt to 
shorten the MBW protocol, an earlier cut-off point of 1/20 was proposed and investigated in a cohort 
of children with cystic fibrosis (CF). Stanojevic et al. 31 reported that although the specificity of MBW 
outcome measures were not affected the sensitivity was reduced. Improvement in the feasibility of 
MBW in young children needs further investigation and warrants the development of preschool-aged 
specific MBW guidelines.   
Figure 1.1: A schematic of the multiple breath Nitrogen washout technique. Oxygen is delivered 
during tidal breathing and the concentration of Nitrogen decreases during expiration (blue tracing) 
29. 
6 
 
Most studies describing the utility of MBW in young children have focused on children with CF 24,32-
36, reporting an improved sensitivity in detecting lung disease compared to spirometry. While the use 
of LCI as an outcome measure over spirometry in clinical trials is supported in preschool-aged 
children, further studies are required to support the use of MBW measurements for the clinical 
management of children with CF 29. In comparison, little research has been done on the application 
in children with wheeze or asthma 37,38. Two different studies from Sonnappa and colleagues in 
wheezy preschool-aged children 38,39 showed that LCI and Scond were elevated in children with wheeze 
compared to healthy controls; however these alterations did not exceed the range of the normal values. 
Further evidence is required to support the use of MBW in young children with wheeze and asthma.   
Despite significant development of the MBW technique, a high level of computerisation of the data 
is required from expertly trained staff. In addition, comparison of measurements between sites is 
challenging due to the different commercial devices available, utilising different software algorithms, 
tracer gases and analytical methods. Although use of this technique is promising and provides unique 
information on the ventilation homogeneity, standardisation and longitudinal data in both health and 
disease are needed to further progress MBW measurements in preschool-aged children.  
 
1.1.3 Measurements of respiratory resistance  
 
Whilst spirometry is the gold-standard measurement of lung function in older children and adults, 
the complex breathing manoeuvre required limits its utility in young children. To overcome this, 
lung function techniques measuring respiratory resistance (Rrs) in preschool-aged children with less 
complicated instructions are commonly utilised. Measurements of Rrs describe the relationship 
between pressure and flow, are highly dependent on airway calibre and can be applied in the 
presence of obstructive and restrictive lung disease. Three different lung function tests; the 
interrupter technique (Rint), specific airway resistance (sRaw) and the FOT have been developed to 
non-invasively measure Rrs. Whilst all techniques estimate Rrs (or components of Rrs), the values 
are not comparable and depend on the measurement technique. An understanding of the 
physiological principles supporting these measurements is crucial in the application of these tests in 
preschool-aged children. 
 
Total respiratory resistance is the sum of lung resistance (comprising of airway (Raw) and tissue 
resistance (Rti)) and the resistance of the chest wall. To measure the total respiratory resistance 
directly the transpulmonary pressure of the respiratory system needs to be accounted for. However, 
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this can only be achieved through the placement of an oesophageal balloon (pressure transducer), an 
invasive measure that cannot be routinely applied in the clinical setting. In comparison, 
measurements of Rrs by Rint, sRaw and FOT are highly feasible, non-invasive techniques with 
commercially available devices. Since FOT is the main focus of this thesis, the other techniques 
will only be discussed briefly. 
    
 
The interrupter technique 
The interrupter technique is a non-invasive measurement of resistance made during tidal breathing. 
Flow at the airway opening is briefly occluded (100 milliseconds) allowing the mouth and alveolar 
pressure to rapidly reach equilibrium 40-44. The magnitude of the rapid increase in pressure after 
occlusion is dependent on the difference between the mouth and alveolar pressure prior to occlusion. 
After occlusion, flow rapidly drops to zero, while pressure at the airway opening rapidly increases 
due to pressure differences in airway resistance occurring at the time of occlusion. The difference in 
the mouth and alveolar pressure divided by the flow at the airway opening prior to occlusion is a 
measure of the interrupter resistance (Rint).   
 
Rint, in theory is a measure of Raw, calculated as the difference in the alveolar and mouth pressure 
at the interruption of flow during tidal breathing. Often overlooked is the contribution of Rti, 
measured as a result of the relaxation of the airways following the rapid increase in the airway 
opening pressure. The assumption with this is that the interruption of flow, albeit short is enough to 
reach equilibrium between the mouth and alveolar pressure.  
 
Although the technique requires tidal breathing only, it has shown to be feasible in as few as 53% of 
2-3 year olds and in as many as 91% of 4-5 years olds in an ambulatory setting 45. To improve the 
interpretation of Rint in preschool-aged children, age specific guidelines have been developed 8, 
reference values with z-scores established 46 and commercial devices made available. Rint devices 
have the option to occlude the measurement either during inspiration or expiration. This has 
resulted in healthy reference data for the both the inspiratory and expiratory manoeuvre 46-50. 
Although Brussee and colleagues 51 reported only a small difference between Rint in expiration and 
inspiration the joint recommendation from the ATS/ERS is that expiratory Rint is measured as a 
better signal-to-noise ratio is achieved 8. Studies investigating the repeatability of Rint 
measurements have reported good intra-subject repeatability in healthy young subjects (coefficient 
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of variations of 11.6-12.1%), but the inter-subject variability is wide and does not discriminate 
between healthy children and those with wheeze 52-54. Further to this, is the limited clinical utility of 
Rint measurements in the presence of heterogeneity and airway obstruction in young children with 
asthma 55-57. The decreased sensitivity of Rint in the presence of airway obstruction may be 
attributed to the equilibrium not being reached between the mouth and alveolar pressure at the time 
of the interruption, therefore underestimating the pressure difference 41,44. This theory is further 
supported in a study of a lung model with airway obstruction where the time to reach equilibrium 
was increased, decreasing the Rint to less than the airway resistance 58, therefore its use in airway 
obstruction and heterogeneity is not reliable. 
 
Specific airway resistance  
 
Measurements of specific airway resistance (sRaw) are made with a body plethysmograph and are 
reflective of the resistive (Raw) and volume (FRC) properties of the respiratory system 59. 
Measurements require the child to perform tidal breathing whilst seated in a body plethysmograph. 
sRaw is calculated as the relationship between flow (recorded through a pneumotach) at the mouth 
and the change of pressure in the body plethysmograph 60. In older children and adults this is a two-
step process; 1) the measurement of the FRC and 2) the measurement of sRaw, calculated as the Raw 
normalised for the FRC. Therefore, the calculation of sRaw reflects Raw at a given lung volume. 
However, in young children accurately measuring FRC is difficult. Therefore, in the presence of an 
abnormal sRaw, it cannot be quantified if this is due to Raw, FRC or both, limiting the clinical 
interpretation of this measurement. 
 
Adaptions to the sRaw measurements to make them more “child friendly” (specialised mouthpiece, 
child sitting on parents lap in the plethysmograph) have allowed sRaw to be measured in children as 
young as 2 years of age 32,60. With feasibility reported between 58-80% for the pre-schooler 
population 60-62. Although commercial devices are available, they are expensive and measurements 
can only be completed in tertiary laboratories equipped with a body plethysmograph and are not 
suitable for field studies. There are also discrepancies between sRaw data collected in different lung 
function laboratories 63. Differences in sRaw between laboratories may be attributed to the calculation 
of the body temperature and pressure saturated (BTPS) correction factor, which vary by manufacturer 
and device. Measurements of sRaw have shown to differentiate between children aged 2-5 years with 
a history of early wheeze (3 or more episodes after the first year of life) and those without 64 and are 
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able to distinguish between atopic and non-atopic 3 year old children 65. Despite the promise that this 
technique displays in young children at risk of developing asthma there is no consensus on the 
measurement technique, quality control, data analysis or outcome variables, limiting the application 
of sRaw in both the clinical and research settings 66.  
 
The Forced Oscillation Technique 
 
The FOT is a non-invasive measurement of respiratory impedance (Zrs) during tidal breathing 67. 
Simply speaking, Zrs describes the relationship between the input and output signals of the 
respiratory system as a function of measurement frequency. The input signal is an external driving 
signal (or flow oscillations), and the output is the resulting changes on this signal in the respiratory 
system in terms of  flow (V’) and pressure (P) 68. For many, understanding the physiology and the 
interpretation of FOT measurements is complex, and a possible barrier to the uptake of FOT in the 
clinical setting. Whilst an in-depth review of the physics behind the FOT is beyond the scope of this 
thesis, an understanding of some key concepts of the FOT will be discussed here, with a more in-
depth description of the technical requirements of the FOT measurement detailed later in this 
Chapter (section 1.2.2). 
 
The non-invasive nature of the FOT has allowed measurements in newborns 69-80 through to adults 
81-84 in both health and respiratory disease. As no active breathing manoeuvre is required, FOT is an 
attractive measurement of Zrs in preschool-aged children. This is reflected in the feasibility of the 
measurement, corresponding to 83-96% in preschool-aged children 85-87. This is attributed to a short 
recording time of between 8-16 seconds (depending on the device used), and a minimum 
requirement of three acceptable and repeatable measurements per testing session 8. Despite this, the 
uptake of FOT measurements in the clinical setting has been limited as for many the interpretation 
of Zrs remains a challenge. Contributing to this are the ways in which Zrs can be measured 
(squarewave vs pseudorandom signal) and the different outcome variables reported. Importantly, 
differences in FOT devices can cause variation in the reported Zrs values in both children 85 and 
adults 83 (Figure 1.2). Furthermore, studies investigating the clinical utility of the FOT in young 
children are conflicting, reporting that FOT is more useful at detecting between group differences 
rather than following disease progression in individuals 17. Encouragingly, FOT measurements have 
seen a resurgence over the last few years which is evident in the development of commercial FOT 
equipment. Although the ATS/ERS have standardised FOT guidelines for preschool-aged children 
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8, they do not reflect the updated literature on FOT measurements and its clinical utility in this age 
group.   
 
 
 
 
 
 
 
 
 
 
 
While it is assumed that Rrs is reflective of airway calibre (Rrs is inversely related to the 4th power 
of radius), in a system as complex as the respiratory system this simplistic approach does not apply, 
especially during tidal breathing. This has been demonstrated by FOT measurements employing a 
single frequency sinusoidal signal whereby Zrs was shown to undergo cyclical changes in both 
inspiration and expiration 88. This may be attributed to the contribution of the upper airway 
resistance and the influence of the changes in tidal flow and volume, suggesting FOT measurements 
employing a single sinusoidal signal provide a more comprehensive assessment of Zrs. I will 
explore this theory later in this review. 
 
As described in Table 1.1, of the lung function tests designed for use in preschool-aged children, the 
FOT is most feasible. In comparison to other lung function tests described in this review, 
commercial FOT equipment is compact and inexpensive and is easily incorporated into a clinical 
setting. This facilitates FOT measurements in the community and remote settings encouraging the 
further development of the FOT.  
 
 
 
 
Figure 1.2: Comparison of resistance data measured using different FOT devices from different 
studies. Resistance data measured in healthy young children (left) 85 and healthy adults (right) 83. 
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 Table 1.1: Lung function tests measured in preschool-aged children with wheeze or asthma 
 
Technique 
Adequate 
reference 
values 
 
Feasibility 
 
Commercial 
equipment 
 
ATS/ERS 
guidelines 
Clinical utility in 
wheeze and asthma 
Spirometry ✓ 55-85% ✓ ✓ Contradictory 
evidence  
Multiple breath 
washout 
✓ 24-87% ✓ ✓ Contradictory 
evidence 
Interrupter 
resistance 
✓ 53-91% ✓ ✓ Contradictory 
evidence 
Specific airway 
resistance 
✓ 58-80% ✓ X Unknown 
Forced 
Oscillation 
Technique 
✓ 83-96% ✓ ✓ Contradictory 
evidence 
✓= yes; X= no. Table adapted and updated from Rosenfeld et al 17. 
 
 
1.1.4 Summary  
 
The development of lung function techniques specifically designed for preschool-aged children 
addresses the unique requirements of measuring lung function in this age group. Over time, the 
application and interpretation of these techniques have undergone significant development in both 
the research and clinical settings. Whilst the feasibility of these lung function tests in preschool-
aged children are comparable, the variability is high. Furthermore, the clinical utility of these tests 
in assessing wheeze and asthma, conditions reported to affect one third of preschool-age children, is 
limited. Given the possible lifelong implications of reduced lung function from wheeze and asthma 
during the preschool years it is imperative that the diagnostic power of lung function tests in 
preschool-aged children is improved. Of the tests described above, the FOT is a highly informative, 
non-invasive and a feasible measurement of Zrs from birth through to adulthood. Nonetheless, for 
the FOT to be of clinical relevance in the diagnosis, treatment and management of wheeze and 
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asthma in this age group, there needs to be significant improvement in both the application and 
interpretation of the Zrs measurements. To investigate this further, this review will now focus on 
the FOT. Firstly, before I investigate how the clinical utility of the FOT can be improved it is 
imperative that a description of the theory and practical application of the FOT is provided.   
 
1.2 The Forced Oscillation Technique  
 
The FOT was first described in 1956 by DuBois and colleagues 67. A modified respirator generated 
sinusoidal oscillations around the body or an oscillated rubber bellows at the mouth and measured 
the resulting changes in the transrespiratory pressure and the flow at the airway opening during 
apnoea. Since this initial work, significant progress in the field of FOT has seen the development of 
this technique to require advanced methods of signal processing and mathematical modelling in the 
calculation of respiratory mechanics. This technique can now be applied in a range of different 
settings from infants through to adults 68. Today, modern commercial FOT equipment applies an 
external driving signal at the mouth, superimposed on spontaneous breathing. The relationship 
between the pressure and flow are analysed in terms of the input pressure at the airway opening 
(Pao) and the resulting flow at the airway opening (V’ao). When measured at the mouth, the input 
respiratory impedance, Zrs is calculated, as: 
Zrs= Pao/V’ao 
Zrs is the combination of the respiratory resistance (Rrs) and respiratory reactance (Xrs) when 
measured in a frequency and where j is the imaginary unit: 
 
Zrs= Rrs + jXrs 
     (j= √(-1)) 
 
1.2.1 Definition of respiratory impedance 
 
The theory of the FOT relies on the assumption that the respiratory system is a linear system and that 
the output flow (V’) of the respiratory system will be proportional to the input pressure (P), but shifted 
in phase and scaled in amplitude 68. However, it is known that the respiratory system is far from 
linear. Nevertheless, if the amplitude of the oscillatory signal is small compared to the breathing 
amplitude of the child it can be assumed that the lung is a linear dynamic system 68. When flow (in 
the form of forced oscillations) is applied to the airway opening the changes in pressure and flow are 
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reflective of the total impedance of the respiratory system as a function of the frequency of the signal 
89. Zrs is generalised as the sum of Rrs (the in-phase component) and Xrs (out-of-phase component), 
expressing the overall impediment to flow within the lungs 8. The calculation of Zrs is based on 
Fourier transformation and other signal processing methods that are beyond the scope of this literature 
review.  
 
Rrs is reflective of the changes in the P/V’ relationship i.e. pressure change in phase with flow at the 
airway opening and is dominated by Raw but also includes a small component of lung tissue and 
chest wall resistance. The Xrs represents the relationship between P/V i.e. the pressure change that is 
in phase with volume. This is characterised by the elastic properties of the respiratory tissues and 
chest as well as the inertive properties of the gas column acceleration (V’’) in the large airways. The 
elastic component of Xrs dominates at low frequencies whereas the inertive properties become 
progressively influential with increasing oscillation frequency. 
 
1.2.2 Measurement of respiratory impedance using the FOT 
 
The theory behind the estimation of Zrs is well-defined however, the practical application of FOT 
measurements and the interpretation of data can cause confusion amongst FOT users. As discussed, 
this is attributed to different FOT methodologies and commercial devices available. Therefore, 
particular attention must be given to the practical aspects of the FOT measurements, including the 
FOT set-up, the output signal and the measurement of the input signal to ensure the accurate 
estimation and interpretation of Zrs. 
  
 
The wave-tube technique 
 
In conventional FOT devices, a loudspeaker encased in a rigid chamber is used to deliver the 
oscillatory signal to the mouth. Zrs is calculated from pressure and flow at the mouth using pressure 
transducers and a pneumotachograph. The use of a wave-tube, a long rigid tube located between the 
loudspeaker and the airway opening is an alternative technique to estimate Zrs. Using this 
technique, Zrs is calculated as a load impedance on the tube from two pressures instead of the 
classical flow and pressure relationship 90. The wave-tube technique was, first described in humans 
by Van de Woestijne and colleagues in 1981 91 and allows the precise estimation of Zrs, even at the 
small flows encountered in young children. This is achieved through the placement of two pressure 
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transducers on the wave-tube, one at the loudspeaker end and the second at the airway opening 
measure the inlet and the outlet pressures of the wave-tube and from the ratios of these pressures 
Zrs is calculated. The ratio of these pressures represents the transfer function of the wave-tube, 
accounting for both the impedance of the tube and respiratory system of the subject 90. As this 
calculation of Zrs and its frequency dependence is predicated by classical physics, the wave-tube 
technique is considered the gold-standard method to measure FOT 92. The differences in the 
calculation of Zrs between FOT devices (commercial devices vs. the wave-tube technique) may 
help to explain the inconsistencies reported in the clinical utility of FOT measurements in young 
children.  
 
To investigate the discrepancies between different FOT devices, our team compared the 
measurement of Zrs in a commercial i2M FOT device (Chess medical, Belgium; Cosmed, Italy) to a 
custom-made wave-tube FOT device 93. In a group of subjects (3.6 - 58.6 years of age) with Rrs 
ranging from 2.31 – 13.10 hPa.s.L-1 the i2M FOT device systematically underestimated Rrs and 
overestimated (less negative) Xrs (Figure 1.3). Importantly, the biggest differences were reported in 
the range of Rrs reflective of young children (8-15 hPa.s.L-1). These same findings were reported in 
a much larger older cohort comparing the wave-tube technique to commercial FOT and IOS devices 
92.  
 
The systematic bias reported between different FOT devices highlights the importance of selecting 
appropriate reference values. If, the reference values selected were established with a different FOT 
device to the one being measured in the test population the interpretation of the Zrs measurements 
may be compromised. To date, FOT reference values in young children have not been developed 
using the gold-standard wave-tube technique. With the known systematic bias of commercial FOT 
devices developing reference data using the wave-tube technique may aid in improving both the 
clinical utility and interpretation of the FOT in young children.  
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Figure 1.3: Bland-Altman and Heteroscedasticity plots of reactance at 8 Hz (X8) and resistance at 8 
Hz (R8) measured with i2M (method 1) and wave-tube (method 2) 93. 
 
 
Oscillatory waveforms  
 
The response of the respiratory system to the input signal is frequency dependent. Therefore, the 
construction of the oscillatory signal is crucial to determining the nature of Zrs to be measured. 
Commonly employed in commercial FOT equipment, composite signals allow multiple frequencies 
to be measured at the same time, significantly reducing FOT measurement time. Two examples of 
composite signals available in conventional FOT devices are the regularly recurring impulses 
lasting 40ms used in impulse oscillometry (IOS) and the pseudorandom noise signal (Figure 1.4).  
 
Whilst both FOT devices are used to measure Zrs, the measurements are not interchangeable with 
the IOS reported to overestimate Rrs compared to the pseudorandom signal 92. IOS devices use 
square-wave signals containing multiple frequencies (5 Hz harmonics). With the impulse nature of 
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the signal the energy distribution of the frequency spectrum at a given impulse cannot be controlled 
68. In comparison, the multi-frequency pseudorandom noise signal is designed to include the 
frequencies of interest with a defined amplitude. Unlike the recurring impulse signal, the signal-to-
noise ratio can be optimised at the frequencies of interest in the pseudorandom noise signal, which 
minimises violating the linear assumptions of the respiratory system 92. From this point forward any 
use of the term ‘conventional FOT’ refers to the pseudorandom multi-frequency signal. 
 
 
 
 
Frequency range of conventional FOT measurements  
 
In humans, conventional FOT measurements utilise a medium frequency oscillatory signal starting 
from 2-4 Hz (one decade above spontaneous breathing) up to 30-40 Hz. In the healthy lung, Rrs 
responds to the medium frequency range in a mostly frequency independent manner 94. In contrast, 
Xrs is significantly frequency dependent, even in the medium frequency range. With increasing 
frequency, Xrs transitions from negative values where the tissue elasticity dominates, to positive 
values because of the dominate inertial properties of the gas in the airways. The frequency at which 
transition occurs is where the magnitudes of the elastic and inertive Xrs values are the same but 
opposite in sign (i.e. Xrs crosses zero and goes from being negative to positive) and is termed the 
resonant frequency (Fres) (Figure 1.5). Commonly, conventional FOT measurements in young 
children report Rrs and Xrs at frequencies between 6 and10 Hz. This range represents the best 
compromise between minimal upper airway shunting and the optimal signal-to-noise ratio 94.  
Figure 1.4: Examples of multiple- frequency oscillatory signals. Panel A: pseudorandom noise, 
panel B, recurrent impulses 68. 
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Zrs has also been determined in both the low and high frequency ranges in research settings. Low 
frequency measurements require a driving signal around the frequency of spontaneous breathing (i.e. 
0.2 Hz). The measurement of Zrs at low frequencies can separate the airway and tissue mechanics 
with more sophistication than any other lung function measurement techniques. Since the low 
frequency FOT requires either voluntary apnoea 95, anaesthesia and paralysis 96 or reflex apnoea 
during sedation 79,80 it is not a suitable measurement for preschool-aged children  in a clinical setting. 
Conversely, high frequency signals in the range of 100-400 Hz reveal unique patterns of Zrs 
frequency dependence 97,98; however, the clinical relevance of these measurements is not well 
characterised.  
 
 
 
Figure 1.5: Frequency dependence of Zrs. Schematic of the response of the healthy respiratory system 
from low to high frequencies 68. 
 
 
Within-breath measurements of Zrs 
 
Historically, the measurement of Zrs has been shifted towards the conventional multi-frequency 
techniques, and Zrs has been calculated as the average over the measured breathing cycles. In 
comparison, limited studies have described the use of single-frequency sinusoid FOT measurements. 
FOT measurements are based on the assumption that the mechanical properties of the respiratory 
system do not change during tidal breathing. Studies employing a single sinusoid signal show that the 
respiratory system responds in a nonlinear fashion to changes in flow and volume during tidal 
breathing 88,99-103.  
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The use of different frequencies to measure the within-breath changes in Zrs have been reported at 8, 
10, 12, 20 and 30 Hz. One of the first studies to continuously measure the within-breath changes of 
Rrs was the early work from Davidson and colleagues 88 who employed a single 10 Hz sinusoid 
signal. This pioneering work showed that Rrs displays negative volume dependence, increasing 
during expiration and decreasing in inspiration, and was reflective of the cyclic changes in the airway 
calibre during tidal breathing. It was also reported that the point of maximum flow during the 
breathing cycle corresponded to an increase in Rrs (flow dependence), due to turbulent air flow 
occurring in the upper airways. These changes are more significant during expiration and therefore 
inspiratory resistance has been suggested as a surrogate measure of the airway resistance 88,103. One 
possible explanation for the flow dependence of expiratory Rrs could be the influence of the 
extrathoracic airways 104,105. Studies measuring the effect of vocal cord movements on airflow showed 
that during the expiratory phase of each breath the vocal cords were narrower. The level of 
constriction between healthy subjects was variable and Rrs, as measured by the FOT, was negatively 
correlated with the distance between the two vocal cords 106,107.  
 
The within-breath changes of Zrs described using a single-frequency sinusoid raise an important 
question about the measurement of Zrs using the conventional FOT. By calculating Zrs as an average 
over several breaths, the well-established within-breath variation of Zrs are not accounted for and 
may help to explain the limited clinical utility of conventional FOT measurements in young children.  
 
1.2.3 Summary of the Forced Oscillation Technique 
 
FOT measurements were first described over 60 years ago 67. More recently, FOT measurements 
and interpretation of Zrs in both health and disease have significantly advanced. Today, commercial 
FOT devices are inexpensive and portable making them an attractive lung function test. This has 
facilitated FOT measurements in the clinical setting, however this is not a routine test in all 
respiratory laboratories. This is most likely attributed to the inconsistencies in measurement 
methodologies which includes choice of waveform, measurement device and the outcome measures 
to be reported. 
 
In light of the systematic bias reported between FOT devices, development of Zrs reference values 
for preschool-aged children using the gold-standard wave-tube technique will ensure an accurate 
measurement of Zrs. And while conventional multi-frequency FOT measurements describe the 
majority of research to date, the significant changes in Zrs reflecting the cyclic changes in the 
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airway calibre cannot be ignored. Importantly, these differences in the estimation of Zrs may 
contribute to limited clinical utility of the FOT in preschool-aged children with wheeze and asthma. 
To explore this further next, I will review the clinical application of both the conventional and 
within-breath FOT measurements in preschool-aged children with wheeze and asthma. 
 
1.3 Clinical application of FOT measurements in preschool-aged children with 
wheeze and asthma 
 
1.3.1 Application of conventional FOT  
 
Several studies have demonstrated conflicting results for FOT when comparing lung function 
between children with wheeze and asthma to healthy children using the FOT 108-111. Children 
recruited from the community and defined as asthmatic or wheezy based on questionnaire data are 
less likely to have abnormal Zrs compared to children recruited from hospital settings 112. This was 
demonstrated by Nielsen and colleagues 108 in a well-defined population of asthmatic children 
recruited from an outpatient clinic in a hospital that Rrs measured at 5 Hz was significantly 
increased (1.24 ± 0.29 vs 1.04 ± 0.22 kPa.s.L-1) and Xrs at 5 Hz was significantly decreased (-0.44 
± 0.16 vs -0.35 ± 0.15 kPa.s.L-1) compared to healthy controls. These differences may be explained 
by the utility of parent reported wheeze compared to clinician diagnosed wheeze which is known to 
overestimate the prevalence of wheeze by up to 30% 113. Highlighting that the discriminative power 
of the FOT in children wheeze and asthma may be influenced by recruitment strategies.  
 
When examining the influence of sex on Zrs, differences have been previously reported in both 
health and respiratory disease 114-117. In the presence of asthma, asthmatic girls have been reported 
to have higher Zrs compared to healthy female controls. These same differences were not reported 
in males 111. When removing the diagnostic challenges involved with wheeze and asthma in this age 
group, the ability of Zrs variables to distinguish between preschool-aged children with asthma and 
wheeze have been documented 64,110. Oostveen et al. 110 showed that children defined as having 
wheeze (early transient and persistent wheeze), at 4 years of age had increased Rrs at 4, 6 and 8 Hz 
compared to children who had never wheezed. Although the between group differences were 
statistically significant, the overlap of Rrs between these groups raises questions around the clinical 
significance of these differences.  
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The utility of the FOT to detect between group differences in Zrs is documented however, others 
have raised concerns about the diagnostic value of Zrs measurements in individual young children 
61,118-122. Most notable of these is the findings of Cuijpers and colleagues 122 who assessed the 
diagnostic value of Zrs using receiver operator curve (ROC) analysis in children 6-12 years of age. 
The cut-off values calculated for the Zrs variables were not sensitive or specific enough to have any 
diagnostic value in asthmatic children. In addition to the study by Cuijpers et al 122, only two studies 
have assessed the diagnostic power of Zrs in individuals 108,123 and both have reported that the FOT 
was unable to discriminate healthy individuals from those with asthma. These findings suggest that 
while the FOT is able to distinguish between groups of children with and without disease (healthy 
vs asthmatic) the FOT’s ability to identify an individual with abnormal Zrs is limited in young 
children with wheeze and asthma. One possible explanation for this is that the normal range of Zrs 
for a child at given height is very wide. As depicted in Figure 1.6, in panel C for example, the 
normal range of Rrs at 8 Hz for a child 110cm tall is approximately 5 – 12 hPa.s.L-1. This wide 
range of normal Rrs cannot be attributed to the within-test variability of the FOT, with a coefficient 
of repeatability of Rrs between 1.1 and 2.6 hPa.s/L 64,85,87. From the literature it is evident that 
conventional FOT measurements have limited diagnostic power in preschool-aged children with 
wheeze and asthma. This may be attributed to the systematic bias in the estimation of Zrs using 
commercial FOT devices which may be eliminated through the use of the gold-standard wave-tube 
technique. 
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1.3.2 Application of within-breath FOT  
 
First described in the mid 1980’s 88, a limited number of studies have investigated the utility of 
tracking FOT measurements in preschool-aged children. Studies have measured within-breath FOT 
in older children in different patient groups including; vocal cord dysfunction 126, exercise induced 
laryngeal obstruction 127, children with a history of chronic cough 99 and in children born extremely 
preterm 128. With only a limited number of studies measuring within-breath FOT in children with 
asthma, this review will extend beyond the preschool age range to include children aged 4-17 years 
of age. To date, no studies have investigated measures of the within-breath FOT in children with 
wheeze.  
 
Figure 1.6: Comparison of four different healthy FOT reference values for Rrs or conductance 
(1/Rrs). The wide spread of normal ranges for a child at a given height is clearly demonstrated. A= 
Klug et al 109, B= Hantos et al 124, C= Calogero et al 114 and D= Ducharme et al 125. 
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The main outcome variables reported from the within-breath FOT are the mean Rrs during the 
expiratory (RmeanE) and inspiratory (RmeanI) phases of the breathing cycle. Unlike the 
conventional FOT, only a very small number of studies have employed within-breath FOT 
measurements in children with asthma. In two of the three studies it was reported that baseline Zrs 
could differentiate healthy children from asthmatic children 129,130. In a similar study by Schweitzer 
et al. 131 there was no difference in baseline Zrs between healthy and asthmatic children. Whilst the 
asthmatic children measured by Schweitzer and colleagues 131 were older, measurements were 
employed using a 12 Hz signal. This compares to an 8 Hz sinusoid in the studies by Vu et al 129 and 
Ioan and colleagues 130. Differences in the frequency of the signal measured make comparisons 
between studies challenging as they reflect a difference in the temporal resolution and the Zrs 
measured. It is important to note that an additional study by Marchal et al. 99 investigated the 
within-breath changes in Zrs in response to a deep inspiration in children (4.5-12.5 years) with 
chronic cough and asthma. The within-breath changes in Zrs did not differentiate the asthmatic 
children from those with chronic cough. 
 
An additional discrepancy arises when considering which variable (RmeanE or RmeanI) more 
accurately detects differences between asthmatic and healthy children. Whilst Vu and colleagues 129 
reported RmeanI as the most clinically useful variable to measure the response to salbutamol. Ioan 
and colleagues 130 report that discriminating healthy children from asthmatics is enhanced when 
reporting the mean R during expiration, rather than inspiration. The significant increase reported in 
R during expiration in the asthmatic children is most likely attributed to the narrowing of the glottic 
aperture 132,133. What is unclear is, the mechanisms behind the increased diagnostic power of 
RmeanI in asthmatics reported by Vu and colleagues 129.   
 
It is evident from the literature that the effects of flow and the airway geometry of the upper airways 
on Zrs are significant. However, the analysis described in these studies only has the ability to 
separate the inspiratory and expiratory phases of the breathing cycle therefore, not eliminating the 
flow dependence in the measurement of Zrs. 
 
1.4 Summary  
 
There are a growing number of longitudinal birth cohort studies highlighting the importance of 
measuring lung function from an early age to detect possible deficits in lung function that may have 
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lifelong consequence. As described in Table 1.1, significant progress has been made in the 
development of lung function tests specifically for use in preschool-aged children. Whilst most of 
these tests are better suited to the research setting, spirometry and the FOT have been incorporated 
into the routine assessment of lung function in some, but not all respiratory laboratories. The uptake 
has been limited by inconsistencies in FOT methodology, analysis and interpretation of Zrs. 
Furthermore, studies have shown limited clinical utility in the conventional FOT in preschool-aged 
children as they do not account for the well-established within-breath changes in Zrs during normal 
breathing. While limited studies have investigated the within-breath measurement of Zrs in 
preschool-aged children the discriminatory power of the within-breath FOT measurements needs to 
be improved if the FOT is to be of any clinical utility in this age group. Whilst these studies extend 
our knowledge on the within-breath measurement of Zrs, further work is required to evaluate the 
well-known effects of flow and volume on Zrs in preschool-aged children. Once this is identified 
the clinical application of the FOT will be improved.  
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Chapter 2  
 
Aims and Hypothesis 
 
The overall aim of my thesis is to improve the clinical utility of Zrs measurements in preschool-
aged children with obstructive lung disease through the development of a novel FOT method. In 
doing so, this will establish a novel lung function technique with an improved diagnostic power that 
facilitates the use of the FOT to investigate other respiratory disease groups. 
 
Specific aims 
 
Aim 1- I aim to establish robust reference values in healthy preschool-aged children using the gold-
standard wave-tube technique. I will challenge the definition of “healthy” in a large population of 
preschool-aged children, as described in Chapter 4. 
 
Hypothesis 1- I hypothesise that recruiting children from different settings will result in robust Zrs 
z-scores for preschool-aged children. Given the inconsistencies in the exclusion criteria for defining 
“healthy” in previously published FOT reference values in preschool-aged children, I expect that a 
more inclusive approach to defining healthy in this age group will not affect the distribution of Zrs 
outcome variables.  
 
Aim 2- To test the feasibility of the measurement of the intrabreath tracking of Zrs (T-FOT) and to 
develop healthy reference data for preschool-aged children, as described in Chapter 5.  
 
Hypothesis 2- Given the feasibility of conventional FOT measurements, I hypothesise that the 
extension of this technique will be a highly feasible measurement of Zrs that can be tested in 
different settings. Hence, facilitating the development of reference values for the intrabreath FOT 
variables, further improving the clinical application of the FOT.  
 
Aim 3- To investigate the diagnostic power of both the conventional FOT and T-FOT 
measurements in preschool-aged children with airway obstruction using the gold-standard wave-
tube technique, as described in Chapter 6.  
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Hypothesis 3- Based on previous studies investigating the clinical utility of Zrs measurements in 
preschool-aged children, I hypothesise that measurements of the conventional FOT using the wave-
tube technique will have low clinical value in discriminating between healthy preschool-aged 
children and children with airway obstruction. The diagnostic power of the FOT will improve 
through the measurement of the points along the breathing cycle where flow has no influence. In 
doing so, eliminating the effect of the variable flow pattern on Zrs measurements and improving the 
diagnostic power of the FOT in preschool-aged children with airway obstruction.   
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Chapter 3  
 
Methodology 
 
The utility of a modified custom-made FOT device in preschool-aged children is the focus of this 
thesis. Key to undertaking the overall aim of my thesis is that this FOT technique was developed 
from scratch during this thesis. This included the development of the FOT equipment, measurement 
software and methodology and the data analysis. This was an ongoing process throughout my 
studies; a collaboration between The University of Szeged and The University of Queensland.  
 
To undertake the aims outlined in Chapter 2, several cohorts of preschool-aged children were 
recruited and measured in different settings. Before I describe the FOT measurements employed in 
this thesis it is important to describe the different recruitment methods of the study participants and 
how each cohort contributed to the overall aims of this thesis. 
 
Children were recruited from three different countries in four different cities; Brisbane and 
Geelong, Australia, Szeged, Hungary and Indianapolis in the United States as part of a European 
Respiratory Society Clinical Research Collaboration, The International Collaboration to Improve 
Respiratory Health in Children (INCIRCLE). All INCIRCLE study sites underwent extensive FOT 
training and all measurements were obtained using the same FOT prototype device described in 
section 3.3 of this Chapter. All of the lung function tests included in this thesis were quality 
controlled and analysed by the Candidate. 
 
3.1 Study participant’s 
 
3.1.1 Recruitment of healthy children 
 
Brisbane, Australia 
 
From April 2014 to September 2016, children 3-6 years of age were recruited from kindergartens in 
the Brisbane metropolitan area. Initial contact with 18 centres was made via email or phone inviting 
centres to participate in the research study. Approval was obtained from 10 of the 18 centres 
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approached (Figure 3.1). Study information packs containing a parent information sheet and a 
modified ISAAC questionnaire (appendix A) along with a letter of invitation were delivered to the 
centres two weeks prior to the scheduled study visit. Centre management distributed the study packs 
to all eligible families (children 3-6 years of age) who were instructed to return the completed 
consent form and questionnaire to the centre prior to the study visit. Study visits were conducted in 
a designated space within the kindergarten and were undertaken as to have minimal impact of the 
daily operations of the centre.  
 
All of the steps involved in the recruitment of children from the Brisbane kindergartens that is; 
selecting and recruiting the kindergartens, organising the study visits, collecting the questionnaires 
and the consent forms were undertaken by the Candidate. In addition, all study visits and FOT 
measurements were performed and analysed by the Candidate as well as the collation and analysis 
of the questionnaire and FOT data for each child. The results and data from children recruited from 
Brisbane kindergartens are discussed in Chapter’s 4, 5 and 6. This study received ethical approval 
from the Children’s Health Services Queensland Human Research Ethics Committee (approval 
number; HREC/12/QRCH/23), appendix B and The University of Queensland Institutional Human 
Research Ethics Committee (approval number: 2014000212), appendix C.  
 
 
 
Figure 3.1: Location of Brisbane kindergarten’s recruited. The location of each kindergarten is 
indicated by a red marker.            
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Szeged, Hungary 
 
Following the recruitment strategies described in the Brisbane cohort, children 3-6 years of age 
were recruited from two kindergartens in Szeged, Hungary. The parent information sheet, consent 
form and the modified ISAAC were translated to the Hungarian language. All FOT measurements 
and questionnaire data collected in Szeged where analysed by the Candidate. Children recruited 
from Szeged kindergartens contributed to the results discussed in Chapter 4. This study received 
ethical approval from the Hungarian Regional Human Ethics Committee (approval number; 
107/2015-SZTE), appendix D.  
 
Indianapolis, United States 
 
Healthy children aged between 2 and 12 years attending the respiratory outpatient clinic at the Riley 
Hospital, Indianapolis between November 2015 and July 2017 were recruited. Generally, children 
were siblings or friends of children attending the respiratory clinic. Prior to FOT measurements, 
children were pre-screened using a questionnaire (appendix E). At this site healthy children were 
defined as born at term (>37 weeks gestation), had no ventilator support during the neonatal period, 
had never been diagnosed with a chronic lung disease or congenital abnormality affecting their lung 
and/or body growth and development, had never wheezed or had a chronic cough (lasting >1 
month). Lung function data from healthy children between 3 and 6 years of age contributed data to 
this thesis in Chapter 5. This study was approved by the Indiana University School of Medicine 
ethics committee (approval number; 1506956908), appendix F.  
 
3.1.2 Recruitment from longitudinal birth cohort studies 
 
The Early Life Lung Function (ELLF) study 
 
The ELLF study is an extension of the Observational Research in Childhood Infectious Diseases 
(ORChID) study 134, a community birth cohort study. Families were recruited from two major 
hospitals in Brisbane, serving the North metropolitan area. Women were excluded from recruitment 
and ongoing participation if the child was born before less than 36 weeks gestational age, had a 
major congenital abnormality, chronic heart, respiratory, neurological, gastrointestinal or 
immunological disorder. In addition, the mother was required to converse and understand English 
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and be planning to live in Brisbane over the two-year study period. The ORChID study was 
established to investigate the role of viral respiratory and gastrointestinal infections in the first two 
years of life. Over a two-year period, families were required to complete a daily respiratory 
symptom diary, collect weekly anterior nasal swabs and soiled nappy swabs from the enrolled child.  
 
Families who collected at least six months of nasal swabs were invited to participate in the ELLF 
study.  The primary aim of the ELLF study was to investigate the impact of early life (0-2 years of 
age) viral infections on lung function between 3-7 years of age. From the ORChID study, 112 
families (71% of ORChID participants) were eligible to participate in ELLF. Face-to-face 
recruitment in participant’s homes took place over a 12-month period and 92 participants were 
recruited for annual study visits and eight as questionnaire only participation. ELLF study visits 
occurred annually between the child’s 3rd and 7th birthday (±6 months). Study visits took place in a 
room dedicated to preschool-aged children and involved measurements of FOT, a respiratory 
questionnaire, an anterior nasal swab, saliva swab, blood test (3 year visit only) and collection of 
airway epithelial cells (3 and 4 year visits). Analysis of the immunological, virus and bacterial 
components obtained in the ELLF study are beyond the scope of this thesis. Analysis of the lung 
function and questionnaire data only will be reported in this thesis.  
 
Recruitment of ORChID participants into the ELLF study, scheduling and performing study visits, 
collating and analysis of all the FOT and questionnaire data for this thesis were undertaken by the 
Candidate. Whilst the ELLF study is still ongoing, participants in the ELLF study contributed to 
results discussed in Chapter’s 4, 5 and 6. Ethical approval for this study was obtained through the 
following institutions; Children’s Health Services Queensland Human Research Ethics Committee 
(approval number; HREC/13/QRCH/156), appendix G and The University of Queensland 
Institutional Human Research Ethics Committee (approval number; 2013001291), appendix H. 
 
The Barwon Infant Study 
 
The Barwon Infant Study (BIS) is a population-derived cohort study that recruited pregnant women 
from the Barwon region, Victoria, Australia 135. BIS infants were followed up in the first four years 
of life investigating microbiome, immune, cardiovascular, neurodevelopment and respiratory 
outcomes. Infants were ineligible to participate in the study if born before 32 completed weeks 
gestation, had a serious illness that was identified within days of birth or had a known major 
congenital malformation or genetic disease. Whilst the BIS is a comprehensive study, only the FOT 
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measurements obtained at the fourth year visit are within the scope of this thesis. These study visits 
commenced in 2014 and in 2015 FOT measurements were introduced to the study protocol, with 
visits taken place in a dedicated room for pre-schooler lung function testing. BIS staff were trained 
in the measurement of the FOT; including the theory, equipment and practical applications of the 
FOT in preschool-aged children by the Candidate. In addition, all FOT data described in this thesis 
were analysed by the Candidate. Whilst the fourth year study visits are ongoing, data from 98 BIS 
participants contributed to the results discussed in Chapter’s 4 and 5. The BIS was approved by the 
Barwon Health Human Ethics Committee (approval number; 10/24), appendix I.  
 
3.1.3 Recruitment of children with wheeze 
 
Children with acute wheeze 
 
To address the third aim of this thesis, between June 2014 and August 2015 children 3-6 years of 
age admitted to the Emergency Department at the Royal Children’s Hospital, Brisbane with acute 
wheeze were recruited. Children were eligible for recruitment if 1) wheeze was detected on 
auscultation; 2) required treatment with short-acting β2 receptor agonists (SABA) and 3) did not 
require supplemental oxygen at the time FOT was measured. FOT measurements were obtained in 
the emergency department or in a dedicated lung function testing room. 
 
The Candidate contributed to the study visits, FOT measurements and questionnaire data collation 
and analysis. Children recruited for this study contributed to data discussed in Chapter 6. Ethical 
approval was provided from the Children’s Health Services Queensland Human Research Ethics 
Committee (HREC/14/QRCH/12), appendix J. 
 
Children with stable recurrent wheeze 
 
Children 3-6 years of age with stable wheeze (3 or more wheezing episodes after the first year of 
life) or with doctor diagnosed asthma were recruited from the Department of Respiratory Medicine 
outpatient clinic at the Royal Children’s Hospital, Brisbane between April and November 2015. 
Children were ineligible to participate if they had experienced respiratory symptoms within the four 
weeks prior to FOT measurements. FOT was measured in a room dedicated to preschool-aged 
children.  
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The Candidate recruited all of the children with stable wheeze, undertook the study visits and 
analysed and collated the FOT measurements and questionnaire data. Children recruited with stable 
recurrent wheeze contributed to data discussed in Chapter 6. Ethical approval was provided from 
the Children’s Health Services Queensland Human Research Ethics Committee (approval number; 
HREC/13/QRCH/22), appendix K and The University of Queensland Institutional Human Research 
Ethics Committee (approval number; 2014000212), appendix C. 
 
3.2  Determining the health status of study participant’s 
Questionnaire data obtained from all study participants described in section 3.1 was used to 
determine the health status of each child. Due to the differing study protocols contributing to this 
thesis, a single standardised questionnaire was not utilised. Indianapolis was the only site where the 
questionnaire data were used as a pre-screening tool to identify healthy children only for 
recruitment. Whereas, at the other sites described in sections 3.1.1 – 3.1.2, lung function was 
measured independently of the health status, which was determined after the analysis of the FOT 
measurements. Despite these inconsistencies, the different questionnaires all addressed the key 
questions used to define the six different health status categories described in Chapters 4-6. Whilst 
each study defined its own inclusion and exclusion criteria for recruitment, the following criteria 
were applied to determine health status in this thesis: 
 
Asthmatic: Doctor diagnosed asthma. 
Current wheeze: Wheezing episodes within the 12 months prior to the study visit. 
Recurrent wheeze: One or more wheezing episodes within the first two years of life, plus wheeze 
within the 12 months prior to the study visit. 
Early-life wheeze: One or more episode of wheeze within the first two years of life but no wheeze 
after. 
Preterm birth: Born prior to 37 completed week’s gestational age. 
Respiratory symptoms: Upper or lower tract respiratory symptoms, or respiratory medication use 
within the four weeks prior to the study visit. 
Healthy children: Born at term (≥37 weeks gestation), free of any respiratory symptoms and no 
respiratory medication use within 4 weeks of the study visit, had never wheezed and no prior 
doctor-diagnosed asthma. 
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Children were allocated to mutually exclusive health groups, determined in the order as described 
above. For example; a child with wheeze episodes in the first year of life who was diagnosed with 
asthma at 4 years of age would be classified as an asthmatic.  
 
3.3 Technical considerations for FOT measurements 
 
The early phase of my studies focused on the development of a custom-made FOT device, as 
described in this Chapter. The primary focus was to define the best measurement settings to 
accurately measure Zrs in preschool-aged children. This was a crucial first step which enabled the 
studies described in Chapters 4-6 to be performed. Each of the sites that contributed FOT 
measurements to this thesis used a FOT device produced under the same precise manufacturing 
standards from the team at The University of Szeged, Hungary. At the beginning of the project, 
measurement software and data analysis had not been established for this novel FOT method. 
Collaborating closely with the hardware and software engineers in Szeged I provided direct 
feedback on the different hardware and software prototypes that were developed during my studies. 
It is important to note, that while the hardware and the software components of the FOT device 
progressed with the different FOT prototypes, the FOT measurement settings established early on in 
this project and the data analysis techniques applied were consistent across all study sites.    
 
3.3.1  The wave-tube FOT device 
 
As described in Chapter 1, section 1.2.2, the wave-tube technique is the gold-standard FOT method. 
A schematic of the most recent prototype of the custom-made FOT device is shown in Figure 3.2. 
The loudspeaker is encased in a rigid chamber and generates the flow oscillations. The device 
electronics are also stored within the rigid chamber. The loudspeaker is connected to a computer via 
a USB connection, from which the input signal was generated. The signal was then delivered to the 
child’s mouth via a wave-tube measuring 17.0 cm in length with an internal diameter of 1.4 cm and 
an antibacterial mouthpiece-filter assembly (Bird Healthcare, RJVKB2, Victoria, Australia). Two 
identical pressure transducers (Honeywell S&C, Model 26PCAFA6D, New Jersey, USA) measured 
the inlet (P1) and outlet pressure (P2) along the wave-tube (from these two pressures Zrs was 
calucalted) and a screen pneumotachograph was included to measure the flow (to record tidal 
breathing during the test). A breathing tube at the opposite end to the mouthpiece made the device 
an open system, minimising re-breathing and CO2 build-up during the measurement.  
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3.3.2 Calibration of the wave-tube FOT device 
 
The impedance of the wave-tube is calculated from the inlet and outlet pressures therefore, the 
calibration of these transducers are of utmost importance. To ensure the transducer sensitivity, 
which may change in response to the ambient environment and time, daily calibration of the FOT 
device was recommended or whenever the device moved locations (e.g. calibrated in the morning in 
the preschool lung function room and then recalibrated in the afternoon in the emergency 
department). The principle of the calibration of the wave-tube setup is to test whether the two 
pressure transducers respond the same way when they are exposed to the same pressure in an almost 
closed system. As the pressure transducers are measuring the same input, if a difference is detected 
an adjustment is generated and accounted for in the daily calibration file.  
 
To calibrate the device, an almost closed system is created by removing the breathing tube and 
replacing it with a stopper with a small leak (small tube) and blocking the patient end of wave-tube. 
The ratio of the measured pressures with the two transduces should be close to 1. Once the ratio is 
calculated (which is technically never exactly 1 because of the physical properties and locations of 
the transducers) software automatically adjusts the setting to the actual calibration and measures Zrs 
accordingly. The automatisation of this step was one of the many improvements carried out over the 
development of this technique during my PhD. With this step, the between-examiner differences 
and the user errors can be minimised. The calibration was carried out every day prior to the test of 
Figure 3.2: Schematic of the wave-tube FOT set-up used to measure Zrs in this thesis. 
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the first child. In the calibration file, engineered specifically for each FOT device, all components of 
the set-up before the child are accounted for as parallel and in-series impedance, including the filter-
mouthpiece assembly. The calibration file includes the physical properties of the wave-tube and a 
comprehensive correction for the filter-mouthpiece assembly. The filter-mouthpiece assembly can 
act as a shunt impedance during the measurements. This is especially crucial when measuring high 
impedance as demonstrated in preschool-aged children.  
 
3.4 Measurement of the conventional and intrabreath tracking FOT in 
preschool-aged children 
 
This section describes the specific requirements for measuring the conventional and intrabreath 
tracking FOT (T-FOT) in preschool-aged children using the custom-made FOT set-up described in 
section 3.3.1. When measuring lung function in preschool-aged children it is crucial to create a 
child friendly environment. It will help ease the anxiety that the child may be experiencing when 
visiting a new location and seeing unfamiliar faces. This will also help the child to perform the tasks 
required of them. Taking the time to prepare the child for the study visit and FOT measurements is 
crucial in achieving feasible FOT measurements in this age group. As such, all staff involved in the 
data collection described in this thesis were highly experienced in working with preschool-aged 
children. To ensure that FOT measurements were consistent across all study sites, standard 
operating procedures (SOPs) were developed. I direct the reader to the SOPs in appendix L for a 
step-by-step guide on measuring the conventional FOT and T-FOT described in this thesis.  
 
Across all study sites and prior to FOT measurements the child’s standing height and weight were 
measured. An adequate amount of time was taken to familiarise the child with the FOT set-up and 
the measurement requirements. FOT was measured with the conventional FOT first, followed by 
the T-FOT. The precise details of these measurements are described below. 
 
3.4.1 Child preparation for FOT measurements 
 
All study sites were strongly encouraged to develop a child friendly room (Figure 3.3) in which the 
FOT measurements and study visit could take place. Prior to the FOT measurements, standing 
height and weight were measured and recorded to one decimal point. Height was measured with 
shoes and hats removed and bulky clothing was removed to measure weight. Next, the FOT set-up 
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and measurement were explained to the child, allowing the child adequate time to practice wearing 
the nose-clips and to demonstrate a tight seal around the mouthpiece. Both the conventional FOT 
and T-FOT measurements required the child to be seated upright, with a tight seal around the anti-
bacterial mouthpiece attached to the custom-made FOT device (Figure 3.3). The child was 
instructed to perform tidal breathing whilst wearing a nose-clip and having their cheeks and the 
floor of the mouth firmly supported by a staff member to minimise the upper airway shunt 136,137. 
 
 
 
Figure 3.3: ELLF participant having her lung function measured using the forced oscillation 
technique. This photo was obtained with parental consent.  
 
3.4.2 Conventional FOT measurements  
 
Conventional FOT measurements required the child to perform tidal breathing over a 16 second 
period. A multi-frequency pseudorandom signal was delivered from the loudspeaker at a frequency 
range from 4-26 Hz (at 2 Hz increments), with a peak-to-peak ratio of <1.5 h.Pa.s.L-1, with the 
amplitude of the signal decreasing with increasing frequency. A minimum of three artefact free, 
reproducible measurements were made. Measurements were not considered technically acceptable 
if there was leak around the mouthpiece, audible noise (e.g. humming), the child was moving and if 
swallowing or coughing during the measurement was detected. As part of the development of this 
technique, the repeatability of the conventional FOT measurements was investigated. The 
coefficient of variation (CV) of each value between 6-26 Hz was determined in a random sample of 
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FOT measurements. From this, repeatable conventional FOT measurements were defined as a 
coefficient of variation (CV) of less than 20% for R and X at all frequencies. 
 
3.4.3 Conventional FOT data analysis  
 
Acceptable and repeatable measurements were selected and band-passed filtered between 3 and 27 
Hz and ensemble averaged. As the signal at 4 Hz often interferes with the harmonics of the 
spontaneous breathing of the child, 4 Hz data cannot be reliably obtained in young children. The 
mean and standard deviation for R and X were estimated between 6-26 Hz. Mean R and X values 
were obtained at each of the measurement frequencies.  
 
R-I-C modelling of Zrs spectra 
 
Mathematical models have been formulated to explain the behaviour of the respiratory system. 
Fitting the Zrs data to a mathematical model allows the Zrs spectrum to be interpreted in 
physiological terms. One such model is the resistance (R) - inertance (I) - compliance (C) model 
described as; 
Zrs= R+j𝜔I+ (1/j𝜔C). 
 
Where j is the imaginary unit and 𝜔 represents angular frequency. 
 
An R-I-C model was fitted to the averaged Zrs spectra obtained from the conventional FOT 
measurements. R was calculated between 10 and 20 Hz from the respiratory resistance (Rrs) data, 
while I and C were estimated between 6 and 26 Hz from the reactance (Xrs) data and the mean and 
standard deviation for R, I and C calculated (Figure 3.4). Applying the R-I-C model fitting to the 
spectral FOT data improves the interpretation of the Zrs outcomes for clinicians. Resistance and 
compliance are terms easily understood by both clinicians and researchers. The re-introduction of 
this data analysis methods was one of the novelties of my studies. 
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Figure 3.4 Schematic of the fitting a resistance (R)- inertance (I)- compliance (C) model to 
measured resistance (Rrs, closed circles) and reactance (Xrs, open circles) data. The red line 
represents the average values for Rrs between 10-20 Hz and Xrs between 6-26 Hz.  
 
 
3.4.4 T-FOT measurements  
 
Like the conventional FOT measurements, T-FOT was measured during stable tidal breathing over 
a 16 second period. A single small-amplitude (<0.25 hPa.s.L-1) 10 Hz sinusoid was employed to 
measure the within-breath tracking of Zrs during tidal breathing. The tracking signal has to fulfil the 
following criteria: 1) to achieve good temporal resolution the signal must be fast enough (high in 
frequency) with a small period time (the smaller the period time, the more times the measurement 
can be repeated in a second therefore, the more data points that can be sampled from a breath), 2) 
the signal frequency should be low enough to measure reactance in the negative range that is 
determined mainly by compliance (i.e. should be below Fres). To achieve optimal tracking 
resolution, the amplitude of the signal should not be bigger than 1/4th of the tidal flow of the child; 
therefore, the amplitude should be kept smaller compared to the conventional FOT measurements.  
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The child was required to be seated upright during the measurements, wearing a nose-clip and 
having their cheeks and the floor of their mouth firmly supported. A test epoch was considered 
technically acceptable if a minimum of 5 artefact free breathing cycles (as defined above) were 
obtained. Repeatable breathing cycles were defined by the CV of inspiratory resistance (R) < 15% 
based on a sample of T-FOT measurements in healthy children.  
 
 
Figure 3.5: Tidal changes in resistance (R) and reactance (X) with the flow and volume traces. Dashed 
lines indicate time points of end expiration (eE), end inspiration (eI), maximum inspiratory flow 
(V’maxI) and maximum expiratory flow (V’maxE). 
 
39 
 
3.4.5 T-FOT data analysis  
 
All recordings were band-pass filtered between 8 and 12 Hz and all acceptable (artefact free) 
breathing cycles were selected for analysis. A breathing cycle was selected and defined as from the 
commencement of inspiration to the end of expiration (Figure 3.5), with only full breathing cycles 
were involved in the analysis. Children with less than 5 acceptable breathing cycles were excluded 
from the analysis. R and X values were obtained at different phases of the breathing cycle. Each 
breath was analysed separately. The median was calculated for the intrabreath R and X variables 
described in Table 3.1 
 
Table 3.1: Definitions of variables measured from tracking the within-breath changes of respiratory 
impedance using a 10 Hz signal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5  Statistical analysis  
The key statistical analysis undertaken to interpret the results described in Chapters 4-6 are 
described below. The statistical analysis and programming outlined in this thesis was undertaken 
with the support of Professor Robert Ware. For all statistical analyses, a p-value of ≤0.05 was 
considered statistically significant. Data analyses were performed in Stata (StataCorp, Texas, 
Phase of the breathing cycles Resistance (R) Reactance (X) 
Mean during expiration RmeanE XmeanE 
Mean during inspiration RmeanI XmeanI 
at maximum expiratory flow 
(maxE) 
RmaxE XmaxE 
at maximum inspiratory flow 
(maxI) 
RmaxI XmaxI 
at end-expiration (eE) ReE XeE 
at end-inspiration (eI) ReI XeI 
Difference between eE and eI ΔR ΔX 
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United States), versions 12.1 and 13.0 and SigmaPlot (Systat Software San Jose, California, United 
States) version 13.0. 
3.5.1 Descriptive statistics  
 
Descriptive statistics are reported in Chapters 4-6, summarising the anthropometric and FOT 
outcome variables. The Shapiro-Wilk test assessed the normal distribution of the data. If data were 
normally distributed the measures of central tendency are reported as the mean, whilst non-normally 
distributed data are described as the median. To assess the variability of the data normally 
distributed outcomes are reported as the standard deviation (SD), and if not normally distributed the 
25th and 75th percentile range are reported. 
 
3.5.2 Calculation of z-scores  
 
Z-scores were generated for the conventional FOT and T-FOT outcome variables, as described in 
Chapters 4 and 5. The steps to develop z-scores are outlined below. 
 
Step 1- Transformation of Zrs outcome variables  
 
All conventional FOT and T-FOT outcome variables described in Chapters 4 and 5 failed the 
Shapiro-Wilk test of normality. To achieve normality Zrs variables underwent natural logarithmic-
transformation prior to analysis.  
 
Step 2- Univariate analysis  
 
Univariate analysis were constructed to investigate the influence of anthropometric measures of 
height, age, weight and sex on the FOT outcome variables measured from the conventional FOT 
and T-FOT. The most significant predictors of the FOT outcome variables were defined as a p-
value of <0.05. 
 
Step 3- Multivariable regression analysis  
 
Multivariate analysis were constructed to determine which of the significant predictors identified in 
the univariate analysis had the strongest relationship with the FOT outcome variables, defined as a 
p-value of <0.05.  
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Step 4- Mixed-effects linear regression modelling  
Normative equations were calculated using mixed-effects linear regression modelling. Mixed-
effects models were used as data points from some children from the ELLF Study were included 
more than once. Then, multivariable models were built using combinations of main effects (height, 
weight, age and sex), before the most parsimonious multivariable model was selected using the 
likelihood ratio test. In all models each child was included as a random effect, to account for the 
probable non-independence of observations from the same child. From the model, prediction values 
for each of the transformed FOT variable outcomes were generated.  
 
Step 5- Generating z-scores  
 
Z-scores were calculated using the equation: Z = (measured transformed FOT variable- predicted 
transformed FOT variable)/ SD, where SD represents the overall standard deviation of the model. 
 
3.5.3 Calculating the lower and upper limits of normal 
 
For FOT outcome variables independent of anthropometry and sex the upper limit of normal (ULN) 
and lower limit of normal were calculated. In line with the recommendations from both the ATS, 
ERS and the Global Lung Initiative multi-ethnic spirometry reference values the ULN was defined 
as the 95th centile and the LLN, the 5th centile 23,138,139.  
 
3.5.4 Between group analyses 
 
Differences in FOT outcome variables between health groups defined in section 3.2 were examined 
in Chapters 4 and 5. To investigate between group differences in normally distributed data and z-
scores, the Student’s t-test was applied or the Mann-Whittney U test for non-parametric data. 
Differences in independent data that were not normally distributed were assessed using the 
Wilcoxon Rank Sum Test. 
 
3.5.5 Testing the diagnostic value of T-FOT outcome variables  
 
The areas under the receiver operator characteristic (ROC) curves (the AUCs) were calculated for the 
T-FOT variables. An optimal cut-off value for each of the variables was determined as the value that 
gave the best compromise between sensitivity and specificity. Diagnostic statistics, including 
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sensitivity, specificity, predictive values and likelihood ratios, of the variables to detect airway 
obstruction were calculated. Negative predictive values (NPV) and positive predicted values (PPV) 
and likelihood ratios; the negative likelihood ratio (NLR) and the positive likelihood ratio (PLR) were 
calculated as the following:    
 
NPV= 
Specificity x (1-Prevalence (P)) 
Specificity x (1-P) + (1-Sensitivity) x P 
 
PPV= 
Sensitivity x P 
Sensitivity x P + (1-Specificity) x (1-P) 
 
NLR= 
Probability of a negative test given the presence of disease  
Probability of a negative test given the absence of disease 
 
PLR= 
Probability of a positive test given the presence of disease  
Probability of a positive test given the absence of disease 
 
 
3.6 Summary 
The methodology described in this Chapter has contributed towards the significant development of 
a novel FOT device. This Chapter highlights the unique nature of my PhD studies, which instead of 
applying an established, commercial method with published and easy-to-follow guidelines in 
preschool-aged children, I used a method that required creativity, originality and a tremendous 
amount of work in the background for this thesis to take place. One of the most important messages 
of this Chapter is that despite the inconsistencies in the recruitment strategies between the sites, the 
methodology, including the lung function testing, data collection, quality control, data analysis and 
processing were strictly standardised. The methodology established as a part of this thesis will 
provide the basis for future research in the field of respiratory physiology.   
  
43 
 
Chapter 4  
 
Defining “Healthy” in Preschool-Aged Children for Forced Oscillation 
Technique Reference Equations 
 
4.1 Introduction 
Employing reference ranges that are from a healthy sample and representative of the test population 
is crucial to interpreting lung function measurements. Also important is whether the equipment used 
to develop the reference ranges are compatible with the equipment to be used on the test population. 
This is of particular importance when measuring Zrs using the FOT because it has been previously 
reported there is a systematic bias between different FOT devices 92,93. The consequences of such bias 
could have a significant impact on the clinical interpretation of the FOT measurements. Together, 
these factors make selecting an appropriate reference set from one of the twenty FOT reference data 
sets 85,109,114,116,119,120,124,125,129,140-151 available challenging. Whilst the participant characteristics for 
these FOT reference equations are well characterised, inconsistencies exist in exclusion criteria and 
the definition of “healthy”. This raises the question, how “healthy” does a child have to be for 
inclusion in healthy reference ranges? This same question has previously been addressed in 
spirometry reference ranges in children 5-11 years of age 152. Lum et al. 152, reported that inclusion 
of children usually excluded from normative data (that is born preterm, low-birth weight, prior asthma 
or being mildly symptomatic at the time of measurement) did not substantially alter the overall z-
scores for FEV1 and FVC.   
This study will i) investigate the feasibility of the wave-tube FOT, the gold-standard measurement of 
Zrs in preschool-aged children, ii) establish Zrs reference values and z-scores in preschool-aged 
children, iii) investigate the effect of relaxing the strict exclusion criteria to define “healthy” and its 
effect on the distribution of z-scores and iv) use the outputs from fitting a model to the Zrs spectra to 
derive the resistive parameter R, representing the frequency-independent Newtonian resistance and 
C, characterising compliance of the respiratory system during tidal breathing.  
Methodology for conventional FOT measurements and data analysis are described in Chapter 3. 
This manuscript was published and selected for an editorial in Respirology in August 2017 153. I 
direct the reader to appendix M for the published manuscript. 
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4.2 Results 
 
4.2.1 Study participants 
 
Children 3-6 years of age were recruited as described in section 3.1.1 of the methodology and in 
Figure 4.1. In total, 494 children (mean age 4.30±0.68 years) contributed 587 acceptable FOT 
measurements. Based on the modified ISAAC questionnaire; 59 children were defined as having 
doctor diagnosed asthma, 50 children as current wheezers, whereas 39 children had early-life 
wheeze (wheeze in the past but not in the last 12 months), 32 children were defined as preterm (<37 
weeks gestation) and 66 children had respiratory symptoms within four weeks of the study visit, 
with the remaining 248 children classified as healthy. The anthropometric characteristic of these 
children are described in Table 4.1. As part of the ORChID study protocol Zrs was measured 
annually (between their 3rd and 6th birthday) with 31 children measured twice; 28 measured three 
times and two children were measured four times, all on separate testing occasions 6-12 months 
apart.  
 
The feasibility of the FOT in this cohort of children was 85.5% (670 testing occasions in total). 
When assessing the feasibility by age group, children 3-4 years of age had a marginally lower rate 
of feasibility (85.2%) compared to the older children, 5-6 years of age who had a feasibility of 
88.1%. When examining the 83 children excluded from the data analysis, 35 measurements (42.2%) 
were unable to meet the acceptability criteria, 32 children (38.6%) were unwilling to co-operate for 
FOT measurements and 16 measurements (19.3%) were excluded to an equipment or user error. 
The majority of the measurements excluded due to equipment or user error account for 
measurements made on an earlier prototype of the custom-made FOT device. Although these errors 
account for 19.3% of the excluded data, this was a crucial step in the development of the custom-
made FOT device.  
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Incomplete ISAAC 
n= 23 
Geelong, 
Australia 
Brisbane, 
Australia 
Szeged, 
Hungary 
Children recruited 
n= 599 
FOT measurements attempted 
n= 670 
Absent on testing day 
n= 11 
Not willing to cooperate 
n= 42 
Equipment or user error 
n= 16 
Acceptable FOT 
measurements 
n=587 
Unacceptable or repeatable  
FOT measurements  
n= 35 
Children with acceptable tests 
n= 494 
Healthy children 
n= 248 
Dr Diagnosed Asthma 
n= 59 
Current wheeze 
n= 50 
Early-life wheeze 
n= 39 
Univariate regression 
Preterm birth 
n= 32 
Respiratory symptoms 
n= 66 
Multivariate regression 
Mixed effects model regression 
Predictive value 
Z-scores 
Figure 4.1: Participant (left) and study flow (right) chart. 
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Table 4.1: Demographic and anthropomorphic characteristics of participants with acceptable and repeatable FOT measurements 
 Healthy 
 
Asthma Current wheeze Early-life wheeze Preterm-birth Respiratory 
symptoms 
n 248 59 50 39 32 66 
Gestational 
Age  
(weeks)  
40 
 (39; 40.6) 
39  
(38; 41) 
39.2  
(38; 40.4) 
40 
 (39; 40.2) 
36.1  
(33.5; 37.0) 
 
40  
(39; 40.3) 
Male (n) 
(%) 
126  
(51%) 
33 
(56%) 
33 
(66%) 
20 
(55%) 
15 
(47%) 
36 
(54%) 
Age 
(years) 
4.1 
(4.0;4.7) 
4.2 
(4.0;4.6) 
4.2 
(3.9;4.7) 
4.5 
(3.9;5.1) 
4.3 
(4.0;4.8) 
4.3 
(3.9; 4.7) 
Height  
(cm) 
105.3 
(102.0; 109.9) 
106.8 
(102.8;109.9) 
105.5 
(101.4;110.0) 
108.1* 
(103.0;113.4) 
103.08 
(99.8;107.1) 
105.5 
(101.0;109.5) 
Weight 
(Kg) 
17.2  
(15.8;19.1) 
17.8*  
(16.1;20.0) 
17.2 
(16.0;19.0) 
18.9* 
 (16.5;21.0) 
16.6  
(15.2;17.9) 
17.5  
(16.1;19.0) 
Data presented as median (25th; 75th percentile) values in a study population in which 92% identify as Caucasian. * p<0.05 compared to the 
healthy children. Preterm-birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia. 
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4.2.2 FOT Measurements  
 
None of the raw Zrs FOT variables were normally distributed and data are presented as median 
(25th; 75th percentile) values. The median raw lung function variables are described in Table 4.2. 
Multivariate regression analysis showed that for the traditional approach to defining “healthy”, all 
Zrs variables were significantly associated with height (p<0.001) and not sex, age or weight. To 
account for the children contributing more than one FOT measurement, mixed effect model 
regression analysis was performed and from this the height coefficient and constant calculated and 
the prediction equations for all Zrs variables were determined.  
 
Next, prediction equations for all Zrs variables were determined (Table 4.3) and z-scores calculated 
for each group. The mean (SD) z-scores for R and X in the commonly reported frequency range of 
6-10 Hz as well as R and C are described in Table 4.4. Compared to “healthy” children, the 
asthmatics had significantly different z-scores at R (p=0.049), Rrs6 (p=0.029), Rrs8 (p=0.024), 
Rrs10 (p=0.032), C (p=0.015), Xrs6 (p=0.047) and Xrs10 (p=0.016). Whereas children classified as 
current wheezers were significantly different at Rrs6 (p=0.031), Xrs8 (p=0.011) and Xrs10 
(p=0.013) and children with respiratory symptoms within 4 weeks of the FOT measurements had 
significantly different z-scores at R (p=0.014), Rrs8 (p=0.012) and Rrs10 (p=0.012). 
 
 The lack of significant differences in Zrs z-scores detailed in Table 4.4 between healthy children, 
children with early-life wheeze and those born preterm validated a more inclusive approach to 
defining healthy. By adding the children with early-life wheeze and those born preterm the newly 
defined “healthy” children dataset increased by 71 children. Prediction equations generated based on 
the newly-defined healthy group are described in Table 4.5. The relationship between R and C against 
height for the newly defined “healthy” children are shown in Figure 4.2. Significant differences in 
the mean z-scores between the newly defined healthy children and children with asthma were still 
significant after including children with early-life wheeze and children born preterm to the normative 
healthy dataset (Table 4.6).  
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Table 4.2: Raw resistance and reactance data for children with acceptable and repeatable measurements 
            
 
 
n                       
 
Healthy  
 
Asthma 
 
Current wheeze 
 
Early-life Wheeze 
 
Preterm-birth 
 
Respiratory 
symptoms 
294 70 71 49 32 67 
R   
(hPa.s.L-1) 
8.27 
(7.25; 9.23) 
8.37 
(7.49; 9.81) 
8.52 
(7.57; 9.54) 
7.86 
(7.10; 9.00) 
8.53 
(7.63; 9.87) 
7.79* 
(6.77; 8.95) 
Rrs6 
(hPa.s.L-1) 
9.47 
(8.28;10.61) 
9.71 
(8.94;11.45) 
10.04 
(8.78;11.68) 
9.63 
(7.99;10.78) 
9.99 
(8.94;11.04) 
9.00 
(7.61;10.67) 
Rrs8 
(hPa.s.L-1) 
9.18 
(7.99;10.27) 
9.57* 
(8.52;10.90) 
9.56 
(8.41;10.81) 
8.88 
(7.95;9.98) 
9.05 
(8.50;10.66) 
8.55 
(7.30;9.93) 
Rrs10 
(hPa.s.L-1) 
8.76 
(7.82;9.87) 
9.04 
(8.26;10.48) 
9.13 
(8.22;10.56) 
8.38 
(7.74;9.80) 
8.84 
(8.02;10.23) 
8.24* 
(7.22;9.61) 
Rrs12 
(hPa.s.L-1) 
8.62 
(7.64;9.63) 
8.90 
(8.17;9.97) 
8.83 
(8.03;10.20) 
8.32 
(7.56;9.29) 
8.58 
(8.01;10.03) 
8.06* 
(7.13;9.31) 
Rrs14 
(hPa.s.L-1) 
8.40 
(7.35; 9.42) 
8.47 
(7.69;9.79) 
8.67 
(7.76; 9.83) 
7.84 
(7.26; 9.24) 
8.64 
(7.65; 10.18) 
7.85* 
(6.98; 9.29) 
Rrs16 
(hPa.s.L-1) 
8.18 
(7.20; 9.15) 
8.11 
(7.46; 9.41) 
8.60 
(7.36; 9.44) 
7.71 
(6.88; 8.97) 
8.48 
(7.47; 9.67) 
7.77* 
(6.78;8.92) 
Rrs18 
(hPa.s.L-1) 
7.88 
(6.82; 8.81) 
7.79 
(7.02; 8.77) 
7.89 
(7.15; 9.08) 
7.61 
(6.67; 8.59) 
8.11 
(7.10; 9.17) 
7.49 
(6.40; 8.53) 
Rrs20 
(hPa.s.L-1) 
7.59 
(6.79; 8.58) 
7.46 
(6.88; 8.92) 
7.88 
(6.90; 8.85) 
7.44 
(6.40;8.29) 
7.98 
(7.01; 8.88) 
7.22 
(6.49; 8.46) 
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Rrs22 
(hPa.s.L-1) 
7.40 
(6.50; 8.39) 
7.29 
(6.70; 8.58) 
7.66 
(6.70; 8.54) 
7.43 
(6.10; 8.12) 
7.90 
(6.81; 8.83) 
7.04* 
(6.21; 8.02) 
Rrs24 
(hPa.s.L-1) 
7.29 
(6.41; 8.19) 
7.22 
(6.46; 8.40) 
7.48 
(6.55; 8.32) 
7.35 
(6.09; 7.97) 
7.66 
(6.82; 8.54) 
6.98 
(5.99; 7.94) 
Rrs26 
(hPa.s.L-1) 
7.14 
(6.33; 8.10) 
7.19 
(6.48; 8.27) 
7.29 
(6.50; 8.12) 
7.26 
(6.17; 7.95) 
7.60 
(6.70; 8.39) 
6.87 
(5.97; 7.88) 
       
C 
(hPa.s.ml-1) 
8.031 
(6.59;9.92) 
7.62 
(5.84;8.98) 
7.81 
(5.91;10.80) 
8.47 
(6.52;10.76) 
7.57 
(4.95;9.60) 
7.89 
(6.75;10.55) 
Xrs6 
(hPa.s.L-1) 
-2.92 
(-3.70;-2.35) 
-3.21 
(-4.10; -2.46) 
-3.14* 
(-4.06;-2.51) 
-3.24 
(-3.73;-2.11) 
-3.21 
(-4.70;-2.46) 
-2.83 
(-3.88;-2.30) 
Xrs8 
(hPa.s.L-1) 
-2.24 
(-2.88;-1.71) 
-2.46 
(-3.04;-1.83) 
-2.50* 
(-3.58;-1.89) 
-2.34 
(-3.20;-1.53) 
-2.62* 
(-3.86;-1.89) 
-2.20 
(-3.18;-1.59) 
Xrs10 
(hPa.s.L-1) 
-1.94 
(-2.60;-1.39) 
-2.25* 
(-2.98;-1.55) 
-2.22* 
(-3.33;-1.70) 
-1.96 
(-2.59;-1.20) 
-2.23 
(-3.41;-1.44) 
-1.87 
(-2.54;-1.10) 
Xrs12 
(hPa.s.L-1) 
-1.64 
(-2.20;-1.11) 
-1.89 
(-2.62;-1.22) 
-1.98* 
(-2.94;-1.42) 
-1.61 
(-2.28;--0.99) 
-1.68 
(-3.32;-1.17) 
-1.55 
(-2.18;-0.88) 
Xrs14 
(hPa.s.L-1) 
-1.45 
(-2.07;-0.84) 
-1.77 
(-2.32;-0.77) 
-1.88* 
(-2.86;-1.16) 
-1.60 
(-2.07;-0.88) 
-1.53 
(-2.79;-0.80) 
-1.28 
(-2.22;-0.78) 
Xrs16 
(hPa.s.L-1) 
-1.31 
(-1.92;-0.72) 
-1.63 
(-2.18;-0.60) 
-1.68* 
(-2.70;-0.97) 
-1.34 
(-2.14;-0.66) 
-1.63 
(-2.54;-0.72) 
-1.23* 
(-1.78;-0.68) 
Xrs18 
(hPa.s.L-1) 
-1.06 
(-1.63;-0.52) 
-1.31 
(-1.89;-0.45) 
-1.56* 
(-2.22;-0.76) 
-1.18 
(-1.84;-0.63) 
-1.31 
(-2.33;-0.39) 
-1.09 
(-1.78; -0.45) 
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Xrs20 
(hPa.s.L-1) 
-0.80 
(-1.32;-0.23) 
-0.93 
(-1.60;-0.15) 
-1.33* 
(-2.06;-0.59) 
-0.93 
(-1.63;-0.49) 
-1.06 
(-2.00;-0.27) 
-0.79* 
(-1.45;-0.16) 
Xrs22 
(hPa.s.L-1) 
-0.49 
(-1.00;0.14) 
-0.41 
(-1.26;0.25) 
-0.83* 
(-1.63;-0.39) 
-0.59 
(1.12;-0.21) 
-0.77 
(-1.58;0.45) 
-0.57 
(-1.02;0.16) 
Xrs24 
(hPa.s.L-1) 
-0.16 
(-0.68;0.43) 
-0.16 
(-0.94;0.45) 
-0.52* 
(-1.18;-0.01) 
-0.52 
(-0.92;0.23) 
-0.55 
(-1.11;0.42) 
-0.24 
(-0.87;0.31) 
Xrs26 
(hPa.s.L-1) 
0.22 
(-0.36;0.72) 
0.15 
(-0.50;0.74) 
-0.31* 
(-0.74;0.36) 
-0.59 
(-0.66;0.55) 
-0.43 
(-0.74;0.80) 
0.02 
(-0.56;0.63) 
Raw data (respiratory resistance (Rrs) and reactance (Xrs)) between 6 and 26 Hz are presented as median (25; 75%). R, represents the frequency-
independent Newtonian resistance and C, the compliance of the respiratory system obtained from the R-I-C model fitting.  * p<0.05 for log 
transformed Zrs variables compared to healthy group. Preterm-birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia. 
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Table 4.3: Regression analyses based on the conventional approach to defining healthy 
Transformed 
Zrs variable 
Covariate Regression 
coefficient 
p-value Overall SD 
R 
 (hPa.s.L-1) 
Height 
Constant 
-.00947   
3.11491 
<0.001 
<0.001 
0.174 
Rrs6  
(hPa.s.L-1) 
Height 
Constant 
-.01033  
      3.35013 
<0.001 
<0.001 
0.200 
Rrs8 
 (hPa.s.L-1) 
Height 
Constant 
-.01071 
3.35032 
<0.001 
<0.001 
0.193 
Rrs10  
(hPa.s.L-1) 
Height 
Constant 
-.01093 
3.33591 
<0.001 
<0.001 
0.180 
Rrs12 
 (hPa.s.L-1) 
Height 
Constant 
-.00991 
3.20757 
<0.001 
<0.001 
0.181 
Rrs14 
 (hPa.s.L-1) 
Height 
Constant 
-0.01067 
3.25900 
<0.001 
<0.001 
0.175 
Rrs16 
 (hPa.s.L-1) 
Height 
Constant 
-0.00920 
3.07681 
<0.001 
<0.001 
0.180 
Rrs18  
(hPa.s.L-1) 
Height 
Constant 
-0.00851 
2.95246 
<0.001 
<0.001 
0.183 
Rrs20 
 (hPa.s.L-1) 
Height 
Constant 
-0.00738 
2.81425 
<0.001 
<0.001 
0.182 
Rrs22 
 (hPa.s.L-1) 
Height 
Constant 
0.00145 
0.15515 
<0.001 
<0.001 
0.187 
Rrs24  
(hPa.s.L-1) 
Height 
Constant 
-0.00636 
2.66052 
<0.001 
<0.001 
0.180 
Rrs26 
 (hPa.s.L-1) 
Height 
Constant 
-0.00531 
2.52980 
<0.001 
<0.001 
0.181 
     
C  
(hPa.s.ml-1) 
Height 
Constant 
.020152 
-0.07249 
0.001 
0.780 
0.298 
Xrs6  
(hPa.s.L-1) 
Height 
Constant 
-.01928 
3.13134 
<0.001 
<0.001 
0.323 
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Xrs8  
(hPa.s.L-1) 
Height 
Constant 
-.02312 
3.26307 
<0.001 
<0.001 
0.415 
Xrs10  
(hPa.s.L-1) 
Height 
Constant 
-.03071 
  3.89182 
<0.001 
<0.001 
0.534 
Xrs12 
 (hPa.s.L-1) 
Height 
Constant 
-0.037570 
4.39386 
<0.001 
<0.001 
0.738 
Xrs14  
(hPa.s.L-1) 
Height 
Constant 
-0.03389 
3.75885 
<0.001 
<0.001 
0.932 
Xrs16  
(hPa.s.L-1) 
Height 
Constant 
-0.04056 
4.35691 
<0.001 
<0.001 
0.921 
X18 
 (hPa.s.L-1) 
Height 
Constant 
-0.25729 
2.57203 
0.004 
0.007 
1.065 
Xrs20 
 (hPa.s.L-1) 
Height 
Constant 
-0.02193 
1.91267 
0.024 
0.064 
1.148 
Xrs22  
(hPa.s.L-1) 
Height 
Constant 
-0.00894 
0.31412 
0.347 
0.757 
1.126 
Xrs24  
(hPa.s.L-1) 
Height 
Constant 
-0.01366 
0.62777 
0.157 
0.541 
1.141 
Xrs26 
(hPa.s.L-1) 
Height 
Constant 
-0.01746 
1.09164 
0.048 
0.245 
1.044 
Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the 
frequency-independent Newtonian resistance and C, the compliance of the respiratory system 
obtained from the R-I-C model fitting. 
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Table 4.4: Mean (SD) z-scores calculated for each group using prediction equations obtained using the conventional definition for healthy children 
 Healthy Asthma Current wheeze Early-life 
wheeze 
Preterm-birth Respiratory 
symptoms 
n 294 70 71 49 32 67 
R  
(hPa.s.L-1) 
-0.01 
(1.00) 
0.25*  
(1.02) 
0.15  
(0.92) 
-0.09  
(1.01) 
0.11 
 (0.95) 
-0.35* 
 (1.10) 
Rrs6 
(hPa.s.L-1)   
-0.03 
(1.00) 
0.27* 
 (1.07) 
0.25*  
(0.96) 
0.06  
(1.00) 
0.05  
(0.86) 
-0.30  
(1.14) 
Rrs8   
(hPa.s.L-1) 
-0.03  
(0.99) 
0.27*  
(1.07) 
0.14  
(0.91) 
-0.10  
(0.96) 
0.03  
(0.92) 
-0.38* 
 (1.10) 
Rrs10   
(hPa.s.L-1) 
-0.02  
(0.99) 
0.27* 
 (1.06) 
0.19 
 (0.96) 
-0.08  
(1.01) 
-0.02 
 (0.92) 
-0.37* 
 (1.12) 
       
C  
(hPa.s.ml-1) 
0.03  
(1.00) 
-0.31* 
(1.19) 
-0.21  
(1.21) 
0.06 
 (1.01) 
-0.23 
(1.23) 
0.22  
(0.96) 
Xrs6    
(hPa.s.L-1) 
0.01 
 (1.00) 
-0.26* 
 (1.38) 
-0.32 
 (1.14) 
-0.01  
(1.01) 
-0.37 
 (1.18) 
0.10 
 (1.06) 
Xrs8    
(hPa.s.L-1) 
0.00 
(0.99) 
-0.22 
 (1.17) 
-0.33* 
 (1.01) 
-0.04 
(1.06) 
-0.24  
(1.03) 
0.08 
 (1.02) 
Xrs10 
(hPa.s.L-1) 
0.03  
(0.99) 
-0.30*  
(1.03) 
-0.25*  
(1.01) 
0.00  
(0.98) 
-0.05  
(1.23) 
0.29  
(0.96) 
Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the frequency-independent Newtonian resistance and C, the 
compliance of the respiratory system obtained from the R-I-C model fitting. *significantly different from healthy children p<0.05. Preterm-birth (≤37-
weeks) and none diagnosed with Bronchopulmonary Dysplasia
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Table 4.5: Prediction equations using the inclusive definition of healthy children 
Transformed 
Zrs variable 
Covariate Regression 
coefficient 
p-value Overall SD 
R  
(hPa.s.L-1) 
Height 
Constant 
-.00989 
3.15919 
<0.001 
<0.001 
0.173 
Rrs6 
 (hPa.s.L-1) 
Height 
Constant 
-.01121 
3.44394 
<0.001 
<0.001 
0.197 
Rrs8 
 (hPa.s.L-1) 
Height 
Constant 
-.01085 
  3.36251   
<0.001 
<0.001  
0.190 
Rrs10  
(hPa.s.L-1) 
Height 
Constant 
-.01100 
3.34105 
<0.001 
<0.001 
0.178 
Rrs12 
 (hPa.s.L-1) 
Height 
Constant 
  -.010124 
3.22816 
<0.001 
<0.001 
0.178 
Rrs14  
(hPa.s.L-1) 
Height 
Constant 
  -.01066 
  3.25635 
<0.001 
<0.001 
0.174 
Rrs16 
 (hPa.s.L-1) 
Height 
Constant 
-.009956 
   3.15684 
<0.001 
<0.001 
0.179 
Rrs18 
 (hPa.s.L-1) 
Height 
Constant 
-.00923   
  3.03284 
<0.001 
<0.001 
0.182 
Rrs20 
 (hPa.s.L-1) 
Height 
Constant 
-.00818 
2.90156 
<0.001 
<0.001 
0.181 
Rrs22 
 (hPa.s.L-1) 
Height 
Constant 
-.00739 
2.78829 
<0.001 
<0.001 
0.186 
Rrs24 
 (hPa.s.L-1) 
Height 
Constant 
-.00717 
  2.75144   
<0.001 
<0.001 
0.180 
Rrs26 
 (hPa.s.L-1) 
Height 
Constant 
-.00636 
2.64685 
<0.001 
<0.001 
0.181 
     
C  
(hPa.s.ml-1) 
Height 
Constant 
.02106   
  -.17367 
<0.001 
0.459 
0.306 
Xrs6  
(hPa.s.L-1) 
Height 
Constant 
  -.02093   
3.31771 
<0.001 
<0.001 
0.333 
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Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the 
frequency-independent Newtonian resistance and C, the compliance of the respiratory system 
obtained from the R-I-C model fitting.  
 
 
 
 
 
 
 
 
 
 
Xrs8  
(hPa.s.L-1) 
Height 
Constant 
-.02525 
  3.50211 
<0.001 
<0.001 
0.416 
Xrs10  
(hPa.s.L-1) 
Height 
Constant 
-.03109   
3.94307 
<0.001 
<0.001 
0.519 
Xrs12  
(hPa.s.L-1) 
Height 
Constant 
-.02931   
3.55509   
<0.001 
<0.001 
0.627 
Xrs14  
(hPa.s.L-1) 
Height 
Constant 
-.03174 
3.63406   
<0.001 
<0.001 
0.781 
Xrs16 
 (hPa.s.L-1) 
Height 
Constant 
-.03624   
4.00148   
<0.001 
<0.001 
0.833 
Xrs18 
 (hPa.s.L-1) 
Height 
Constant 
-.03624 
4.00148 
<0.001 
<0.001 
0.833 
Xrs20 
 (hPa.s.L-1) 
Height 
Constant 
-.02172 
2.15665 
0.004 
0.008 
0.943 
Xrs22  
(hPa.s.L-1) 
Height 
Constant 
  -.02108 
  1.8677 
0.008 
0.026 
0.950 
Xrs24 
 (hPa.s.L-1) 
Height 
Constant 
-.03846   
3.48901   
<0.001 
<0.001 
0.994 
Xrs26 
 (hPa.s.L-1) 
Height 
Constant 
-.02527 
1.74426 
0.027 
0.149 
1.179 
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Figure 4.2: Resistance (R) and compliance (C) obtained from the R-I-C model fitting in 
healthy preschool aged children using a more inclusive approach to define healthy. 
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Table 4.5: Mean (SD) z-scores calculated for each group using reference equations obtained 
based on the inclusive definition of healthy children to include those born preterm and those 
with early-life wheeze. 
 Healthy Asthma Current wheeze Respiratory 
symptoms 
n 319 59 50 66 
R  
(hPa.s.L-1) 
0.00 
(1.00) 
0.26* 
(1.03) 
0.15 
(0.92) 
-0.35 
(1.11) 
Rrs6  
(hPa.s.L-1)   
-0.03 
(1.00) 
0.27* 
(1.09) 
0.25* 
(0.97) 
-0.30* 
(1.16) 
Rrs8   
(hPa.s.L-1) 
-0.02 
(1.00) 
0.27* 
(1.07) 
0.14 
(0.91) 
-0.38* 
(1.11) 
Rrs10   
(hPa.s.L-1) 
-0.01 
(1.00) 
0.29* 
(1.07) 
0.20 
(0.97) 
-0.36* 
(1.13) 
     
C  
(hPa.s.ml-1) 
0.03 
(1.00) 
-0.29* 
(1.16) 
-0.18 
(1.18) 
0.23 
(0.94) 
Xrs6 
(hPa.s.L-1) 
0.00 
(1.00) 
-0.22 
(1.35) 
-0.28 
(1.10) 
0.13 
(1.03) 
Xrs8  
(hPa.s.L-1) 
0.00 
(1.00) 
-0.19 
(1.17) 
-0.29* 
(1.00) 
0.12 
(1.01) 
Xrs10 
(hPa.s.L-1) 
-0.04 
(1.04) 
-0.29* 
(1.06) 
-0.24* 
(1.04) 
0.32* 
(0.99) 
Data are presented as mean (SD). Respiratory resistance (Rrs) and reactance (Xrs) between 6 
and 26 Hz and R, represents the frequency-independent Newtonian resistance and C, the 
compliance of the respiratory system obtained from the R-I-C model fitting. *significantly 
different from healthy children, p<0.05. 
 
 
4.3 Study Limitations 
A large component of the data in this study were measured in kindergartens, a setting that 
presents its own unique challenges. One of these challenges is in the recruitment of participants. 
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Rather than face-to-face recruitment, I relied on the managers of each kindergarten to distribute 
the study recruitment packs to families with children within the 3-6-year age range. Although 
the rate of recruitment at each site was approximately 40% of the potential recruits, it may have 
been higher if face-to-face recruitment was possible. Despite this, recruitment in the 
kindergartens allowed for a large number of FOT measurements to be undertaken in a short 
amount of time. Another limitation of this recruitment method was that it was difficult to 
follow-up questionnaire queries that arose. With some queries going unanswered, the health 
status of some participants could not be correctly determined, and as a result, the lung function 
data could not contribute to the final dataset.  
 
The dataset described in this study is from a large sample. While the healthy children 
represent a robust number of children, only 32 children were classified as being born preterm. 
The small number of preterm children in this study is most likely attributed to the BIS and 
ELLF cohort studies who excluded participants born less than 36 and 33 weeks gestation 
respectively. The Brisbane site which recruited the largest number of children for this study, 
included preterm children. This resulted in the relatively late median gestational age of 36.1 
weeks for this group of children. The effect of gestational age is not known, but may 
contribute to the lack of statistical differences in lung function between the healthy children 
and children born preterm. Although the number of children born preterm in this study is 
small our data suggest that children born between 34 and 37-weeks gestational age, could be 
included in normative FOT reference data. Whereas, children born very preterm (<32-weeks) 
should not. As such, two sets of prediction equations have been developed allowing 
comparisons to be made. The first using the traditional definition of healthy and the second, 
the inclusive approach with the early-life wheeze and preterm groups included.  
 
 
4.4 Summary 
This study is the first to investigate the effect a strict exclusion criterion has on the distribution 
of z-scores established for Zrs in preschool-aged children using the gold-standard wave-tube 
technique. The findings support a more inclusive approach to selecting healthy children for 
developing FOT reference equations, without compromising the test performance. As such, I 
believe that the reference equations defined in this study are more representative of the 
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preschool-aged children in which the FOT is measured. It is important to note that the lack of 
statistical significance reported between the conventional FOT outcomes in children born 
preterm and with early-life wheeze compared to healthy children does not imply that the lung 
function between these groups is the same. Rather, it highlights the lack of sensitivity of 
conventional FOT measurements. Whilst obtaining acceptable and repeatable measures of lung 
function in young children can be challenging, this study presents a large sample size, which 
to my knowledge is the largest FOT reference dataset published in preschool-aged children. 
Unique to this study is the inclusion of a modelling approach to calculate R and C, with C a 
more robust parameter more easily understood than Xrs by clinicians.  
This study describes the development of robust reference values using a highly feasible 
technique in preschool-aged children. Despite this, the clinical utility of conventional FOT 
measurements in tracking disease progression remains controversial. Studies employing a 
single-sinusoid signal compared to the conventional multi-frequency signal described in this 
study have reported large within-breath fluctuations in Zrs during tidal breathing. Suggesting, 
that calculating Zrs as an average over several breathing cycles may mask cyclical changes in 
Zrs. These findings may attribute to the limited utility of conventional FOT measurements, 
warranting further investigations into within-breath FOT measurements in young children.   
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Chapter 5  
 
Intrabreath Tracking of Respiratory Mechanics: Normal Values 
and Application in Young Children 
 
5.1 Introduction 
Traditionally, the within-breath changes in R and X have been measured as the mean R and X 
during inspiration and expiration. Inspiratory R measured with the FOT was reported to have 
a stronger correlation with plethysmographic airway resistance compared to expiratory R 
88,128 and was a more sensitive measure of the effect of an intervention 16,103,127,129,131. Whilst 
this technique is more sensitive and specific to interventions, the well-known effects of flow 
and the upper airways are not accounted for when measuring Zrs during normal breathing.   
 
To address this and as described in Chapter 3, our team developed a custom-made FOT 
device. Using a single 10 Hz sinusoid, measurements of the intrabreath tracking (T-FOT) of 
R and X every 0.1 of a second during tidal breathing can be made. The zero-flow points at the 
end of expiration and the end of inspiration can be determined. It is believed at these points 
along the breathing cycle, the variable breathing pattern (flow) seen in preschool-aged 
children and the effect of the upper airways will be minimised, revealing important 
physiological information. Furthermore, the changes in R and X between FRC (end-
expiration, zero flow) and at the end of inspiration (the other zero flow point) reflect the 
volume dependence of R and X during tidal breathing. The changes in R with the tidal 
volume is assumed to be different in the presence of airway obstruction and might be 
important to investigate these measures in wheezy and asthmatic children.  
 
Before the clinical utility of T-FOT measurements in preschool-aged children can be 
investigated measurement guidelines, feasibility and normative T-FOT reference values need 
to be determined. When these parameters are established this will facilitate research into the 
utility of this novel technique in preschool-aged children with respiratory disease. In this 
study I aim to i) assess the feasibility of T-FOT measurements in a large population of 
preschool-aged children in various research settings, ii) develop guidelines for data collection 
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and analysis, iii) characterise the intrabreath changes in R and X in healthy children between 
3 and 6 years of age, iv) establish normal values and z-scores for T-FOT outcome variables 
and v) characterise outcome variables between group differences in T-FOT measurements. 
 
Methodology and data analysis of T-FOT measurements are described in Chapter 3. 
 
This study was submitted to the American Journal of Respiratory and Critical Care Medicine 
in November 2017 and is currently under review. I direct the reader to appendix N to review 
the submitted manuscript. 
 
5.2 Results 
 
5.2.1 Feasibility   
 
Of the 634 children enrolled, T-FOT measurements were not attempted in 38 as they were 
either absent on the day of testing, had an incomplete questionnaire or the child did not 
cooperate in the measurement of height. In the remaining 596 children, a further 79 were 
excluded for reasons outlined in Figure 5.1. Acceptable T-FOT measurements were obtained 
in 517 children, corresponding to a feasibility of 86.7% (517/596), with the highest percentage 
of successful measurements (95%) achieved at the Indianapolis site. All children in the study 
were naïve to the T-FOT test. In the children with acceptable T-FOT measurements, 317 were 
excluded as they did not meet the criteria for ‘healthy’. These children were classified as one 
of five health groups (doctor-diagnosed asthma, current wheeze, early-life wheeze, preterm 
birth or respiratory symptoms) based on criteria outlined in section 3.2 and as described in 
Figure 5.1. Healthy children fulfilled the following four criteria: born term (>37 weeks 
gestation), free of any respiratory symptoms and no respiratory medication use within four 
weeks of the study visit, had never wheezed and no prior doctor-diagnosed asthma. Overall, 
200 healthy children (48.3% male) with a median age of 4.2 (range: 2.2-6.9) years and a median 
height of 105.7 (range: 86.0-130.0) centimetres contributed 240 acceptable and repeatable T-
FOT measurements. Successful T-FOT measurements were obtained in 39 children from 
Indianapolis, 61 children from Geelong and 100 children from Brisbane. In the children 
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recruited for the ORChID study, 13 were measured twice, 12 three times and one child 
contributed four annual sets of measurements (between 3 and 6 years of age). Anthropometric 
characteristics of healthy children with acceptable and repeatable T-FOT measurements are 
described in Table 5.1. The study population was >90% Caucasian.  
 
Table 5.1: Demographic and anthropomorphic characteristics of healthy children from the 
three sites contributing acceptable and repeatable intrabreath FOT measurements. 
Data are presented as median (25th; 75th percentile).
 Brisbane,  
Australia 
 
Geelong,  
Australia 
Indianapolis,  
United States of 
America 
n 100 61 39 
Observations 140 61 39 
Male (n) 
(%) 
66  
(66%) 
28 
(46%) 
22 
(56%) 
Age  
(years) 
4.3 
 (3.7;5.0) 
4.1 
(4.0;4.2) 
4.9 
( 3.8; 5.9) 
Height  
(cm) 
105.5 
(101.1;110.2) 
105.5  
(103.8; 108.3) 
110. 0  
(101.0; 120.0) 
Weight  
(Kg) 
17.6 
 (16.2;19.8) 
16.8  
(15.2; 17.9) 
19.0 
 (16.0; 23.0) 
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Figure 5.1: Participant flow chart 
Consent obtained n=634 
Excluded n=38  
- Absent on day of testing n=7 
- ISAAC questionnaire not completed 
n=18 
- Unable to measure height n= 13 
Acceptable T-FOT measurements n=517 
Healthy respiratory status n=200 
T-FOT testing observations n=240 
Excluded n=79 
- Participant unwilling to co-operate 
n=53 
- T-FOT measurements not 
acceptable n=22 
- Equipment/user error n=4 
Excluded due to respiratory status n= 317 
- Asthma n=60 
- Current wheeze n=64 
- Early-life wheeze n=90 
- Pre-term n=23 
- Respiratory symptoms n =80 
Testing attempted n=596 
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5.2.2 Acceptable T-FOT measurements in healthy children 
 
A median of 12 (8; 17) (25th; 75th percentile) artefact-free cycles per child were included in the 
analysis with a median VT of 272 (229; 355) mL at a breathing frequency (Fbr) of 27 (23; 33) 
min-1. The highest R [10.35 (8.97; 11.91) hPa.s.L-1] corresponded to the maximum flow during 
expiration, whereas R at the end of inspiration represented the lowest R in the breathing cycle 
[7.15 (6.21; 8.33) hPa.s.L-1, Figures 5.2, panel A and 5.3]. These changes were mirrored in X 
with the end of inspiration more negative (lower) than the end of expiration [-1.54 (-2.13; -
1.05) vs -1.04 (-1.64; -0.51) hPa.s.L-1, Figures 5.2, panel B and 5.4]). Within-breath FOT 
studies traditionally report the mean R and X values for the inspiratory and expiratory phases 
of the breath cycle. In this cohort the mean expiratory R was significantly higher [8.75 (7.72; 
10.07) hPa.s.L-1] than the mean inspiratory R [8.04 (7.08; 9.31) hPa.s.L-1, p<0.001]. Whereas, 
the mean X during expiration [-1.82 (-2.68; -1.20) hPa.s.L-1] was slightly lower than the mean 
X in inspiration [-1.76 (-2.39; -1.25) hPa.s.L-1, p<0.28]. The differences in R and X at the end 
of expiration and the end of inspiration, ΔR [0.60 (0.12; 1.00) hPa.s.L-1] and ΔX [0.45 (0.11; 
0.84) hPa.s.L-1] respectively are illustrated in Figure 5.5.   
 
Height was the only significant predictor of the transformed intrabreath R and X variables, with 
weight, age and sex having no significant influence in multivariable models. The raw values 
of the intrabreath lung function variables as functions of height are depicted in Figures 5.3 and 
5.4. Height showed the strongest relationship with resistance at the end of expiration (ReE, 
p<0.001, R2=0.17) and with reactance at the end of inspiration (XeI, p<0.001, R2=0.15), 
measures that were independent of flow. Z-scores were established for all the relevant 
intrabreath measures using the prediction equations described in Table 5.3. None of the 
intrabreath tracking variables were outliers based on a z-score of < -5.0 or >5.0 23. There was 
no difference in the z-scores between the three sites. ΔR and ΔX were independent of height 
(Figure 5.5), weight, age and sex. The ULN and LLN for ΔR and ΔX corresponded to the 95th 
centile and 5th centile respectively 23,138,139. The ULN of ΔR was defined as 1.96 hPa.s.L-1 and 
the LLN for ΔX as -0.54 hPa.s.L-1.  
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Figure 5.2: Intrabreath values of resistance (R), panel A and reactance (X), panel B in healthy children (n=237) measured at 10 Hz. meanE: 
mean expiratory value; meanI: mean inspiratory value, maxE: value at the maximum expiratory flow, maxI: value at the maximum inspiratory 
flow, eE: value at the end of expiration, eI: value at the end of inspiration.
A B
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Figure 5.3: Resistance values (R) measured at 10 Hz as a function of height in preschool-age 
children. Note the differences in the absolute values of R between the graphs. R was the highest 
at the maximum expiratory flow (Rmaxe) while it was the lowest at the end of inspiration (ReI). 
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Figure 5.4: Reactance values (X) measured at 10 Hz as a function of height in preschool-age 
children. Note the differences in the X absolute values between the graphs. X was the lowest 
at the maximum expiratory flow (XmaxE) while it reached its maximum at the end of 
expiration (XeE). 
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Figure 5.5: Volume dependence of resistance (ΔR) and reactance (ΔX) measured at 10 Hz as a function of height in healthy preschool-aged 
children. Both ΔR and ΔX were independent of height. The solid lines represent the upper limit of normal in ΔR or the lower limit of normal in 
ΔX. 
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Table 5.2: Prediction equations for the intrabreath changes in respiratory impedance in 
preschool-aged children. 
Intrabreath lung 
function variable 
Prediction Equation SD 
ReE 3.3296 + (-0.0120* height) 0.1927 
ReI 3.3264 + (-0.0127* height) 0.2021 
Rmax,E 
3.5136 + (-0.0110* height) 0.2072 
Rmin,E 3.2554 + (-0.0124 * height)  0.1978 
Rmax,I 3.3800 + (-0.0108* height) 0.1963 
Rmin,I 3.2550 + (-0.0126* height) 0.1964 
RmeanE 3.3567 + (-0.0111* height) 0.1980 
RmeanI 3.367 + (-0.0120 * height) 0.1899 
XeE -1.909 + (0.0114* height) 0.4483 
XeI -2.8220 + (0.0179 * height) 0.3231 
XmaxE -1.7375 + (0.0111* height) 0.4655 
XminE -2.5352 + (0.1112* height) 0.3653 
XmaxI -2.0392 + (0.0136* height) 0.4150 
XminI -2.8602+ (0.0152* height) 0.2955 
XmeanE -2.2220 + (0.0111* height) 0.3925 
XmeanI -2.6342 + (0.0154* height) 0.3242 
All R variables were transformed by natural logarithm and X variables underwent log 
modulus transformation (sign (T-FOT variable)* natural logarithm (absolute (T-FOT 
variable) +1. All units are hPa.s.L-1. 
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5.2.3 Comparison of T-FOT Outcome Variables between Health Groups 
 
The median value for the T-FOT outcome variables for children with acceptable measurements 
for each health status are outlined in Table 5.4 and the mean z-scores for each health group in 
Table 5.5. Asthmatic children had significantly higher z-scores for all of the R intrabreath 
outcome variables compared to healthy children (ReE p<0.001, RmaxI p=0.003, RmaxE 
p<0.001, RmeanI p=0.004 and RmeanE p<0.001), except for at the end of inspiration 
(p=0.079). Whereas the XmeanE was the only significant outcome variable decreased for the 
X intrabreath measurements (p=0.002). 
 
The mean z-score’s for children with current wheeze were significantly increased, at RmaxE 
(p=0.006), RmeanE and RmeanI (p=0.004 and p=0.042 respectively) with the most significant 
differences corresponding to ReE (p<0.001). Significant differences were detected in all of the 
X intrabreath outcome variables for children with current wheeze (XmaxE P=0.012, XmaxI 
p=0.006, XmeanE p=0.029, XmeanI P=0.018). The difference between these two groups was 
most significant at the end of expiration (p=0.007), while it was not significant at end of 
inspiration (p=0.227).  
 
Mean X z-scores corresponding to the maximum flow during inspiration and expiration were 
significantly lower in children born preterm (p=0.020 and p=0.044 respectively). This was not 
detected in the z-scores of children who were classified as symptomatic or with early-life 
wheeze. Symptomatic children were the only group to have a significantly higher z-score for 
X at the end of inspiration compared to healthy children (p=0.019). The mean z-scores for X 
during inspiration and expiration were the only T-FOT outcome variables in children with 
early-life wheeze to be significantly lower than healthy children (p=0.005 and p<0.001, 
respectively). No significant differences in the R intrabreath z-scores were detected between 
healthy children and children born preterm, with early-life wheeze or those with respiratory 
symptoms within the four weeks prior to testing were detected. 
 
Compared to healthy children, ΔR is significantly increased in asthmatic children (p=0.024), 
current (p<0.001) and early-life wheezers (p=0.001) and in children who were symptomatic at 
the time of testing (p=0.025), but not in children born preterm (p=0.627) (Figure 5.6, panel A). 
In comparison, ΔX is significantly higher in asthmatic children (p=0.018), early-life wheezers 
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(p=0.0168) and children who were symptomatic (p=0.048). No differences were detected in 
ΔX between healthy children, children with current wheeze (p=0.115) and children born 
preterm (p=0.497) (Figure 5.6, panel B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Mean ΔR (panel A) and mean ΔX (panel B) data by health status. * Statistically 
significant from healthy children p<0.05. 
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Table 5.3: Median T-FOT outcome variables by health status. 
 Healthy Asthma Current wheeze Early-life wheeze Preterm-birth Respiratory 
symptoms 
n 200 60 64 90 23 80 
Observations 240 74 76 110 23 81 
ReE 
(hPa.s.L-1) 
7.66 
(6.79;8.93) 
8.24 
(7.10;9.78) 
8.32 
(7.50;9.31) 
7.66 
(6.69;8.89) 
7.87 
(6.60;9.27) 
7.87 
(6.60;9.27) 
ReI 
(hPa.s.L-1) 
7.15 
(6.21;8.33) 
7.28 
(6.65;8.46) 
7.43 
(6.46;8.46) 
6.99 
(5.84;7.90) 
7.05 
(5.97;8.24) 
7.05 
(5.97;8.24) 
ΔR 
(hPa.s.L-1) 
0.60 
(0.12; 1.00) 
0.78 
(0.31;1.36) 
0.85 
(0.33;1.46) 
0.88 
(0.34;1.35) 
0.30 
(-0.23;1.26) 
0.80 
(0.37;1.19) 
RmaxE 
(hPa.s.L-1) 
10.35 
(8.97 11.91) 
10.91 
(9.49;12.70) 
10.87 
(9.50;13.03) 
10.45 
(8.86;11.84) 
10.65 
(8.89;12.71) 
10.65 
(8.89;12.71) 
RmaxI 
(hPa.s.L-1) 
9.13 
(8.16;10.80) 
9.70 
(8.71;11.01) 
9.77 
(8.47;11.13) 
9.04 
(7.96;10.38) 
9.66 
(7.81;10.68) 
9.66 
(7.81;10.68) 
RmeanE 
(hPa.s.L-1) 
8.75 
(7.72;10.07) 
9.44 
(8.16;10.47) 
9.22 
(8.38; 10.89) 
8.73 
(7.56;10.21) 
8.52 
(7.88; 10.19) 
8.80 
(7.66; 10.32) 
RmeanI 
(hPa.s.L-1) 
8.04 
(7.08; 9.31) 
8.22 
(7.53; 9.40) 
8.51 
(7.49; 9.53) 
8.07 
(6.96; 9.28) 
8.13 
(7.52; 9.21) 
8.11 
(6.77; 9.60) 
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XeE 
(hPa.s.L-1) 
-1.04 
(-1.64; -0.51) 
-1.23 
(-2.04; -0.69) 
-1.40 
(-.189; -0.89) 
-1.07 
(-1.77; -0.42) 
-1.54 
(-3.04; -0.72) 
-1.10 
(-1.89; -0.36) 
XeI 
(hPa.s.L-1) 
-1.54 
(-2.13; -1.05) 
-1.46 
(-2.15; -0.94) 
-1.57 
(-2.38; -1.25) 
-1.48 
(-2.06; -1.03) 
-2.04 
(-2.81; -1.31) 
-1.30 
(-2.04; -0.90) 
ΔX 
(hPa.s.L-1) 
0.45 
(0.11; 0.84) 
0.28 
(-0.02; 0.66) 
0.39 
(-0.03; 0.66) 
0.30 
(-0.14;0.73) 
0.39 
(-0.02;1.00) 
-0.28 
(0.04;0.65) 
XmaxE 
(hPa.s.L-1) 
-0.86 
(-1.44; -0.35) 
-0.92 
(-1.59; -0.56) 
-1.12 
(-1.61; -0.66) 
-0.84 
(-1.53; -0.22) 
-1.03 
(-2.17; -0.60) 
-0.78 
(-1.60; -0.18) 
XmaxI 
(hPa.s.L-1) 
-0.92 
(-1.39; -0.44) 
-1.00 
(-1.54; -0.58) 
-1.25 
(-1.64; -0.68) 
-0.93 
(-1.41; -0.34) 
-1.24 
(-2.21; -0.86) 
-0.84 
(-1.49; -0.33) 
XmeanE 
(hPa.s.L-1) 
-1.82 
(-2.68; -1.20) 
-2.36 
(-3.18; -1.56) 
-2.07 
(-3.08; -1.58) 
-1.91 
(-2.92; -1.24) 
-2.33 
(-3.16; -1.25) 
-1.71 
(-2.57; -1.02) 
XmeanI 
(hPa.s.L-1) 
-1.76 
(-2.39; -1.25) 
-1.94 
(-2.59; -1.33) 
-1.99 
(-2.60; -1.41) 
-1.67 
(-2.43; -1.13) 
-2.49 
(-3.12; -1.70) 
-1.76 
(-2.31; -1.08) 
Data are presented as median (25th; 75th percentile). Preterm-birth (≤37-weeks gestational age) and none diagnosed with Bronchopulmonary 
Dysplasia. 
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Table 5.4: Mean z-scores for T-FOT outcome variables for each group using prediction equations as described in Table 5.3. 
 Healthy Asthma Current wheeze Early-life wheeze Preterm-birth Respiratory 
symptoms 
n 200 60 64 90 23 80 
Observations 240 74 76 110 23 81 
ReE 
(hPa.s.L-1) 
-0.01 
 (1.00) 
0.38* 
(1.12) 
0.35*  
(0.92) 
-0.07  
(0.99) 
0.11 
(1.04) 
-0.09 
(1.17) 
ReI 
(hPa.s.L-1) 
-0.02  
(1.00) 
0.22 
 (0.96) 
0.15  
(0.91) 
-0.23  
(0.92) 
0.12  
(0.87) 
-0.23  
(1.09) 
RmaxE 
(hPa.s.L-1) 
-0.10  
(1.01) 
0.42* 
 (1.00) 
0.26* 
(0.94) 
-0.07 
(0.90) 
-0.10  
(0.78) 
-0.00  
(1.01) 
RmaxI 
(hPa.s.L-1) 
-0.03 
(1.00) 
0.35* 
(1.06) 
0.15 
(0.85) 
-0.12 
(0.94) 
0.07 
(0.92) 
-0.12 
(1.09)  
RmeanE 
(hPa.s.L-1) 
-0.02 
 (1.00) 
0.42* 
(0.99) 
0.29* 
(0.90) 
-0.08  
(0.89) 
-0.03  
(0.84) 
-0.05  
(1.07) 
RmeanI 
(hPa.s.L-1) 
-0.03  
(1.00) 
0.33* 
 (1.05) 
0.20* 
(0.86) 
-0.09  
(0.94) 
0.10  
(0.82) 
-0.13  
(1.10) 
 
XeE 
(hPa.s.L-1) 
-0.00 
(1.00) 
-0.22 
(1.11) 
-0.34 * 
(1.09) 
-0.04 
 (1.07) 
-0.39 
(1.27) 
0.13 
(1.22) 
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XeI 
(hPa.s.L-1) 
-0.00 
(-1.00) 
-0.07 
(1.00) 
-0.23 
(0.99) 
0.06 
(0.95) 
-0.39 
(1.07) 
0.30* 
(1.13) 
XmaxE 
(hPa.s.L-1) 
-0.00 
(1.00) 
-0.22 
(1.00) 
-0.32* 
(1.00) 
-0.06 
(1.01) 
-0.43* 
(1.08) 
0.13 
(1.17) 
XmaxI 
(hPa.s.L-1) 
-0.00 
(1.00) 
-0.24 
(1.03) 
-0.35* 
(1.03) 
-0.03 
(1.03) 
-0.46* 
(1.14) 
0.10 
(1.13) 
XmeanE 
(hPa.s.L-1) 
-0.00 
(1.00) 
-0.38* 
(1.10) 
-0.30* 
(1.01) 
-0.09* 
(0.96) 
-0.22 
(1.07) 
0.20 
(1.25) 
XmeanI 
(hPa.s.L-1) 
-0.00 
(1.00) 
-0.28 
(1.05) 
-0.33* 
(1.00) 
-0.02* 
(0.99) 
-0.46* 
(1.17) 
0.14 
(1.18) 
Data are presented as mean (SD). * Significantly different from healthy children, p<0.05. 
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5.2.4 Comparison between the Conventional FOT and T-FOT Outcome 
Variables at Detecting Between Group Differences in Zrs 
 
Based on the z-scores, T-FOT has identified both the early wheezers and the children who were 
born preterm as having lower lung function than healthy children. These between group 
differences were not detected with the conventional FOT (see also in Chapter 4). These results 
suggest an increased sensitivity of T-FOT compared to the conventional technique. In order to 
assess the power of T-FOT and the conventional FOT in identifying children with abnormal 
lung function, the percentage of children above the ULN or below the LLN of the relevant 
outcome measures of both tests were calculated.  
 
Since conventional FOT measurements were also performed in the same children, R and C 
were obtained with model fitting. The percentage of children outside the limit of normal in 
each health was group defined for the T-FOT outcome variables as a ΔR >1.96 hPa.s.L-1 and 
<-0.54 hPa.s.L-1 for ΔX. This corresponded to a z-score of ±1.65 for the R and C conventional 
FOT variables. As detailed in Figure 5.6, ΔR was significantly increased in all health groups 
except the preterm children, corresponding to more children with an abnormal ΔR than R. 
Similarly, ΔX was below the LLN for a higher percentage of children compared with C. 
Furthermore, significant between group differences were detected in children with asthma, 
early-life wheezers and children who were symptomatic when compared to C. C was only 
significantly different in children with asthma, but not the other health groups. These 
comparisons suggest that compared to the conventional FOT outcome variables, T-FOT 
measurements are more sensitive at detecting between group differences in Zrs in preschool-
aged children. 
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Table 5.5: Zrs data above 1.65 z-scores (R and C) and the ULN and LLN (ΔR and ΔX). 
  
Healthy 
 
Asthma 
 
Current 
wheeze 
 
Early-
life 
wheeze 
 
Preterm-
birth 
 
Respiratory 
symptoms 
n 248 59 50 39 32 66 
R  
(hPa.s.L-1) 
4.4% 5.7%* 4.2% 2.0% 6.3% 3.0% 
C 
(hPa.s.mL-1) 
2.0% 4.3%* 4.2% 4.1% 3.1% 9.0% 
 Healthy Asthma Current 
wheeze 
Early-
life 
wheeze 
Preterm-
birth 
Respiratory 
symptoms 
n 200 60 64 90 23 80 
ΔR 
(hPa.s.L-1) 
5% 9.5%* 14.5%* 4.5%* 13.0% 7.4%* 
ΔX 
(hPa.s.L-1) 
5% 12.2%* 9.2% 10.9%* 13.0% 7.4%* 
Percentage (%) of children with a z-score ≥1.65 for R and C and a ΔR ≥ULN (1.96 hPa.s.L-
1) and a ΔX ≤LLN (-0.54 hPa.s.L-1). Note, that 5% of the healthy children had a ΔR  above 
the ULN and ΔX below the LLN because of the way the ULN and LLN were defined (above 
95th or below the 5th percentile, respectively) * Significantly different z-scores (R and C) or 
mean data (ΔR and ΔX) compared to healthy children 
 
5.3 Study Limitations 
Similar to the limitation discussed in the previous Chapter, defining the eligibility criteria of 
the participants included in reference value datasets is imperative to the clinical interpretation 
of lung function data 154,155. In this study, a modified ISAAC questionnaire defined the health 
status of all study participants (except for the Indianapolis site, where only healthy children 
were recruited). Although validated in children across different populations, the ISAAC 
questionnaire relies on parent recall over a 12 month period which has been reported to be 
unreliable 113,156. The uncertainty in the area of early life respiratory events (as a well-known 
limitation of the questionnaires that rely on parent reports) may have influenced the estimation 
of both the upper and lower limit of normal for ΔR and ΔX.  
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Comparisons between the conventional and T-FOT outcome variables described in section 
5.2.4 may be somewhat limited as the two groups compared are not the same. It should be 
noted however that in both datasets health status was determined using the modified ISSAC 
questionnaire and the criteria outlined in section 3.2. Whilst the sample size and number of 
children represented in each health group is comparable, further analysis comparing paired 
conventional and T-FOT measurements from a large cohort of children would strengthen 
these comparisons. 
 
5.4 Summary 
Across multiple sites and in a large cohort of mainly Caucasian children, this study has 
established measurement and analysis guidelines for the intrabreath tracking of Zrs in 
preschool-aged children. The custom-made FOT device described in this study is portable 
and compact facilitating the development of a highly feasible technique that can be employed 
in different settings.  
In Chapter 5, an inclusive approach to defining ‘healthy’ was described for the conventional 
FOT reference values was described. In this Chapter, this inclusive approach to defining 
‘healthy’ was not applied because the intrabreath measurement of Zrs is a novel lung function 
technique developed over the course of this thesis. Firstly, the normal range of the T-FOT 
outcome variables in ‘healthy’ children, based on the traditional definition of healthy need to 
be determined. To further develop this novel technique, it is important to establish if the T-
FOT variables can distinguish healthy children from those with lung disease.  
The T-FOT outcome variables (ΔR and ΔX) detected differences in lung function between 
healthy children and children diagnosed with asthma. This is in agreement with previous 
studies measuring the within-breath Zrs parameters (mean E and I during expiration and 
inspiration, respectively) in healthy children and children with asthma 129,130. Furthermore, 
this study is the first to report the use of T-FOT outcome variables to detect differences in Zrs 
in children with current and early-life wheeze and children who are symptomatic at the time 
of testing or who were born preterm compared to healthy children. Importantly, this study 
investigated the ability of the conventional FOT outcome variables compared to the T-FOT to 
identify children with abnormal lung function based on the z-scores, ULN and LLN defined 
in this study and in Chapter 5. These findings suggest that T-FOT measurements are more 
sensitive at detecting abnormal Zrs compared to the conventional FOT outcome measures in 
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the preschool-aged children described in these studies. These findings, in addition to the 
robust T-FOT references values developed in this study, suggest that measuring the 
intrabreath changes in Zrs may improve the clinical utility of FOT measurements. To address 
this, the utility of T-FOT measurements to detect differences in Zrs between individuals, 
rather than between groups of children needs to be addressed to determine the diagnostic 
power of T-FOT measurements in preschool-aged children. 
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Chapter 6   
 
Tidal Changes in Respiratory Resistance are Sensitive Indicators 
of Airway Obstruction in Children 
 
6.1 Introduction 
Respiratory resistance, reflective of airway calibre is the most common measure of lung 
function in preschool-aged children. However, there are conflicting results when R is 
measured using the conventional FOT to distinguish healthy children from children with 
different wheezing phenotypes 17. Significant between group differences in Zrs variables have 
been reported, while others report no between group differences. When investigating the 
clinical utility of the FOT using receiver operator characteristic analysis, the conventional 
measures of R and X at 6 and 8 Hz are not sensitive or specific enough to have any clinical 
utility in distinguishing preschool-aged children with asthma from those healthy children. 
These studies suggest that conventional FOT measurements are more useful at detecting 
differences between groups rather than following disease progression in an individual, 
limiting the clinical utility of these measurements.  
 
In Chapter 5, the introduction of a novel, highly feasible lung function technique, the T-FOT 
was described in healthy preschool-aged children. The data from this study is working 
towards improving the clinical application of T-FOT measurements. Comparisons between 
the conventional and T-FOT outcome Zrs variables shows that the T-FOT variables are more 
sensitive at detecting differences between healthy children and different health groups. To 
truly improve the clinical utility of these measurements the diagnostic power of the T-FOT 
compared to conventional FOT measurements needs to be determined.  
 
In the present study I will i) examine the utility of the conventional FOT to discriminate 
children with acute wheeze from healthy children, ii) determine which of the T-FOT outcome 
variables are a more sensitive and specific measure of airway obstruction in preschool-aged 
children with acute wheeze, iii) determine the diagnostic power of T-FOT outcome variables 
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in these children and, iv) validate the application of T-FOT measurements in children with 
stable recurrent wheeze. 
 
Methodology and data analysis of T-FOT measurements are described in Chapter 3. 
 
This manuscript was published in Thorax in May 2016. I direct the reader to appendix O for 
the published manuscript. 
 
6.2 Results 
 
6.2.1 Part I- The clinical utility of conventional FOT measurements in 
preschool-aged children with acute wheeze 
 
Preschool-aged children 3-6 years of age presenting to the emergency department at the 
Royal Children’s Hospital, Brisbane with acute wheeze and healthy children from local 
kindergartens in Brisbane were recruited for part I and II of this Chapter. Of the 111 children 
eligible for participation, three children with acute wheeze had received SABA less than one 
hour prior to the FOT measurements and two healthy children were unable to perform lung 
function testing. These five children were excluded from the analysis. Participant flow 
through the study is described in Figure 6.1 and the anthropometric data for the two groups 
are summarised in Table 6.1. 
 
Table 6.1: Anthropometric and tidal breathing data of children (part I and II). 
 Healthy   Acute wheeze  p-value 
Age (year) 4.8 (4.3;5.2) 4.8 (3.9;6.0) 0.93 
Height (cm) 108.3 
(105.9;116.9) 
110.6  
(102.1;118.5) 
0.24 
Weight (kg) 19.0 (16.2;21.1) 20.7 (17.7;23.6) 0.46 
Tidal volume (ml) 289 (232;378) 337 (270;428) 0.15 
Fbr (breath/min) 28 (23;32) 26 (22;34) 0.30 
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Te/Ttot 0.54 (0.52;0.57) 0.57 (0.55;0.59) 0.002* 
Data are presented as median (25th; 75th percentile) values for healthy children (n=75) and 
children with acute wheeze (n=26). Fbr: breathing frequency, Te: time of expiration, Ttot: total 
time of a breathing cycle. *statistically significant difference.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants identified as eligible n=111 
(Children with acute wheeze n=31 healthy 
n=80) 
Eligible participants:  
n=106 
Wheezy n=28 
Healthy n=78 
Excluded n=5 
- Wheezy (n=3): salbutamol administration in 1 h 
prior to the study visit  
- Healthy (n=2): child did not fulfil the healthy 
criteria based on the questionnaire data  
No FOT test n= 5 
- Insufficient cooperation 
FOT test n=101 
Wheezy n=26 
Healthy n=75  
ROC analysis: cut-off 
for airway obstruction: 
ΔR ≥1.42 hPa.s.L
-1
 
Negative test n=69 
Healthy n=67 
Wheezy n=2 
Positive test n=32 
Healthy n=8 
Wheezy n=24 
Figure 6.1: Participant flow through the study 
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Conventional FOT Measurements 
 
The conventional FOT variables (R6, R8, R10, X6, X8 and X10) did not differ between the two 
groups (p=0.54, 0.88, 0.60, 0.72, 0.16 and 0.37, respectively) as assessed with the Wilcoxon 
Rank Sum test. As depicted in Figure 6.2, there was a tendency for the children with acute 
wheeze to have lower lung function, where R was increased and X, more negative. Despite 
these differences, the overlap between the groups, as evident in the large standard deviation 
for the FOT variables, these differences were not statistically significant. In agreement with 
previous studies, the conventional FOT variables had limited clinical utility in preschool-aged 
children.  
frequency (Hz)
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Figure 6.2: Impedance (Zrs) spectra between 6 and 26 Hz obtained in children with acute 
wheeze (open circles) and that in healthy subjects (closed circles). Bars represent standard 
deviation. 
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6.2.2 Part II- Can T-FOT Measurements Improve the Clinical Utility of FOT 
Measurements in Preschool-Aged Children with Acute Airway 
Obstruction? 
 
T-FOT Measurements 
 
The mean values of R during inspiration (RmeanI) and expiration (RmeanE) did not differ 
between the two groups whereas the inspiratory and expiratory mean reactances (XmeanI and 
XmeanE, respectively) were significantly lower in children with acute airway obstruction. The 
changes in the group mean values of R and X during tidal breathing are illustrated in Figure 
6.3. At the end of expiration (eE), R was significantly higher in children with acute airway 
obstruction compared to healthy subjects (p<0.001). By the end of inspiration (eI), R 
decreased, with the difference in R between the groups no longer present (p=0.51). The onset 
of expiratory flow resulted in a fast rise in R in both groups (maxE); however, in children 
with acute airway obstruction R was higher (p=0.02) and remained elevated at the end of 
expiration. The changes in X during tidal breathing mirrored the changes in R, with 
statistically significant differences between the two groups at end- expiration (p<0.001).  
The most significant differences between the two groups were the changes in R and X 
between the beginning and the end of inspiration (ΔR and ΔX respectively), as illustrated by 
typical R and X vs volume and flow loops in Figure 6.4. Children with acute airway 
obstruction exhibited a significantly increased difference in ΔR (Figure 6.4, panel B) 
compared to healthy children (Figure 6.4, panel A; 2.42±1.31 vs 0.61±0.66 hPa.s.L-1, 
p<0.001). This was mirrored in the tidal changes of X (ΔX) which was similar between the 
two groups, but opposite in sign (0.29±1.08 vs -0.40±0.54 hPa.s.L-1, p<0.001). 
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Figure 6.3: Mean values of resistance (R, top) and reactance (X, bottom) in children with 
(open circles) and without acute airway obstruction (closed circles) at the end of expiration 
(eE), maximum inspiratory flow (maxI), end of inspiration (eI) and maximum expiration. 
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Figure 6.4: Tidal changes with volume (panels A and B) and flow (panels D and C) in 
resistance (R, top) and reactance (X, bottom) during inspiration (open circles) and expiration 
(closed circles) in a healthy subject (panels A and C) and in a child with acute wheeze. 
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6.2.3 The Diagnostic Value of Impedance Measures for Detecting Airway 
Obstruction 
 
Unlike the conventional FOT variables, the T-FOT variables were significantly different 
between preschool-aged children with airway obstruction and healthy children. To assess the 
diagnostic value of the T-FOT variables, ROC analysis was performed and is presented in 
Figure 6.5. As described in Table 6.2, the largest area under the curve (AUC) was observed 
for ΔR (0.95) and ΔX (0.79), corresponding to higher values of sensitivity and specificity to 
detect airway obstruction than that of the mean inspiratory or mean expiratory Zrs variables 
(RmeanE: 0.60; RmeanI: 0.60; XmeanE: 0.65 and XmeanI: 0.70; all p<0.0001 vs ΔR).  
 
The optimal detection of airway obstruction was established with a ΔR of ≥1.42 hPa.s.L-1, 
which corresponded to a sensitivity of 92% (75 to 99) and a specificity of 89% (57 to 89) 
with a negative predictive value and a positive predictive value of 97% (90 to 99) and 75 (57 
to 89), respectively, calculated for the prevalence of wheeze in the study population (25.7%; 
26/101 children). As both ΔR and ΔX were independent of height, the cut-off values 
established in this study are generalizable to the preschool population.  
 
6.2.4 Part III- Testing the Application of the Cut-Off Value for Airway 
Obstruction  
 
To test the cut-off value established in Part II of this Chapter, T-FOT was measured in 
healthy children and children with stable recurrent wheeze. Twenty children with recurrent 
wheeze (age: 4.04 ± 0.55 years, height: 101.3 ± 7.4 cm) were recruited along with 23 healthy 
children. Pre and post bronchodilator T-FOT measurements were obtained in all but three 
children with recurrent wheeze.  
 
ΔR and RmeanI were significantly increased at baseline in the wheezy children compared to the 
healthy children. Sixteen of the 20 wheezy children had a baseline ΔR higher than the cut-off 
value defined for airway obstruction in Part II, while ΔR was below the cut-off in 96% of the 
healthy children (22 out of the 23). The difference in ΔR between the groups disappeared 
after the administration of salbutamol (Figure 6.6, p=0.38).  
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Figure 6.5: Receiver operator characteristic (ROC) curves for within-breath resistance (panel A) and reactance measures (panel B). The open 
squares represent the difference between the end-expiratory and end-inspiratory resistance (ΔR) or reactance (ΔX) values; open circles and 
triangles indicate the mean values of the resistance and reactance in expiration (RmeanE, XmeanE) and inspiration (RmeanI, XmeanI), respectively. 
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Table 6.2: Results of the receiver operator characteristic (ROC) analysis for the impedance variables. 
Impedance 
variable 
(hPa.s.L-1) 
Area under 
the curve 
Cut-off 
value 
(hPa.s.L-1) 
Number of cases 
above cut-off value 
(obstructive, healthy) 
Sensitivity 
(%) 
Specificity 
(%) 
Positive 
likelihood 
ratio 
Negative 
likelihood 
ratio 
ΔR 
0.95 (0.90 to 
0.99) 
1.42 24, 8 92 (75 to 99) 89 (80 to 95) 
8.7 (4.5 to 
16.8) 
0.1 (0.02 to 
0.3) 
ΔX 
0.82 (0.71 to 
0.92) 
-0.16 20, 20 77 (56 to 91) 73 (62 to 83) 
2.63 (1.68 to 
4.11) 
0.28 (0.12 to 
0.62) 
RmeanE 
0.60 (0.47 to 
0.73) 
9.07 15, 31 58 (37 to 77) 59 (47 to 70) 
1.4 (0.9 to 
2.1) 
0.7 (0.4 to 
1.2) 
RmeanI 
0.60 (0.47 to 
0.72) 
7.98 17, 30 65 (44 to 83) 60 (48 to 71) 
1.6 (1.1 to 
2.4) 
0.6 (0.3 to 
1.0) 
XmeanE 
0.65 (0.53 to 
0.78) 
-1.99 16, 33 62 (41 to 78) 56 (44 to 68) 
1.4 (0.9 to 
2.1) 
0.7 (0.4 to 
1.2) 
XmeanI 
0.70 (059 to 
0.81 
-2.07 16, 30 62 (41 to 80) 60 (48 to 71) 
1.5 (1.0 to 
2.3) 
0.6 (0.4 to 
1.1) 
Data are presented as value (95% Confidence Interval). Results are reported for 26 children with airway obstruction and 75 healthy children
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Figure 6.6: Individual changes in the volume dependence of ∆R pre and post salbutamol. Symbols and lines represent data in healthy children 
(A) and children with recurrent wheeze (B). The cut-off value for ∆R is indicated by the dashed line. 
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6.2.5 Comparison between the upper limit of normal and the cut-off limit for ΔR 
 
In accordance with the findings of Chapter 5, ∆R and ∆X were independent of sex and anthropometry 
in the smaller cohort of children characterised in this study. Following the approach recommended 
by the Global Lung Initiative 23 the ULN for ΔR and the LLN for ΔX in Chapter 5 were calculated as 
the 95th centile and 5th centile, respectively. This gave higher values for ΔR and lower values for ΔX 
than the cut-off limit’s defined in the present study. In the T-FOT reference data set described in 
Chapter 5, ∆R was above the cut-off limit of 1.42 hPa.s.L-1in 10.8% of the healthy children,  in line 
with the figure of 10.7% observed in this current study.   
 
The cut-off limit for ∆R defined in this study of 1.42 hPa.s.L-1 corresponded to the 89th percentile of 
the data in the T-FOT reference data set and was slightly lower than the ULN calculated for the same 
population. Whilst the introduction of the ULN minimises the false positive cases and increases the 
specificity of ∆R, the cut-off value established in this study is based on a diseased population and was 
calculated as the best compromise between specificity and sensitivity. To investigate the utility of the 
ULN, lung function data from the acutely wheezing children described in this study and from the 
healthy population described in Chapter 5 were compared. The ULN of ∆R (1.96 hPa.s.L-1) defined 
in Chapter 5 corresponded to 95% specificity (as it was calculated as the 95th percentile), but the 
sensitivity of ∆R to detect airway obstruction decreased to 54%. The best compromise between 
sensitivity (92%) and specificity (89%) was 1.43 hPa.s.L-1, confirming the cut-off value in a much 
larger population. The cut-off value of ∆X reported previously in wheezy children (-0.16 hPa.s.L-1) 
corresponds to the 86th percentile in the present population of healthy children.  
 
 
6.3 Study limitations 
The emergency department in a tertiary hospital is a fast paced and stressful environment. 
Recruitment of young children at a time when families are tired and greatly concerned about their 
child’ health presented many challenges to our research team. In addition to this stressful 
environment, children recruited were often extremely tired after minimal sleep, making it difficult 
to engage with the child to obtain acceptable and repeatable FOT measurements. The primary focus 
in the emergency department is the child’s health and it was not possible to withhold medications 
for the purpose of the research described in this Chapter. Therefore, due to the treatment plans 
potential recruits received SABA within the four hours prior to FOT measurements making them 
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ineligible to participate in this study. Another limitation of the study is the small number of children 
with recurrent wheeze, which did not allow us to assess meaningfully the effect of the medication 
use and asthma control on the lung function data.  
 
6.4 Summary 
 
This study is the first to describe the intrabreath changes of respiratory resistance as a highly 
sensitive and specific measure of airway obstruction in preschool-aged children. In comparison, the 
conventional FOT failed to discriminate between the wheezing and healthy preschool-age children. 
The novel measurements of T-FOT demonstrates physiologically and clinically important 
alterations in airway function in preschool-aged children with wheeze. By focusing on the parts of 
the breathing cycle where flow is equal to zero (ΔR), we have established a highly sensitive and 
specific test that is an indicator of airway obstruction in young children. By identifying the optimal 
cut-off limit for detecting of airway obstruction as ΔR ≥1.42 hPa.s.L-1, 80% of children with 
recurrent wheeze were identified as having airway obstruction and 96% of healthy children were 
correctly identified. The assessment of the bronchodilator response in children with stable wheeze 
further validates the clinical application of ΔR in identifying airway obstruction. Overall, this study 
has improved the diagnostic power of the FOT significantly in preschool-aged children. Whilst 
these results represent preschool-aged with wheeze the findings from this study warrant further 
investigation of the within-breath changes of Rrs in other disease groups.   
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Chapter 7  
 
Discussion  
 
 
Measurements of respiratory resistance describe the majority of lung function tests developed 
specifically for preschool-aged children. Of the lung function tests measured in preschool-aged 
children the Forced Oscillation Technique is a non-invasive measurement of respiratory impedance 
requiring minimal co-operation from the child. Despite the availability of commercial FOT 
equipment and the development of ATS/ERS guidelines, for most respiratory laboratories, the FOT 
is not a routine lung function test in clinical practice. This is attributable to factors including the 
complexities surrounding both the application and interpretation of the FOT measurements. 
Furthermore, the diagnostic power of the test is limited with the conventional FOT more useful at 
detecting differences between groups in lung function rather than following disease progression in 
individuals or identifying children with lung disease. To improve the clinical utility of FOT 
measurements in preschool-aged children these factors need to be addressed.  
 
Firstly, I investigated the use of a gold-standard wave-tube FOT device to establish normative 
healthy reference data and z-scores for the conventional FOT outcome measures. To overcome the 
interpretation issues encountered by FOT users, a modelling approach to calculate robust measures 
of resistance and compliance was introduced which will vastly improve the interpretation of the 
conventional FOT measures. Secondly, the introduction of the intrabreath tracking of respiratory 
impedance in healthy children was examined, significantly improving the diagnostic power of FOT 
in young children with airway obstruction. This was achieved by measuring the zero-flow points 
along the breathing cycle, where the effect of flow and the variable breathing pattern encountered in 
young children has minimal effect on the measurement of Zrs. The utility of this novel 
measurement is enhanced by establishing normative reference values for the intrabreath T-FOT 
outcome measures based on a large cohort of healthy preschool-aged children. Importantly, the 
findings support the utility of T-FOT outcome measures that are a more sensitive and specific 
measure of detecting airway obstruction in preschool-aged children, unlike conventional FOT 
measurements.  
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7.1 Conventional FOT measurements 
 
The minimal co-operation required for conventional FOT measurements has seen the development 
of multiple FOT reference equations for young children 85,109,114,116,119,121,124,125,129,140-151. Whilst the 
participants are well-characterised, inconsistencies in the definition of ‘healthy’ and the FOT 
devices measured make selecting reference values for a test population difficult. To date, all 
reference values reported have measured Zrs using commercial FOT devices. With a reported 
systematic bias (Rrs underestimated, Xrs overestimated) 92,93 when compared to the wave-tube 
technique the interpretation of Zrs is influenced. The differences reported were greatest at the Zrs 
range reflective of young children 93. To address this, this study is the first to provide a description 
of healthy reference values for conventional FOT outcomes measured using the gold-standard 
wave-tube technique in children 3-6 years of age. Furthermore, the typically applied strict criteria to 
define ‘healthy’ when developing normative reference data were found to be unnecessary. A more 
inclusive approach to defining ‘healthy’ had no effect on the distribution of conventional FOT z-
scores and increased the reference data set without losing discriminatory power for detecting lung 
disease.  
 
Previous studies have reported limited utility in the conventional FOT in children with wheeze and 
asthma. In our study and in agreement with previous studies 110 we report that the conventional FOT 
outcomes detect group differences in lung function between healthy children and children with 
asthma and current wheeze. These same between group differences in the conventional FOT 
outcomes were not detected in Chapter 6 between healthy children and children with acute wheeze. 
The lack of difference between these two groups is most likely attributed to the smaller group size 
compared to those described in Chapter 4. This is supported by Figure 6.2 where there is a tendency 
for the children with acute wheeze to have lower lung function. With an increased sample size this 
may have been statistically significant. This has highlighted that the between group differences 
detected by the conventional FOT are small and statistically, but not clinically significant because 
of the large overlap of Zrs variables between healthy children and those with lung disease.  
 
With over 60 years of research describing FOT measurements, the interpretation of respiratory 
impedance and more importantly reactance may be one of the factors limiting greater uptake of the 
FOT in clinical practice. Clinicians have an understanding of the concept of resistance. Whereas 
reactance which, by convention has a negative number at lower frequencies can be more 
challenging. This is complicated further when decreases in lung function correlate to a more 
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negative reactance. In an attempt to make conventional FOT measurements more “user friendly” an 
R-I-C model was applied to Zrs data. Reporting compliance, a reflection of the distensability of the 
respiratory system, in addition to normative data and z-scores improves not only the interpretation 
but the generalisability of the conventional FOT measurements in preschool-aged children. 
Compliance is a concept more easily understood than reactance. It should be noted however that X 
does not equate to C and should be treated with caution in the presence of airway obstruction. When 
fitting the hyperbolic model for C, the reactance component of the curve is flatter in appearance 
compared to healthy controls, increasing the model fitting error. Whilst reporting C may help 
improve the application of conventional FOT measurements in preschool-aged children its 
application in children with airway obstruction may be limited. Users of the R-I-C model must 
understand that in airway obstruction, especially in the presence of peripheral inhomogeneity, a 
lower C value does not mean stiffer lungs but rather, an increase in the communication between the 
peripheral airways (so called pendelluft). With this in mind, R-I-C modelling can be applied and C 
can be reported accordingly. It is important to note here that Xrs certainly has the same limitations 
and interpretation problems. Prediction equations for the traditional values for Rrs and Xrs are 
reported at 6, 8 and 10 Hz in addition to the more comprehensive R and C derived from the simple 
R-I-C modelling of respiratory mechanics for both the traditional and inclusive approach to defining 
healthy (Table 4.3and Table 4.5 respectively). This facilitates the utility of the conventional FOT 
outcome measures where Rrs and Xrs are reported at the individual frequencies of interest in 
addition to the mean R and C parameters.  
 
Whilst the clinical utility of conventional FOT measurements have been scrutinised in the literature, 
the findings in this thesis improve both the application and interpretation of respiratory mechanics 
in young children. These measurements in combination with the intrabreath tracking of Zrs describe 
important physiological information about the respiratory mechanics of young children with wheeze 
and asthma.. 
 
7.2 Measurement of the intrabreath tracking FOT 
 
The majority of FOT research has focused on the measurements of Zrs in a wide frequency range, 
with only a small number of studies describing the use of a single-frequency signal. Importantly, 
single-frequency studies have shown that within-breath changes in respiratory impedance occur 
during tidal breathing. This was reported in young children by partitioning the inspiratory and 
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expiratory phases of the breathing cycle. In doing so, not accounting for the effect flow and the 
upper airway geometry exert on the measurement of Zrs. This thesis is the first to describe the 
introduction of the intrabreath tracking of Zrs in preschool-aged children. When applying this 
technique, advances in the computerisation of the measurement allow the phases of the breathing 
cycles to be accurately detected and the whole breathing cycle to be measured point-by-point. 
Together, these factors make this technique unique and different from all other tests previously 
described in the literature to measure Zrs. Calculating the difference in these points, I report the 
introduction of ΔR, a highly sensitive and specific index for detecting airway obstruction in 
preschool-aged children. The diagnostic power of ΔR reported in this thesis is far greater than any 
other lung function index and with the support of the findings reported in this thesis, significantly 
improves the measurement of FOT in young children with airway obstruction.  
 
In accordance with the pioneering work of Davidson et al. 88 and previous studies in children 
16,103,129,130 we found that R and X fluctuate significantly throughout the breathing cycle in 
preschool-aged children in both health and disease. R increases and X decreases with flow in both 
expiration and inspiration; suggesting, the use of averages of R and X from several whole breathing 
cycles masks important information and over-simplifies the description of respiratory mechanics of 
children during tidal breathing. When examining these variables in Chapter 5, it was reported that 
significant differences in the Rmean z-scores during inspiration and expiration were detected 
between healthy children and children with asthma and current wheeze. The same between group 
differences were also detected in the Xmean z-scores as well as in children born preterm. However, 
when assessing the diagnostic power of these variables in children with acute wheeze as described 
in Chapter 6, the diagnostic value of R and X mean during inspiration and expiration to detect 
airway obstruction was weak compared to that reported for ΔR and ΔX (Figure 6.5). From the 
findings reported in this thesis it is suggested that the use of the mean values of R and X further 
limits the understanding of respiratory mechanics in young children with airway obstruction. 
 
The low diagnostic power of the mean R variables is attributed to the large fluctuations in resistance 
which are related primarily to flow changes during tidal breathing, masking changes in the airway 
calibre. Consistent with this, the mean expiratory resistance has been shown to be only weakly 
related to the plethysmographic airway resistance 88 and to be influenced by the flow pattern and 
changes in the glottic aperture 130,133. Although the diagnostic power of the mean R and X within-
breath FOT variables was poor in young children with airway obstruction, reference values and z-
scores are described for these outcome measures. Since most of the current commercial FOT 
 97 
 
devices are able obtain these data, the reference values obtained with the gold-standard method will 
facilitate further investigations into the utility of FOT.  
 
The lung function measurements described in this thesis were undertaken using a custom-made wave-
tube FOT device. The device described is compact and portable, facilitating the measurement of Zrs 
in different research and clinical settings. Developing a lung function test that is portable is crucial to 
the uptake of that test as, in today’s world the clinical environment extends far beyond the hospital 
setting, encompassing respiratory clinics and field work in remote communities. Although the focus 
of the research described in this thesis has been on preschool-aged children with airway obstruction, 
this thesis has laid the ground work in the development of this novel FOT technique. The T-FOT 
reference values established are based on a large, well-characterised healthy preschool-age 
population. The first description of T-FOT reference values or preschool-aged children is a starting 
point for the introduction of these measurements in both the research and clinical setting. Based on 
predominately Caucasian children, the utility of the T-FOT reference values cannot be extrapolated 
to other ethnicities, with further research into the effect of ethnicity on respiratory mechanics 
required.   
 
In support of the hypothesis, the intrabreath tracking of respiratory resistance and reactance is a highly 
sensitive and specific method to detect airway obstruction in young children. T-FOT, like the 
conventional FOT is highly feasible in both clinical and research environments in preschool-aged 
children. In both studies described in Chapters 5 and 6, the clinically most relevant ΔR and ΔX were 
independent of anthropometry and sex. This facilitates the application of the cut-off limit defined for 
airway obstruction to populations with similar demographics beyond the age range of 3-6 years. 
Further to this, defining z-scores for the T-FOT outcome variables provides a bias free interpretation 
of respiratory mechanics. Whilst the cut-off limit and the ULN for ΔR were established from both a 
diseased and healthy population respectively, children with abnormal lung function beyond these 
limits will be encountered. To investigate abnormal lung function, longitudinal FOT measurements 
are recommended together with an in-depth clinical history investigating medication use and 
compliance.  
 
As has been shown, the intrabreath tracking of Zrs in preschool-aged children with airway obstruction 
is a sophisticated measurement of the cyclical changes in Zrs during tidal breathing. T-FOT unveils 
significant physiological information about respiratory mechanics that were previously masked with 
the conventional FOT measurements. Most significant of these is the introduction of the measure of 
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ΔR and ΔX, greatly improving the diagnostic power of FOT in young children with airway 
obstruction.  
 
7.3 Feasibility 
In the time pressure environment of the clinical setting, lung function tests with variable feasibility 
are less likely to be adopted by respiratory laboratories. Unlike other lung function tests but, in 
agreement with the literature the conventional and T-FOT measurements were highly feasible in 
85.5% and 86.7% of children, respectively. The slight increase in the feasibility of the T-FOT may 
be attributed to the testing order. T-FOT was measured after the conventional FOT allowing the 
child to become accustomed to the testing requirements, improving compliance. The feasibility of 
the FOT, unlike spirometry, MBW, sRaw and Rint, was not vastly different between the younger 
and older preschool-aged children or in children naïve to the T-FOT measurements. Whilst different 
cohorts of children are described in Chapters 4 and 5, anthropometry and ethnicity did not differ 
and the size of the groups are comparable. More males then females were represented in the spectral 
healthy cohort compared to the T-FOT dataset (51% vs 48.3%) however; there was no difference in 
the median age (4.1 vs 4.2 years) and height (105.3 vs 105.7cm) between the two FOT reference 
datasets. The feasibility of FOT measurements in preschool-aged children are not affected by the 
introduction of a custom-made FOT device nor additional FOT measurements, improving the 
application of FOT in both the research and clinical settings. 
 
7.4 Future directions 
 
This thesis has improved both the application and interpretation of respiratory mechanics in young 
children with wheeze and asthma. All FOT measurements described were obtained using a gold-
standard wave-tube FOT device. The data presented in this thesis justifies the development of a 
commercial FOT device incorporating the intrabreath tracking of Zrs. Current commercial FOT 
devices can only accommodate conventional FOT measurements, with one device allowing for the 
measurement of the mean R and X during inspiration and expiration. As was demonstrated in 
Chapter 6, these outcome measures are not sensitive or specific enough to improve the clinical 
utility of FOT in preschool-aged children with airway obstruction. As such, a consensus between 
manufactures and clinicians on FOT measurement standards needs to be developed if the 
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application and interpretation of FOT measurements in clinical practice is to be improved beyond 
the findings described in this thesis.  
 
The intrabreath FOT test described has greater potential to measure the longitudinal changes in lung 
function with its capacity to be used in infants, adults 81 and now preschool-aged children. This is 
further supported by the feasibility and improved diagnostic power of the intrabreath tracking, 
warranting investigations of these measurements in an age range beyond the preschool years.  A 
wider range of respiratory impedance will be measured, justifying investigations into how the 
intrabreath tracking and conventional FOT can improve the interpretation of respiratory mechanics.  
 
The application of the cut-off limits defined for detecting airway obstruction in other respiratory 
disease groups have not yet been investigated and if applied should be interpreted with caution. 
Although the utility of the FOT measurements beyond airway obstruction are not clear, the results 
reported in this thesis facilitate future investigations into the intrabreath measurement of Zrs in 
different respiratory disease groups. While conventional FOT measurements are reported to be 
insensitive to detecting underlying disease in young children with CF 157, the intrabreath tracking of 
Zrs may provide a more sensitive measure. It is speculated that the presence of air trapping, an 
indirect marker of small airways disease 158,159 present in over 50% of children with CF by the age 
of six years 160, would be reflected in the measurement of X and ∆X before progressing to reflect 
change in R and ∆R. If this theory is correct, these changes in X should correlate with changes in 
LCI as both will be influences by peripheral ventilation inhomogeneity. However, the measurement 
of T-FOT would be a much quicker in a clinical setting.  
 
 
7.5 Concluding statement 
 
Measuring acceptable and repeatable lung function in preschool-aged children presents a unique set 
of challenges. The physiology of young children is different to older children and adults, meaning 
young children cannot simply be treated as small adults. On top of this, a shorter attention span and 
an inability to follow complex instructions further complicates the task at hand. As W.C Fields so 
famously quoted “to never work with children and animals”, he secretly admired them. While I 
have never had the opportunity to measure lung function in animals, I too admire the challenges of 
measuring lung function in young children. The biggest drive is the potential for lung function tests 
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measured during the preschool years to detect deficits in lung function which may have lifelong 
consequences. Detecting these changes which alter the lungs growth trajectory will work to improve 
the long term health outcomes for these children.  
 
FOT is a highly feasible measurement of respiratory mechanics in young children yet, despite 
significant improvement in both the measurement technique and interpretation of Zrs the clinical 
utility in young children with wheeze or asthma has been limited. This thesis is the first description 
of the novel, intrabreath tracking of Zrs in children 3-6 years of age. Assessment of the tidal, flow-
independent changes in Zrs has resulted in significant improvements in the diagnostic power of the 
FOT in young children with airway obstruction. The ability of this technique to reveal previously 
masked information about the respiratory system suggests a significant number of advantages over 
conventional FOT measurements in this group of children. The application of which is further 
improved through the development of robust reference ranges and z-scores in a large cohort of 
healthy preschool-aged children. Together these findings improve both the measurement and 
interpretation of FOT measurements in young healthy children and children with airway 
obstruction. Importantly though, the potential for this technique to extend beyond the patient groups 
described in this thesis and to improve our understanding of respiratory mechanics in other disease 
groups through future research is facilitated.   
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Chapter 9  
 
Appendices 
 
 
Appendix A 
 
Modified International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire 
 
 
Measurements of Height and Lung Function in Healthy Young Children Questionnaire 
 
Thank-you for your interest in this study and for taking the time to fill out this questionnaire. The aim 
of this questionnaire is to help us better understand your child’s health, medical history and 
environmental exposures.  By answering these questions we will be able to accurately define the 
group of children taking part in this study and better understand our study results. 
 
Because of the type of questions asked, it is best if the questionnaire is completed by the 
parent/guardian of the child taking part in this study. It is okay if you do not know the answer to all 
of the questions asked. If there are any questions which you do not wish to answer, you may choose 
not to provide an answer.  
 
If there is not enough room for you to answer the questions, please continue answering the question 
on page 21 of this questionnaire. 
 
If you have any questions, or want to discuss the questionnaire further please contact our study co-
ordinator: 
 
Name: Claire Shackleton 
Contact number: (07) 3069 7196 
Email: c.shackleton@uq.edu.au 
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In case we need to clarify one of your answers to the questions can you please provide us with your 
email address and postal address. 
 
Relationship between the 
person completing the 
questionnaire and child:  
Child’s name:  
Date of birth:  
Address:  
Suburb:  
Postcode:  
Email:  
 
Section A: Birth Questionnaire 
These questions collect details on your child’s pregnancy and birth. 
It is okay if you do not know the answer to any of the questions asked. Some of the answers to the 
questions can be found in your child’s red Personal Health Record for babies book.  
 
 
 Yes – continue to question 1b. 
 No – continue to question 1b. 
 Do not know 
 
 
 …………………………………….. (for example; 35 weeks) 
 
 
1 Was your child born at full term (more than 37 weeks gestation at birth)? 
1b How many weeks old was your child at birth? 
2 
What was your child’s birth weight and length?  
This information can be found in your child’s red Personal Health Record for babies book. 
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 Child’s weight at birth…………………  kilograms / pounds / grams (please circle) 
 Child’s length at birth………………… centimetres 
   
 
 Yes – continue to question 3b. 
 No – continue to section B: Child Health Questionnaire. 
 Do not know 
 
 
 
 ……………………………………..weeks / months / years (please circle) 
 
Section B: Child Health Questionnaire 
These questions collect details on your child’s current health and medical history. If there are any 
questions which you do not wish to answer, you may choose not to provide an answer. 
 
 
 Yes – continue to question 4b. 
 No – continue to question 5. 
 Do not know 
 
 
 
 
Medical Condition Child’s age at diagnosis 
3 Was your child breast fed from birth? 
3b At what age did your child stop being exclusively breast fed? 
4 Has a doctor ever diagnosed your child with a medical condition?  
4b Please complete the table below.  
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(eg: Cystic Fibrosis) (eg: 3 months of age) 
                                months / years  (please 
circle) 
                                months / years  (please 
circle) 
                                months / years  (please 
circle) 
                                months / years  (please 
circle) 
                                months / years  (please 
circle) 
                                months / years  (please 
circle) 
 
 
 
 Yes – continue to question 5b. 
 No – continue to question 6. 
 Do not know 
 
 
 
 
 
Medical Condition 
(eg: Scoliosis) 
Child’s age at diagnosis 
(eg: 4 years of age) 
5 
Has a doctor ever diagnosed your child with a condition that affects the growth of their bones, 
including the spine? For example scoliosis. 
5b Please complete the table below about the condition affecting your child’s growth. 
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 Yes – continue to questions 6b and 6c. 
 No – continue to question 7. 
 Do not know 
 
 
 …………………………………. months / years (please circle) 
 Do not know 
 
 
 
 Yes – continue to question 6d - 6f. 
 No – continue to question 7. 
 Do not know 
 
 
 1 – 3 times 
 4 – 12 times 
 More than 12 times 
6 Has your child ever had wheezing or whistling in the chest? 
6b At what age did you first notice your child wheezing or whistling? 
6c Has your child had wheezing or whistling in their chest in the past 12 months? 
6d How many times has your child had wheezing or whistling in their chest in the past 12 months? 
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 Never woken with wheezing 
 Less than one night per week 
 One or more nights per week 
 
 
 
 Yes 
 No 
 
 
 Yes – continue to question 7b. 
 No – continue to question 8. 
 Do not know 
 
Age of asthma diagnosis: ………………………………………………………months / years  (please 
circle) 
Please list any asthma medications your child has been prescribed: 
Name of 
medication 
 (eg: ventolin) 
Dose and frequency 
medication is taken 
(eg:1 puff / day) 
Age when medication was 
first commenced 
Has this medication been 
taken in the last 12 
months? 
6e 
In the past 12 months, how often, on average has your child’s sleep been disturbed due to 
wheezing or whistling in their chest? 
6f 
In the past 12 months, has your child’s speech been limited to only one or two words at a time 
due to wheezing? 
7 Has a doctor ever diagnosed your child with asthma? 
7b Please complete the table below about your child’s asthma diagnosis. 
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  ………  months/years 
(please circle) 
 Yes / No (please circle) 
  ………  months/years 
(please circle) 
Yes / No (please circle) 
  ………  months/years 
(please circle) 
Yes / No (please circle) 
  ………  months/years 
(please circle) 
Yes / No (please circle) 
  ………  months/years 
(please circle) 
Yes / No (please circle) 
  ………  months/years 
(please circle) 
Yes / No (please circle) 
 
 
 
 Yes  
 No  
 Do not know 
 
 
 Yes – continue to question 9b. 
 No – continue to question 10.  
 Do not know 
 
8  
In the past 12 months, has your child had a cough at night that was not associated with a cold 
or chest infection? 
9 
Has your child ever been hospitalised for a respiratory condition? 
Please do not include presentations to the emergency department. 
9b  
Please complete the table below, providing details about your child’s admission for a respiratory 
condition.  
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Date of 
admission 
Length of stay Child’s age Reason for hospitalisation 
    
    
    
    
    
    
 
 
 
 Yes – continue to question 10b. 
 No – continue to question 11.  
 Do not know 
 
 
 Yes – continue to question 10c - 10e. 
 No – continue to question 11. 
 Do not know 
 
 
 Yes  
 No  
10  
Has your child ever had a problem with sneezing, or a runny blocked nose when they did not 
have a cold or flu? 
 
10b 
In the past 12 months, has your child had a problem with sneezing, or a runny blocked nose 
when they did not have a cold or flu? 
10c In the past 12 months, has this nose problem been accompanied by itchy watery eyes? 
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 Do not know 
 
 
 
 Not at all 
 A little (once a month) 
 A moderate amount (once a week) 
 A lot (everyday) 
 
 Yes  
 No  
 Do not know 
 
 
 Yes – continue to question 12b. 
 No – continue to question 13. 
 Do not know 
10d Please tick what months of the year this nose problem has occurred in the past 12 months. 
  January   May   September 
  
 
February   June     October 
  
 
March   July   November 
  
 
April   August   December 
10e In the past 12 months, how much did this nose problem interfere with your child’s activities? 
11 Has your child ever had hayfever? 
12 Has your child ever had an itchy rash which was coming and going for at least 6 months? 
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 Yes  
 No  
 Do not know 
 
 
 Yes  
 No  
 Do not know 
 
 
 Yes – continue to question 14b. 
 No – continue to section C: Demographic and Family Health Questionnaire 
 Do not know 
 
 
 Yes – continue to question 14c. 
 No – continue to section C: Demographic and Family Health Questionnaire 
 
 
Condition 
(eg: cough) 
Medication Given 
 
Date medication 
started 
Date medication 
stopped 
12b Has your child had this itchy rash in the past 12 months? 
13 Has a doctor diagnosed your child with eczema? 
14 Has your child had a cough, cold or flu in the past 4 weeks? 
14b Is your child currently taking any medication for a cough, cold or flu? 
14c Please complete the table below. 
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Section C: Demographic and Family Health Questionnaire 
These questions collect details on your family structure and demographic information, such as your 
level of education and the family income.  It also asks questions on the health and medical history 
of other family members. If there are any questions which you do not wish to answer, you may 
choose not to provide an answer. 
 
Questions 15-20 are specific to the child’s biological mother. 
 
 
 Caucasian Australian/American/European/English 
 Aboriginal or Torres Strait Islander 
 Asian 
 Indian 
 Middle Eastern/ Arabic 
 Do not know 
 Other – Please specify: ……………………………………………………………………… 
 
15 
What ethnic group does the child’s mother most identify with?  
Select as many that apply. 
16 What is the highest level of qualification that the child’s mother has completed? 
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 University or other tertiary institute degree 
 TAFE Certificate or Diploma 
 Year 12 (or equivalent in another country) 
 Completed primary school 
 
 
 
 Yes – continue to question 17b. 
 No – continue to question 18. 
 Do not know 
 
Age of asthma diagnosis: ………………………………………………………months / years  (please 
circle) 
How many asthma exacerbations have you had in the past 12 
months?......................................................... 
Do you require medications for your asthma?  Yes / No  (please circle) 
Please list any asthma medications you have needed in the last 12 months: 
Name of medication (eg: 
ventolin) 
Dose and how often medication is taken (eg:1 puff / day) 
  
  
  
  
17 Has the child’s mother ever been diagnosed by a doctor with asthma? 
17b Please complete the table below about your asthma diagnosis. 
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 Yes – continue to questions 18b. 
 No – continue to question 19. 
 Do not know 
 
 
 
Allergy 
(eg: bees) 
Age allergy first experienced 
(eg: 15 years) 
Reaction to allergen 
(eg: rash, breathlessness) 
   
   
   
   
   
   
   
 
 
 
 
18 
Does the child’s mother have any allergies? 
(including but not limited to allergies to food, medication, materials, animal and plants) 
18b Please complete the table below about your allergies. 
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 Yes – continue to questions 19b. 
 No – continue to question 20. 
 Do not know 
 
 
 Yes  
 No  
 
 
 Never smoked - continue to question 21. 
 Ex-smoker. Year you first started smoking…………… 
                    Year you quit smoking……………………… - continue to questions 20b and 20c. 
 Have recently been giving up smoking (smoke-free in the last 6 months) 
       Year you first started smoking…………… - continue to questions 20b and 20c. 
 Current smoker. Year you first started smoking………….. 
       Average number of cigarettes smoked a day………….. - continue to questions 20b and 
20c. 
 Do not know - continue to question 21. 
 
 
 Outside the home only 
 Inside the home only 
 Both inside and outside of the home 
 
19 Has the child’s mother ever been diagnosed by a doctor with allergic rhinitis or hayfever? 
19b Has your allergic rhinitis or hayfever been a problem in the last 12 months? 
20 Please tick which of the following statements best describes the mother’s smoking status. 
20b  When at the family home, where do you smoke cigarettes? 
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 Yes – continue to question 20d. 
 No – continue to question 21. 
 
 
 …………………..average number of cigarettes smoked. 
 
 
 Yes  
 No  
 Do not know 
 
Questions 22-26 are specific to the child’s biological father. 
 
 
 Caucasian Australian/American/European/English 
 Indigenous Aboriginal or Torres Strait Islander 
 Asian 
 Indian 
 Middle Eastern/ Arabic 
 Do not know 
 Other – Please specify: ……………………………………………………………………… 
 
20c  Did you smoke during your pregnancy? 
20d What was the average number of cigarettes smoked during your pregnancy? 
21 
Apart from the biological mother and father, was anyone living in the family home a smoker 
during the pregnancy of the child who is taking part in this study? 
22 
What ethnic group does the child’s father most identify with?  
Select as many that apply. 
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 University or other tertiary institute degree 
 TAFE Certificate or Diploma 
 Year 12 (or equivalent in another country) 
 Completed primary school 
 
 
 
 Yes – continue to question 24b. 
 No – continue to question 25. 
 Do not know 
 
Age of asthma diagnosis: ………………………………………………………months / years  (please 
circle) 
How many asthma exacerbations have you had in the last 12 
months?......................................................... 
Do you require medications for your asthma?  Yes / No  (please circle) 
Please list any asthma medications you have needed in the last 12 months: 
Name of medication (eg: 
ventolin) 
Dose and how often medication is taken (eg:1 puff / day) 
  
  
  
23 What is the highest level of qualification that the child’s father has completed? 
24 Has the child’s father ever been diagnosed by a doctor with asthma? 
24b Please complete the table below about your asthma diagnosis. 
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 Yes – continue to question 25b. 
 No – continue to question 26. 
 Do not know 
 
 
 
Allergy 
(eg: bees) 
Age allergy was first 
experienced 
(eg: 15 years) 
Reaction to allergen 
(eg: rash, breathlessness) 
   
   
   
   
   
   
   
 
 
25 Does the child’s father have any allergies? 
25b Please complete the table below about your allergies. 
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 Yes – continue to question 26b. 
 No – continue to question 27. 
 Do not know 
 
 
 
 
 Yes  
 No  
 
 
 Never smoked - continue to question 28. 
 Ex-smoker. Year you first started smoking…………… 
       Year you quit smoking……………………………… - continue to question 27b. 
 Have recently been giving up smoking (smoke-free in the last 6 months) 
        Year you first started smoking…………………….. - continue to question 27b. 
 Current smoker. Year started smoking………….. 
        Average number of cigarettes smoked a day………….. - continue to question 27b. 
 Do not know - continue to question 28. 
 
 
 Outside the home only 
 Inside the home only 
 Both inside and outside of the home 
26 Has the child’s father ever been diagnosed by a doctor with allergic rhinitis or hayfever? 
26b Has your allergic rhinitis or hayfever been a problem in the last 12 months? 
27 Please tick which of the following statements best describes the father’s smoking status. 
27b  When at home, where do you smoke cigarettes? 
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Questions specific to the biological mother and father of the child are now complete. 
Please continue to question 28. 
 
 
 Zero 
 
(eg: sibling 1) 
Age of sibling 
( 3 months) 
Gender of sibling 
(male) 
Relationship of sibling to the child 
(half-brother) 
    
    
    
    
    
    
    
    
    
    
 
 
 
 
 Less than $25,000 
 $25,000 to $49,999 
28  
How many siblings does your child participating in this study have? If your child has siblings 
please fill out the table below. 
29 
Which income bracket best describes the total combined household income (before tax) in the 
past 12 months? 
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 $50,000 to $74,999 
 $75,000 to $99,999 
 $100,000 to $149,999 
 More than $150,000 
 Do not want to answer 
 
 
 
 
 
The questionnaire is now complete. 
Thank-you for completing this questionnaire.  
Data collected from this questionnaire will allow us to better understand your child’s health 
and environment in relation to their lung function test. 
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Appendix B 
 
Ethical approval from the Children’s Health Services Queensland Human Research Ethics 
Committee for the study entitled ‘Height prediction from ulna length in young children’. 
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Appendix C 
 
Ethical approval from The University of Queensland Institutional Human Research Ethics 
Committee for the study entitled ‘The contribution of wheeze and asthma to airway stiffness 
in children’.  
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Appendix D 
 
Ethical approval from the Hungarian Regional Human Ethics Committee for the study 
entitled ‘Lung function measurements in children with a new Forced Oscillation Technique’. 
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Appendix E 
Inclusions and exclusion criteria questionnaire for the Indianapolis site 
 
Inclusion/Exclusion Criteria  
Study Title:  INCIRCLE: a European Respiratory Society Clinical Research Collaboration to 
improve children’s respiratory health by improving assessment of lung function 
Name of Principal Investigator:  Dr. Stephanie Davis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inclusion Criteria (Answer all questions) 
If the answer to any inclusion criteria is NO, do not enter the subject into the study. 
1. Greater than or equal to 2-12 years at time of enrollment.                                
YES      NO 
2. Informed consent by parent or legal guardian.                                                                         
YES      NO 
3. Ability to comply with study visits and study procedure.                                                         
YES      NO 
Exclusion Criteria (Ans er all questions) 
If the answer to any exclusion criteria is YES, do not enter the subject into the study. 
1. History of prematurity (<37 weeks gestation).     
 YES       NO 
2. Required any ventilator support in neonatal period.     
 YES      NO        
3. Diagnosed with any chronic lung disease (asthma, Cystic Fibrosis, BPD, interstitial lung 
disease), cardiac disease or major congenital abnormality affecting the heart, lungs, or 
airways.   YES      NO 
4. History of neuromuscular, spinal, or bony abnormalities that may affect lung function or 
accurate measurement of height (ex. muscular dystrophy, scoliosis, significant chest wall 
deformities, spina bifida, etc).        
     YES      NO                      
5. More than three (3) wheezy episodes ever, episodes of chronic cough (lasting > 1 
month), wheezing in past year.        
    YES      NO 
6. Physical findings that would compromise the safety of the subject or the quality of the 
study data as determined by the investigator.      
   YES      NO 
Signature and Date of Investigator: 
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Appendix F 
 
Ethics approval from The Indiana University School of Medicine ethics committee for the study 
entitled ‘INCIRCLE: a European Respiratory Society Clinical Research Collaboration to improve 
children’s respiratory health by improving assessment of lung function’.  
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Appendix G 
 
Ethical approval from the Children’s Health Services Queensland Human Research Ethics 
Committee for the project entitled ‘Early Life Lung Function and respiratory healthy study’. 
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Appendix H 
 
Ethical approval from The University of Queensland Institutional Human Research Ethics 
Committee for the study entitled ‘Early Life Lung Function and Respiratory Health Study’.  
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Appendix I 
 
Ethical approval from the Barwon Health Human Ethics Committee for the study entitled ‘ 
BIS-Barwon Infant Study’.  
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Appendix J 
 
Ethical approval from the Children’s Health Services Queensland Human Research Ethics 
Committee for the study entitled ‘Effect of viral wheeze on airway distensibilty assessed via 
the Forced Oscillation Technique’.
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Appendix K 
 
Ethical approval from the Children’s Health Services Queensland Human Research Ethics 
Committee from the study entitled ‘The contribution of wheeze and asthma to airway 
stiffness in children’.  
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Appendix L 
 
Forced Oscillation Technique: Standard Operating Procedure 
 
For the application of the spectral-temporal forced oscillation technique (ST-FOT) in preschool 
children 
 
INTRODUCTION 
DESCRIPTION OF THE ST-FOT EQUIPMENT 
Principle of operation 
The key concept of the forced oscillation technique (FOT) is the superposition of a specially designed, 
small-amplitude external pressure (or flow) excitation on spontaneously breathing, and the 
measurement of the resulting flow (or pressure) response signal of the respiratory system. The FOT 
investigates the mechanical impedance of the respiratory system (Zrs), which is computed at the 
oscillation frequencies by using spectral analysis on the pressure and flow signals (the conventional 
FOT setup) or two pressure signals (the wave-tube FOT arrangement). Zrs has real (resistance, Rrs) 
and imaginary (reactance, Xrs) components, which characterise the dissipative and energy storing 
properties of the respiratory system, respectively. Rrs is the sum of the airway resistance and the 
tissue resistance (including the chest wall), the latter being progressively more significant with 
decreasing oscillation frequency. Xrs is dominated by the elastic properties of the respiratory tissues 
at the lower frequencies (i.e. <10 Hz), whereas the inertial properties (mostly arising from the large 
airways) predominate at frequencies greater than 10-20 Hz depending on patient age. Since the upper 
harmonics of the respiratory signal prohibit obtaining reliable estimates of Zrs, the frequency range 
of oscillations usually starts at frequencies ~10 times higher than the spontaneous breathing rate; this 
corresponds to 2-4 Hz in adults and 4-8 Hz in infants and children. The highest frequencies that are 
meaningful for the mechanics of respiration are limited to 20-40 Hz. 
The present FOT device has 2 modes of operation. The spectral technique (S-FOT) uses multiple-
frequency oscillations and addresses mean Zrs spectra obtained by averaging several breathing 
cycles; these spectra are evaluated in terms of resistance (R), compliance (C) and inertance (I) of the 
respiratory system. In the temporal measurements (T-FOT) a single sinusoidal excitation at a medium 
frequency (e.g. 8 or 16 Hz) is employed to track down the changes in Rrs and Xrs within the 
respiratory cycle, in order to characterise the dynamics of airway impedance in terms of flow (V’) 
and volume (V) dependency. 
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Layout of the equipment 
The measurement setup (Fig. 1) is an implementation of the wave-tube technique, in which the inlet 
(P1) and outlet pressure (P2) are measured for the calculation of the load impedance Zload, according 
to the formula 
𝑍𝑙𝑜𝑎𝑑 =
𝑍0 ∙ 𝑠ℎ(𝛾𝐿)
𝑃1
𝑃2
∙ 𝑇21 − 𝑐ℎ(𝛾𝐿)
 
where Zo and g are the characteristic impedance and the propagation wave number of the wave-tube, 
respectively; these are determined by the tube geometry and the material constants of the resident gas 
and the tube wall. L is the length of the tube and T21 is the transfer function describing the relative 
gain of the two pressure channels. sh and ch denote complex hyperbolic trigonometric functions. 
Zrs is calculated from Zload via the removal of the in-series and parallel impedances of the assembly 
beyond the P2 measurement point. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The oscillatory signal is delivered by a loudspeaker. The wave tube is connected to 
a pneumotachograph recording the breathing signal and a bacterial filter-mouthpiece 
assembly. The breathing tube has a low-impedance pathway for the subject’s breathing but it 
imposes a sufficiently high impedance against the oscillatory signal. 
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TESTING AND RE-CALIBRATION OF THE EQUIPMENT 
Transducer sensitivity and amplifier circuit component values may depend on the ambient 
temperature and also change with time. This requires regular testing of the equiment. To this end, a 
mechanical impedance device (a „lung model”) has been constructed and supplied with each ST-FOT 
setup. The model consist of the arrangement of a mesh screen resistor (approx. 10 hPa.s/L resistance), 
and a plastic tube (10 cm long, 1 cm ID) fitted into a 3-L plastic container. This model mimicks the 
Zrs of a child and thus probes the performance of the setup rigorously.  
The equipment should be tested prior to every measurement session (usually daily). The test consists 
of connecting a physical lung model to the filter/mouthpiece adaptor of the wave tube and performing 
a set of measurements. 
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CHILD PREPARATION 
Prior to visit 
During the recruitment phase, it is useful to provide a sample mouthpiece and noseclip to the child 
which they can play with in order to familiarise them to the ST-FOT equipment.  
It is also necessary to record any medication which the child may be taking as they may be required 
to withhold the use of some medications prior to ST-FOT testing.  
 
Calibration 
Calibration needs to be performed prior to each patient visit. 
1. Open up the NDAQ-INCIRCLE measurement program. Click run. 
2. Make sure the FOT equipment is connected to the computer via the USB cable and that the 
black power cable is also connected to the equipment. And the power switched on. 
3. To perform the calibration click on the     C button. Follow the instructions on the screen. 
4. Insert the stopper at the opening of the wave-tube. 
5. Remove the breathing tube and replace with stopper. 
6. Click OK. Calibration is automatically performed over 10 seconds. 
7. If the calibration passes the measured amplitude for channel 1, 2 and 3 will be displayed and 
will ask “do you accept these data for calibration?” Click Yes. Calibration data will be 
automatically stored. 
8. If the calibration fails, a warning message will appear advising that the amplitude values differ 
by more than 5%. Check equipment set-up and that stoppers are inserted correctly. Re-do 
calibration. 
9. Once calibration is OK, remove stoppers and replace breathing tube. 
10. Click on the      button to open the patient demographics window. 
11. Enter the patient’s study and demographics details.  
 
Setting up the software prior to patient 
1. Spectral FOT measurements are measured first. 
2. To open the spectral settings go to file – open set-up - K:drive – child health research unit – 
preschool review – FOT – software. 
3. Click on the spectral setting.ndq file 
4. Click on        button or spacebar to turn on the loudspeaker. 
5.  Now the equipment is ready to measure spectral FOT.  
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Prior to testing  
 
Test explanation 
It is important to provide both the parent and the child with an explanation of what will happen during 
testing and specifically, what will be required of the child.  
1. Explain the aim of the visit. 
2. Briefly go through the setup and how it works.  
3. Outline to the child what they will have to do. It is important to stress to the child that we 
required spontaneous tidal breathing (“breathing in and out, nice and slowly.”) 
4. Explain the role of the second research staff member who will provide the cheek support.  
 
MEASUREMENTS 
Child position  
1. The child will need to be seated upright with a straight back and their hands placed in their 
lap. Their legs and feet should also be together. 
2. The child’s head and neck must remain in the neutral position when carrying out the FOT 
measurements. In order to do this, it is useful to:  
a. Adjust the height of the chair so that the child is able to reach the mouthpiece without 
having to strain their neck or slouch. 
b. Position the chair directly in front of the FOT setup to prevent any neck rotation.  
c. Place the FOT setup at an appropriate distance away from the child to prevent them 
having to lean forward to reach the mouthpiece.  
3. Instruct the child to bite down halfway up the mouthpiece, and then squeeze their lips tightly 
around it creating a seal. 
a. During testing, it is important that the child  
i. is not blocking the mouthpiece with their tongue – it is recommended that the 
child place their tongue under the rim of the mouthpiece.  
ii. is not making any noise (this includes talking, singing and/or humming) 
iii. does not swallow  
iv. is spontaneously breathing 
 
4. Place the noseclip on the child’s nose. 
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5. A second staff member will be required to provide cheek support to the child. This is done 
by firmly holding the child’s cheeks with the palms and placing the fingers under the child’s 
jaw (providing support to the floor of the mouth) for the duration of the measurement.  
 
 
Spectral-Forced Oscillation Technique measurements 
From the spectral FOT recordings the examiner is able to decide whether the child is following the 
instructions correctly and also the obvious artefacts (e.g. leak) are more noticable. Therefore the 
spectral measurements are always performed prior to the temporal-FOT. 
The spectral-FOT measurement screen is divided into several different sections. On the left hand side 
of the screen is the real-time display of pressure transducer 1 (channel 1), pressure transducer 2 
(channel 2) and the flow (channel 3) against time (seconds). On the right hand side of the screen is 
the real-time measurement of the respiratory resistance (red line) and the respiratory reactance (blue 
line) against frequency (4-26 Hz).  
1. The child is seated with their mouth tightly sealed around the mouthpiece, nose-clip on and 
their cheeks and floor of the mouth firmly supported.  
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2. To commence the spectral-FOT measurement select the play        button or press the space 
bar to view the tidal breathing trace.      
3. Observe the flow and volume tracing to confirm that the child has established a stable tidal 
breathing pattern (no more than 2 breaths). As the child is performing tidal breathing the flow 
and volume tracing as well as the scale on the real-time respiratory impedance screen can be 
auto scaled by pressing Tab on the keyboard. 
4. To display the integrated volume right click on channel 3 and select intergrate. 
5. Once a stable tidal breathing pattern is obtained start recording the measurement with the 
record       button or  by pressing the space bar. The flow and volume trace will turn red to 
indicate the measurement is being recorded. 
6. During the measurement encourage the child to perform normal tidal breathing. The real-time 
measurement of the respiratory resistance and reactance is displayed in the right hand side of 
the screen. Here you can observe how the respiratory resistance and reactance change during 
tidal breathing. 
7. A technically acceptable spectral-FOT measurement should be free of any artefact including 
noise, swallow, leak around the mouthpiece, glottis closure or movement. During the 
measurement observation of the flow and volume trace and also the real-time display of the 
respiratory impedance as well as watching the  child will minimise potential artefacts or 
abnormal tidal breathing patterns.  
8. Once a spectral-FOT measurement is complete the measurement is automatically saved. 
Check that the file name and location of where the data will be saved is correct. 
9. Between measurements ask the child to take their mouth off the mouthpiece and remove the 
noseclip. During this rest time leave the loudspeaker on by pressing the space bar, flushing 
the dead space of the set-up.  
10. Ensure that the entire spectral measurement is displayed in the flow and volume tracing. To 
do this double click on the flow and volume tracing to include the entire spectral-FOT tracing. 
11. If the operator is satisfied the spectral-FOT measurement is technically acceptable and free 
from artefact add the measurement to the stored impedance screen by clicking on the Z+ 
button. The stored impedance screen displays all spectral-FOT measurements to be analysed. 
12. To undertake another spectral-FOT measurement, complete steps 2-11. 
13. A minimum of three technically acceptable spectral measurements need to be performed by 
the child. In order to achieve this, up to 8 measurements may be required. 
14. All technically acceptable spectral-FOT measurements will be displayed in the stored 
impedance screen.  
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15. Press F5 to observe the measurements on full screen. 
 
 
16. Once a minimum of three technically acceptable and repeatable spectral-FOT measurements 
have been measured, temporal-FOT measurements can be performed.  
Temporal Forced Oscillation Technique measurements 
1. To open the temporal settings go to file – open set-up - K:drive – child health research unit – 
preschool review – FOT – software. 
2. Select the temporal setting.ndq file. 
3. The previous spectral measurements will still be displayed in the stored impedance screen. 
They can be removed by clicking on the scissors icon. 
4. To commence the temporal-FOT measurement select the play       button or pressing the space 
bar.      
5. Observe the flow and volume tracing to confirm that the child has established a stable tidal 
breathing pattern. As the child is performing tidal breathing the flow and volume tracing as 
well as the scale on the real-time respiratory impedance screen can be auto scaled by pressing 
Tab on the keyboard. 
6. Once a stable tidal breathing pattern is obtained start recording the measurement with the 
record       button or  by pressing the space bar. The flow and volume trace will turn red to 
indicate the measurement is being recorded. 
7. During the measurement encourage the child to perform normal tidal breathing . The real-
time within breath tracking of the respiratory resistance and reactance is displayed above the 
flow and volume recording. 
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8. A technically acceptable temporal-FOT measurement should containe at least 3 stady state 
breaths which are free of any artefact including noise, swallow, leak around the mouthpiece, 
glottis closure or movement . The stady state means that these 3 breaths have the same tidal 
volume and the same level of impedance.  
9. During the measurement observation of the flow and volume trace and also the real-time 
display of the respiratory impedance as well as watching the child will minimise potential 
artefacts or abnormal tidal breathing patterns.  
10. A technically acceptable temporal-FOT measurement will display a normal tidal breathing 
pattern free of any artefact and abnormal breaths. 
11. Once a temporal-FOT measurement is complete the measurement is automatically saved.  
12. Between measurements ask the child to take their mouth off the mouthpiece and remove the 
noseclips. During this rest time leave the loudspeaker on by pressing the space bar, flushing 
the dead space of the set-up.  
13. Ensure that the entire temporal measurement is displayed in the flow and volume tracing. To 
do this double click on the flow and volume tracing to include the entire temporal-FOT 
tracing. 
14. To undertake another temporal-FOT measurement, complete steps 2-9. 
15.  A minimum of three technically acceptable temporal measurements need to be performed by 
the child. In order to achieve this, up to 8 measurements may be required. 
16. Once a minimum of three technically acceptable and repeatable temporal-FOT measurements 
are obtained testing is complete. 
During testing (both spectral and temporal measurements) 
During the measurement observation of the flow and volume trace and also the real-time display of 
the respiratory impedance as well as watching the  child will minimise potential artefacts or abnormal 
tidal breathing patterns.  
1. Keep the system running between recordings by pressing the space bar or    the       button to 
flush the dead space within the wave-tube. 
2. Make sure the child is sitting as still as possible. 
3. Ensure that the child is spontaneously breathing. 
a. If the child appears to be holding their breath, then you must remind them to “breathe 
in and out”. 
b. If the child’s breathing frequency and/or tidal volume appears to be unnaturally high 
or low, instruct the child to breathe quietly. 
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Appendix M 
 
Manuscript entitled ‘Defining “healthy” in preschool-aged children for forced oscillation technique 
reference equations”. Accepted for publication in Respirology August 2017 and discussed in 
Chapter 4. 
 
Link to manuscript: 
http://onlinelibrary.wiley.com/doi/10.1111/resp.13186/abstract;jsessionid=333FA67C38B99961243
94ECE7FF5494D.f04t04 
 
Claire Shackleton1, Dorottya Czovek1, Keith Grimwood2,3, Robert S. Ware2, Bence Radics4, Zoltan 
Hantos1,4 and Peter D Sly1 
1 Children’s Lung Environment and Asthma Research, Child Health Research Centre, The 
University of Queensland, Brisbane, Australia 
2 School of Medicine and Menzies Health Institute Queensland, Griffith University, Gold Coast, 
Australia. 
3 Departments of Infectious Diseases and Paediatrics, Gold Coast Health, Gold Coast, Australia. 
4 Department of Pulmonology, University of Szeged, Deszk, Hungary 
 
 
Summary at a glance 
Normative data for respiratory impedance measured with the forced oscillation technique in 
preschool-aged children use strict criteria to define healthy. Respiratory impedance z-scores in 
preterm-births and early-life wheezers did not differ from healthy children allowing a more 
inclusive approach for reference equations, without losing discriminative power for detecting lung 
disease.  
 
Abstract  
Background and objective: Selecting “healthy” preschool-aged children for reference ranges may 
not be straightforward. Relaxing inclusion criteria for normative data does not affect spirometry z-
scores. We therefore investigated the effect of similarly relaxing inclusion criteria in pre-schoolers 
on reference ranges for respiratory impedance (Zrs) using a modified forced oscillation technique 
(FOT).   
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Methods: The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire 
classified 585 children into a healthy and five mutually exclusive groups. Zrs was measured 
between 4-26 Hz and resistance (R) and compliance (C) obtained by model fitting. Prediction 
models were determined using mixed effect models and z-scores compared between healthy 
children and the five groups. 
 
Results: Zrs data were obtained for 494 participants (4.30±0.7 years) on 587 occasions.  
Comparison of the Zrs z-scores between the healthy children and the health groups found 
significant differences in children with asthma, current wheeze and respiratory symptoms, but not in 
children born preterm or with early-life wheeze. Adding these two groups to the healthy dataset had 
no significant effect on the distribution of z-scores and increased the size of the dataset by 22.3%.   
 
Conclusion: Our data suggest that preschool-aged children born preterm or with early-life wheeze 
can be included in FOT reference equations, while those with asthma, current wheeze and 
respiratory symptoms within 4 weeks of testing should be excluded. This more inclusive approach 
results in more robust FOT reference ranges. 
 
Key words: Child, preschool, healthy subjects and reference values  
Short title: FOT reference equations in preschoolers. 
 
Abbreviations: 
ATS: American Thoracic Society 
BIS: Barwon Infant Study 
BPD: Bronchopulmonary Dysplasia 
C: Compliance 
ERS: European Respiratory Society 
FEV1: Forced Expiratory Volume in one second 
FOT: Forced Oscillation Technique 
FVC: Forced Vital Capacity 
ISAAC: International Study of Asthma and Allergies in Childhood 
ORChID: Observation Research in Childhood Infectious Diseases 
R: Resistance 
Rrs: Respiratory resistance 
Xrs: Reactance 
 159 
 
Zrs: Respiratory impedance 
Introduction 
The respiratory system undergoes significant growth and development during the preschool years1. 
Being able to accurately and reliably measure these physiological changes would benefit the 
diagnosis, treatment and management of children with suspected or known respiratory disease. 
Emphasis should therefore not only be placed on the lung function measurement itself, but also on 
the establishment of reference equations used to define normal lung function2. The unique challenges 
of measuring lung function during the preschool years were addressed previously by developing lung 
function tests and reference values specific to preschool-aged children3. However, many of these lung 
function tests remain in the research setting and not employed routinely in clinical practice3,4 due, in 
part, to challenges in performing the test and interpreting the results. 
 
The forced oscillation technique (FOT) is employed widely in the preschool population as a non-
invasive measure of respiratory impedance (Zrs)3-5 and there are several published reference 
equations specific to this age group6-27.  In general, reference equations are based on data from 
“healthy” children, ideally obtained from an unbiased and representative sample of the population 
where the test is being administered28. Whilst the participant characteristics for FOT reference 
equations are well characterised, inconsistencies exist in exclusion criteria and the definition of 
“healthy”. Children with an asthma diagnosis are excluded from most reference equations8,10,11,14-16,18-
27, while an asthma family history excluded children from six of these equations8,14,15 18,19,21. Other 
inconsistencies in exclusion criteria include the time interval following a respiratory infection8,10-
16,18,19,21,22,24-26, a history of wheeze and preterm-birth24,18,21,25,26. These inconsistencies in exclusion 
criteria (Table 1), between different reference equations highlight the challenges of defining and 
identifying “healthy” preschool-aged children when developing reference equations.  
 
So, how “healthy” does a child have to be for inclusion in reference equations for lung function 
measurements? A previous study examined the influence of exclusion criteria on spirometry z-scores 
in children aged 5-11 years of age29. It found including children normally excluded from normative 
data (born preterm, low-birth weight, prior asthma or being mildly symptomatic at the time of 
measurement) did not substantially alter the overall z-scores for forced expiratory volume in one 
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second (FEV1) and forced vital capacity (FVC).  Adding these children who are typically excluded 
from “healthy” reference equations increased the sample size by 25%. This more inclusive approach 
to defining populations for establishing reference equations allows a more generalizable reference 
set, and is potentially more representative of patients in the clinical setting.  
We therefore investigated whether preschool-aged children with: doctor-diagnosed asthma, early-life 
or current wheeze, preterm-birth, or respiratory infection within 4 weeks of the study visit could be 
included in FOT reference equations developed for preschool-aged children without compromising 
the integrity of the equations. We also used the outputs from fitting a model to the Zrs spectrum to 
derive the resistive parameter R, representing the frequency-independent Newtonian resistance and 
C, characterising compliance of the respiratory system during tidal breathing.  
Methods 
Preschool children, aged 3-6 years from an urban setting were recruited from kindergartens in 
Brisbane, Australia and from community birth cohort studies; the Observational Research in 
Childhood Infectious Diseases study (ORChID), Brisbane, Australia30 and the Barwon Infant Study 
(BIS), Geelong, Australia31. Children were also recruited from a local kindergarten in Szeged, 
Hungary.  To optimise recruitment in kindergartens, parents of all attendees aged 3-6 years received 
recruitment packages (parent information sheet, consent form and a modified International Study of 
Asthma and Allergies (ISAAC) questionnaire32) and were asked to return the completed consent form 
and questionnaire before the study visit. The child’s guardian was not required to be present at the 
study visit. The Children's Health Queensland (HREC/12/QRCH/23), The University of Queensland 
(2014000212), the Barwon Health (10/24) and the Hungarian Regional (107/2015-SZTE) Human 
Ethics Committees approved the study.  
 
Clinical definitions 
 Inclusion criteria for ORChID and BIS included: healthy at birth, without a major congenital 
abnormality or serious illness identified in the first days of life (BIS) and born at >36 weeks 
(ORChID) and >33 weeks (BIS) gestation. Whereas, all children 3-6 years of age from the 
kindergartens were eligible for recruitment, and children diagnosed with a chronic respiratory illness 
other than asthma, a congenital abnormality affecting their ability to stand or a disorder compromising 
lung development were excluded”. “Healthy” children fulfilled the following criteria: born term (≥37 
weeks gestation), free of any respiratory symptoms and no respiratory medication use within 4 weeks 
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of the study visit, had never wheezed and no prior doctor-diagnosed asthma. Children who did not fit 
these criteria were classified into one of five groups; doctor-diagnosed asthma, current wheeze 
(wheeze episodes in the past and the last 12 months), early-life wheeze (wheeze episodes in the past, 
but not in the last 12 months), children born preterm (<37 weeks gestation) and the respiratory 
symptom group (children with upper or lower respiratory infections within 4 weeks of the study visit).  
Classifications were determined from the modified ISAAC and were mutually exclusive with children 
assigned to the most abnormal; e.g. a child born preterm with current wheeze and an asthma diagnosis 
was included in the “asthma” group. 
 
Measurements of Respiratory Impedance 
Respiratory impedance (Zrs) was measured using custom made FOT equipment incorporating a 
wave-tube and a loudspeaker33, in accordance with the ATS/ERS guidelines3. Measurements were 
obtained using a pseudorandom signal between 4 and 26 Hz. Children breathing tidally whilst wearing 
a nose-clip, had their cheeks firmly supported and a tight seal around an antibacterial mouthpiece 
(Bird Healthcare, Melbourne, Victoria, Australia). A minimum of three, 16-second artefact free and 
reproducible measurements were obtained and from these the Zrs spectra were ensemble averaged. 
A resistance (R) - compliance (C) – inertance (I) model was fitted to the averaged Zrs spectra: 
Zrs=R+jωI + (1/jωC), where j is the imaginary unit and ω is angular frequency; R was calculated 
between 10 and 20 Hz from the respiratory resistance (Rrs) data, while C  and I were estimated 
between 6 and 26 Hz from the reactance (Xrs) data34.  
 
Statistical analysis 
Demographic and anthropometric data are presented as median and 25th-75th percentiles. Lung 
function variables were not normally distributed and all Xrs variables were transformed to absolute 
values. To achieve normality all Zrs variables underwent natural logarithmic-transformation prior to 
analysis. Differences in lung function between healthy children and children in other health groups 
were assessed using Student’s t-test. Normative equations were calculated using mixed-effects linear 
regression modelling. Mixed-effects models were used as data points from some children from the 
ORChID Study were included more than once. Initially, successive univarible models with height, 
weight, age and sex were included as the main effect were constructed. Then multivariable models 
were built using combinations of main effects, before the most parsimonious multivariable model 
was selected using the likelihood ratio test. In all models each child was included as a random effect, 
to account for the probable non-independence of observations from the same child. Z-scores were 
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calculated using the equation: Z = (measured- predicted)/ SD, where SD represents the overall 
standard deviation of the model. The influence of adding successively “less healthy” children to the 
data set was determined by recalculating the regression equations and z-scores and comparing the z-
scores between the newly defined healthy children and the children in other health groups to those 
obtained from the original equation. 
 
Results  
494 children (mean age 4.30±0.68 years) provided 587 analysable measurements of lung function; 
31 children were measured twice; 28 measured three times and two children were measured four 
times, all on separate testing occasions. The overall feasibility percentage was 85.5% (670 testing 
occasions in total). Reasons for failure are detailed in Figure 1. Feasibility was marginally lower in 
children aged 3-4 years (85.2%) than 5-6 years of age (88.1%). 
 
Demographic and clinical characteristics of the health groups are summarised in Table 2, and lung 
function is shown in table 3 for the common FOT outcome variables as well as for R and C. The full 
range of Zrs variables are shown in supplementary table S1. Significant differences in lung function 
variables were detected between “healthy” children and children with asthma (Rrs8 p=0.044 and 
Xrs10 p=0.025), children born preterm (Xrs6 p=0.011 and Xrs8 p=0.038), children with current 
wheeze (Xrs6 p=0.046, Xrs8 p= 0.013 and Xrs10 p= 0.004) and in children with respiratory 
symptoms (R p= 0.037 and Rrs10 p=0.046), with the major differences seen in the 6-10Hz range 
(Table 3). 
 
For the traditional approach of defining “healthy”, all Zrs variables were significantly associated with 
height only (p<0.001) (supplementary table S2). Z-scores calculated for each group using this analysis 
are shown for the commonly reported variables in Table 4. Compared to “healthy” children, the 
asthmatics had significantly different z-scores at R (p=0.049), Rrs6 (p=0.029), Rrs8 (p=0.024), Rrs10 
(p=0.032), C (p=0.015), Xrs6 (p=0.047) and Xrs10 (p=0.016). Whereas children classified as current 
wheezers were significantly different at Rrs6 (p=0.031), Xrs8 (p=0.011) and Xrs10 (p=0.013) and 
children with respiratory symptoms within 4 weeks of the FOT measurements had significantly 
different z-scores at R (p=0.014), Rrs8 (p=0.012) and Rrs10 (p=0.012). 
 
 The lack of significant differences in Zrs z-scores detailed in table 4 between healthy children and 
children with early-life wheeze and those born preterm validated a more inclusive approach to 
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defining healthy, increasing the healthy dataset by 71 children. Prediction equations generated based 
on the newly-defined healthy group are provided in supplementary table S3 and the relationship 
between R and C against height in figure 2.  Significant differences in the mean z-scores between the 
newly defined healthy children and children with asthma (R (p=0.042), Rrs6 (p=0.024), Rrs8 
(p=0.016), Rrs10 (p=0.025), C (p=0.035) and Xrs10 (p=0.022)), with current wheeze (Rrs6 
(p=0.031), Xrs8 (p=0.021) and Xrs10 (p=0.019)) and children with respiratory symptoms within 4 
weeks of the FOT measurements (Rrs6 (p=0.041), Rrs8 (p=0.009), Rrs10 (p=0.009) and Xrs10 
(p=0.031)) (supplementary table S4) were still significant after including children with early-life 
wheeze  and children born preterm to the normative healthy dataset.  
 
Discussion 
A more inclusive approach to selecting children for developing FOT reference equations is possible 
without compromising test performance. This more inclusive approach to defining healthy preschool-
aged children had no effect on the healthy group’s FOT z-score distributions or on the ability to 
differentiate healthy children from children with asthma, current wheeze or those with respiratory 
symptoms within 4 weeks of FOT measurements. Combining the Zrs measurements of children with 
early-life wheeze and born preterm with the healthy children together to form a newly-defined healthy 
normative group is more generalizable to the preschool-aged population in which FOT is being 
measured. Despite these children representing a small proportion of the study cohort, their inclusion 
to the normative data set increased the healthy population by 22.3%, which to our knowledge makes 
this FOT reference set the largest published in Caucasian preschool-aged children. 
 
Reference equations have typically applied strict criteria when defining a healthy population. But, as 
our study suggests this strict approach may not be required when establishing normative FOT 
reference data. Currently published FOT reference equations 9,12,14-16,18,20-22,24-26 excluded participants 
with a history of wheeze, whereas our data indicate that this is unnecessary in the preschool age range. 
This more inclusive approach is better reflective of the preschool population where wheeze with or 
without a viral illness is also commonly reported but has shown to be transient with minimal effects 
into older childhood35.  Data from the present study document that including children with wheeze in 
early life, but without wheeze in the past 12-months does not adversely influence the reference 
equations. In many cross-sectional studies, especially in older children, parents may have forgotten 
mild episodes of wheeze in early life. Our data suggest this does not matter. Children born preterm 
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are another group often excluded from FOT normative datasets (Table 1).  Studies undertaking FOT 
measurement’s in children born preterm report reduced lung function compared to healthy children, 
which is independent of a history of bronchopulmonary dysplasia (BPD)36, 37-39. In the present study 
lung function in 32 children born preterm (<37-weeks) was comparable to healthy children. The 
median (25; 75%) gestational age of children born preterm in the present study was 36.1 (33.5; 37.1) 
weeks, whereas the studies reporting worse lung function in children with or without BPD were born 
at a much earlier gestation (<32-weeks). Although the number of children born preterm in this study 
is small our data suggest that children born between 34 and 37-weeks gestational age, should be 
included in normative FOT reference data, whereas children born very preterm (<32-weeks) should 
not. Consideration is also given to respiratory symptoms when selecting healthy children for inclusion 
in reference ranges. Yet establishing an asymptomatic period in preschool-aged children can be 
difficult. Children attending childcare have increased exposure to other children and a greater risk of 
acute respiratory tract infections30,40,41. Interestingly in our cohort children with upper or lower 
respiratory infections had better lung function compared to healthy children. There are many possible 
explanations for this observation, all of which highlight the special requirements for collecting lung 
function data in the field in preschool-aged children. In this study, children were classified as having 
a respiratory infection if symptoms occurred within 4 weeks of the study visit.   These data were 
obtained from a modified version of the ISAAC questionnaire administered before the study visit. 
Time between completing the ISAAC questionnaire and the study visit may have meant respiratory 
symptoms had subsided and medication used during this symptomatic period might have improved 
lung function. 
One of the factors limiting greater uptake of FOT in clinical practice may be the outcome variables 
reported. Clinicians have a concept of resistance, but the reporting of Rrs6, Rrs8 and Rrs10 begs the 
questions “do they provide different information” and “if not, why report three values?” Xrs as a 
concept is more challenging, especially as it has, by convention a negative value at low frequencies. 
Worse lung function is associated with more negative Xrs. In an attempt to make FOT more “user 
friendly”, we included a modelling approach to produce single values for R and C, a concept more 
easily understood as C reflects the distensibilty of the respiratory system. And although C is a robust 
parameter more easily understood than Xrs, it should be treated with caution in the presence of airway 
obstruction. When fitting the hyperbolic model for C, the negative component of the Xrs curve is 
selected and is flatter in appearance compared to healthy controls, increasing the model fitting error. 
In the present study, there is essentially no difference in the clinical message from FOT, whether 
considering the traditionally reported single-frequency values of Rrs6, Rrs8, Rrs10, Xrs6, Xrs8, 
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Xrs10 or the more comprehensive R and C derived from the simple resistance-compliance-inertance 
concept of respiratory mechanics. Accordingly, we have reported normative equations for both sets 
of data allowing comparisons to be made.  
In summary, the data from the present study suggest a more inclusive and realistic approach can be 
taken to define a healthy population when developing FOT reference equations, without losing 
discriminate power for detecting  lung disease.   
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Figure legends: 
Figure 1: Participant flow through study. 
Figure 2: Resistance and compliance in healthy preschool aged children using a more inclusive 
approach to define healthy.  
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 Consent obtained n=599 
FOT testing occasions n=714 
Excluded n=44  
- Absent on day of testing n=11 
- ISAAC questionnaire not completed n=19 
- Incomplete ISAAC questionnaire n=4 
Testing occasions n=670 
- Healthy n=335 
- Asthma n=78 
- Recurrent wheeze n=85 
- Early life wheeze n=53 
Acceptable spectral FOT measurements n=587  
- Healthy n=295  
- Asthma n=70  
- Recurrent wheeze n=71 
- Early life wheeze n=49 
- Pre-term n=35 
Excluded n=83 
- Equipment/user error n=16 
- Participant unwilling to co-operate n=32 
- FOT measurements not acceptable or    
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Table 1: Exclusion criteria for determining the selection of children included in reference equations for FOT adapted from Stanojevic 42. 
 
Reference  
 
Signal and 
frequency 
(Hz) 
 
 
n 
 
Age 
(years) 
 
Exclusion criteria to define “healthy” 
Williams et al 
(1979)7 
Pseudorandom 
15-35 Hz 
16 3-5 Not stated. 
Morgan et al 
(1982)8 
Pseudorandom 
2-15 Hz 
101 3-5 Family or personal history of asthma, respiratory symptoms at testing. 
Duiverman et 
al (1985)9 
Pseudorandom 
2-26 Hz 
255 2-12 Wheeze (present and or past), recurrent cough. 
Hantos et al 
(1985)10 
Pseudorandom  
3-10 Hz 
121 4-16 History of respiratory disease, acute respiratory symptoms at testing. 
Hordvik et al 
(1985)11 
Pseudorandom 
2-26 Hz 
138 2-16 History of chronic or systemic disease affecting the respiratory system, acute 
respiratory symptoms (within 3-weeks of testing), more than incidental smoke 
exposure. 
Solymar et al 
(1985)12 
Single 
frequency  
2,4,12 Hz 
218 2-18 History of recurrent cough, wheeze, pneumonia, cardiac disease, recent 
respiratory infection and cigarette smoke exposure. 
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Lierl and 
Hilman 
(1986)13 
Pseudorandom 
2-26 Hz 
90 4-7 History of respiratory disease, respiratory symptoms at testing. 
Lebecque et al 
(1991)14 
Single 
frequency 
10 Hz 
377 3-18 Prior history of wheeze or use of bronchodilators, chronic cough, exercise 
intolerance, frequent or severe upper respiratory tract infections URTI’s, use of 
cigarettes, major thoracic or cardiac disorders, familial history of asthma, 
respiratory symptoms within 4-weeks of testing. 
Ducharme et 
al (1998)15 
Single 
frequency 
8,12,16 Hz 
200 3-17 Personal or family history of wheeze, asthma, allergic rhinitis or dermatitis, low 
birth weight, preterm-birth (<37-weeks), bronchopulmonary dysplasia, neonatal 
ventilation, active or passive smoke exposure, obesity, upper respiratory tract 
infection, dyspnoea, cough, wheeze, SpO2 <95%. 
Klug et al 
(1998)16 
Square-wave 
5-35 Hz 
121 2-7 Chronic disease, history of recurrent cough, wheeze, severe pneumonia, eczema, 
atopic first degree relatives, significant exposure to tobacco smoke (>3 cigarettes 
a day), respiratory symptoms within 4-weeks of testing. 
Hellinckx et al 
(1998)27 
 Impulse 
5-35 Hz 
247 3-6 A scoring system to define asthma that considered history of wheeze, shortness 
of breath, cough, asthma diagnosis and the use of respiratory medications 
Frei et al 
(2005)18 
Impulse 
5-35 Hz 
222 3-10 Same exclusion criteria as Ducharme et al15. 
Dencker et al 
(2006)19 
Impulse 
5-35 Hz 
360 2-11 Past or present chronic respiratory disease, family history of asthma, respiratory 
symptoms within 2-weeks of testing. 
Hall et al 
(2007)20 
Pseudorandom 
4-48 Hz 
158 2-7 Doctor-diagnosed or parent reported respiratory disease, asthma or wheeze (past 
or present), parent reported cough in last 12-months. 
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Nowowiejska 
et al (2008)21 
Impulse 
5-35 Hz 
626 3-19 Same exclusion criteria as Ducharme et al15. 
Vu et al 
(2008)22 
Single 
frequency 
8 Hz 
175 6-11 History (past and present) of wheeze, acute respiratory symptoms at testing.  
Amra et al 
(2008)23 
Square-wave 
5-25 Hz 
509 5-18 Past or current history of respiratory disease (including asthma), lifelong history 
of smoking 100 or more cigarettes 
Calogero et al 
(2010)25 
Pseudorandom 
4-48 Hz 
163 2-6 Preterm-birth (<36-weeks), supplemental O2 after birth for more than 30 days, 
doctor diagnosed asthma, >3 wheeze episodes ever or wheeze in the past 12- 
months and free of respiratory symptoms and sing at the time of testing.  
Calogero et al 
(2013)24 
Pseudorandom 
4-48 Hz 
760 2-13 Preterm-birth (<36-weeks), supplemental O2 at birth, doctor diagnosed-asthma, 
>3 wheeze episodes ever or wheeze in the past 12- months, respiratory symptoms 
within 3-weeks of testing 
Gochicoa-
Rangel et al 
(2015)26 
Impulse 
5-20 Hz 
283 2-15 Presence of chronic illness including heart, liver kidney and respiratory disease 
(asthma, wheezing and rhinosinusitis). Past history of prematurity, pneumonia, 
bronchiolitis and regular exposure to environmental tobacco smoke or biomass 
smoke. Absence of acute respiratory morbidity within 15 days of testing and 
without suspicion of sleep apnoea/hypopnea or gastroesophageal reflux. 
Age (years) presented as range. 
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Table 2: Demographic and anthropomorphic characteristics of participants with acceptable and repeatable FOT measurements. 
 
 Healthy 
 
Asthma Current wheeze Early-life wheeze Pre term birth Respiratory 
symptoms 
n 248 59 50 39 32 66 
Gestational 
Age  
(weeks)  
40 
 (39; 40.6) 
39  
(38; 41) 
39.2  
(38; 40.4) 
40 
 (39; 40.2) 
36.1  
(33.5; 37.1) 
 
40  
(39; 40.3) 
Male  
(n) 
126 33 33 20 15 36 
Age 
(years) 
4.1 
(4.0;4.7) 
4.2 
(4.0;4.6) 
4.2 
(3.9;4.7) 
4.5 
(3.9;5.1) 
4.3 
(4.0;4.8) 
4.3 
(3.9; 4.7) 
Height  
(cm) 
105.3 
(102.0; 109.9) 
106.8 
(102.8;109.9) 
105.5 
(101.4;110.0) 
108.1* 
(103.0;113.4) 
103.08 
(99.8;107.1) 
105.5 
101.0;109.5) 
Weight 
(Kg) 
17.2  
(15.8;19.1) 
17.8*  
(16.1;20.0) 
17.2 
(16.0;19.0) 
18.9* 
 (16.5;21.0) 
16.6  
(15.2;17.9) 
17.5  
(16.1;19.0) 
Data presented as median (25; 75%) in a study population in which 92% identify as Caucasian. * p<0.05 compared to the healthy children. Preterm-
birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia. 
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Table 3: Zrs outcome variables for 6, 8 and 10Hz for each of the health groups. 
 
 
Healthy Asthma Current 
wheeze 
Early-life 
wheeze 
Pre term birth Respiratory 
symptoms 
n 248 59 50 39 32 66 
R  
(hPa.s.L-1) 
8.27  
(7.25; 9.23) 
8.37 
 (7.49; 9.81) 
8.52   
(7.57; 9.54) 
7.86   
(7.10; 9.00) 
8.53   
(7.63; 9.87) 
7.79* 
(6.77; 8.95) 
       
Rrs6 
(hPa.s.L-1)   
9.47  
(8.28;10.61) 
9.71  
(8.94;11.45) 
10.04  
(8.78;11.68) 
9.63  
(7.99;10.78) 
9.99 
 (8.94;11.04) 
9.00 
(7.61;10.67) 
Rrs8   
(hPa.s.L-1) 
9.18 
 (7.99;10.27) 
9.57*  
(8.52;10.90) 
9.56 
 (8.41;10.81) 
8.88 
 (7.95; 9.98) 
9.05 
(8.50;10.66) 
8.55 
 (7.30;9.93) 
Rrs10   
(hPa.s.L-1) 
8.76  
(7.82;9.87) 
9.04  
(8.26;10.48) 
9.13  
(8.22;10.56) 
8.38 
 (7.74;9.80) 
8.84 
(8.02;10.23) 
8.24* 
(7.22;9.61) 
       
C  
(hPa.s.ml-1) 
8.03 
 (6.59;9.92) 
7.62  
(5.84;8.98) 
7.81 
 (5.91;10.80) 
8.47 
(6.52; 10.76) 
7.57 
 (4.95;9.60) 
7.89  
(6.75;10.55) 
Xrs6    
(hPa.s.L-1) 
 
-2.92 
(-3.70;-2.35) 
-3.21  
(-4.10; -2.46) 
-3.14* 
 (-4.06;-2.51) 
-3.24 
 (-3.73; -2.11) 
-3.21*  
(-4.70;-2.46) 
-2.83  
(-3.88;-2.30) 
Xrs8    
(hPa.s.L-1) 
 
-2.24  
(-2.88;-1.71) 
-2.46  
(-3.04;-1.83) 
 
-2.50* 
 (-3.58;-1.89) 
-2.34 
(-3.20; -1.53) 
-2.62*  
(-3.86;-1.89) 
-2.20  
(-3.18;-1.59) 
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Xrs10 
(hPa.s.L-1) 
 
-1.94  
(-2.60;-1.39) 
-2.25*  
(-2.98;-1.55) 
-2.22* 
 (-3.33;-1.70) 
-1.96  
(-2.59;-1.20) 
-2.23 
 (-3.41;-1.44) 
-1.87 
 (-2.54;-1.10) 
Raw data (respiratory resistance (Rrs) and reactance (Xrs)) between 6 and 26 Hz are presented as median (25; 75%). R, represents the frequency-
independent Newtonian resistance and C, the compliance of the respiratory system obtained from the R-I-C model fitting.  * p<0.05 for log 
transformed Zrs variables compared to healthy group. Preterm-birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia. 
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Table 4: Mean (SD) z-scores calculated for each group using reference equations obtained using the conventional definition for healthy children 
 Healthy Asthma Current wheeze Early-life wheeze Preterm-birth Respiratory 
symptoms 
n 294 70 71 49 32 67 
R  
(hPa.s.L-1) 
-0.01 
(1.00) 
0.25*  
(1.02) 
0.15  
(0.92) 
-0.09  
(1.01) 
0.11 
 (0.95) 
-0.35* 
 (1.10) 
Rrs6 
(hPa.s.L-1)   
-0.03 
(1.00) 
0.27* 
 (1.07) 
0.25*  
(0.96) 
0.06  
(1.00) 
0.05  
(0.86) 
-0.30  
(1.14) 
Rrs8   
(hPa.s.L-1) 
-0.03  
(0.99) 
0.27*  
(1.07) 
0.14  
(0.91) 
-0.10  
(0.96) 
0.03  
(0.92) 
-0.38* 
 (1.10) 
Rrs10   
(hPa.s.L-1) 
-0.02  
(0.99) 
0.27* 
 (1.06) 
0.19 
 (0.96) 
-0.08  
(1.01) 
-0.02 
 (0.92) 
-0.37* 
 (1.12) 
       
C  
(hPa.s.ml-1) 
0.03  
(1.00) 
-0.31* 
(1.19) 
-0.21  
(1.21) 
0.06 
 (1.01) 
-0.23 
(1.23) 
0.22  
(0.96) 
Xrs6    
(hPa.s.L-1) 
0.01 
 (1.00) 
-0.26* 
 (1.38) 
-0.32 
 (1.14) 
-0.01  
(1.01) 
-0.37 
 (1.18) 
0.10 
 (1.06) 
Xrs8    
(hPa.s.L-1) 
0.00 
(0.99) 
-0.22 
 (1.17) 
-0.33* 
 (1.01) 
-0.04 
(1.06) 
-0.24  
(1.03) 
0.08 
 (1.02) 
Xrs10 
(hPa.s.L-1) 
0.03  
(0.99) 
-0.30*  
(1.03) 
-0.25*  
(1.01) 
0.00  
(0.98) 
-0.05  
(1.23) 
0.29  
(0.96) 
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Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the frequency-independent Newtonian resistance and C, 
the compliance of the respiratory system obtained from the R-I-C model fitting. *significantly different from healthy children p<0.05. Preterm-
birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia
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SUPPLEMENTARY INFORMATION  
Table S1- Respiratory impedance variables by health status. 
            
 
 
n                       
 
Healthy  
 
Asthma 
 
Current wheeze 
 
Early-life Wheeze 
 
Preterm-birth 
 
Respiratory 
symptoms 
294 70 71 49 35 67 
R   
(hPa.s.L-1) 
8.27 
(7.25; 9.23) 
8.37 
(7.49; 9.81) 
8.52 
(7.57; 9.54) 
7.86 
(7.10; 9.00) 
8.53 
(7.63; 9.87) 
7.79* 
(6.77; 8.95) 
Rrs6 
(hPa.s.L-1) 
9.47 
(8.28;10.61) 
9.71 
(8.94;11.45) 
10.04 
(8.78;11.68) 
9.63 
(7.99;10.78) 
9.99 
(8.94;11.04) 
9.00 
(7.61;10.67) 
Rrs8 
(hPa.s.L-1) 
9.18 
(7.99;10.27) 
9.57* 
(8.52;10.90) 
9.56 
(8.41;10.81) 
8.88 
(7.95;9.98) 
9.05 
(8.50;10.66) 
8.55 
(7.30;9.93) 
Rrs10 
(hPa.s.L-1) 
8.76 
(7.82;9.87) 
9.04 
(8.26;10.48) 
9.13 
(8.22;10.56) 
8.38 
(7.74;9.80) 
8.84 
(8.02;10.23) 
8.24* 
(7.22;9.61) 
Rrs12 
(hPa.s.L-1) 
8.62 
(7.64;9.63) 
8.90 
(8.17;9.97) 
8.83 
(8.03;10.20) 
8.32 
(7.56;9.29) 
8.58 
(8.01;10.03) 
8.06* 
(7.13;9.31) 
Rrs14 
(hPa.s.L-1) 
8.40 
(7.35; 9.42) 
8.47 
(7.69;9.79) 
8.67 
(7.76; 9.83) 
7.84 
(7.26; 9.24) 
8.64 
(7.65; 10.18) 
7.85* 
(6.98; 9.29) 
Rrs16 
(hPa.s.L-1) 
8.18 
(7.20; 9.15) 
8.11 
(7.46; 9.41) 
8.60 
(7.36; 9.44) 
7.71 
(6.88; 8.97) 
8.48 
(7.47; 9.67) 
7.77* 
(6.78;8.92) 
Rrs18 
(hPa.s.L-1) 
7.88 
(6.82; 8.81) 
7.79 
(7.02; 8.77) 
7.89 
(7.15; 9.08) 
7.61 
(6.67; 8.59) 
8.11 
(7.10; 9.17) 
7.49 
(6.40; 8.53) 
Rrs20 
(hPa.s.L-1) 
7.59 
(6.79; 8.58) 
7.46 
(6.88; 8.92) 
7.88 
(6.90; 8.85) 
7.44 
(6.40;8.29) 
7.98 
(7.01; 8.88) 
7.22 
(6.49; 8.46) 
Rrs22 
(hPa.s.L-1) 
7.40 
(6.50; 8.39) 
7.29 
(6.70; 8.58) 
7.66 
(6.70; 8.54) 
7.43 
(6.10; 8.12) 
7.90 
(6.81; 8.83) 
7.04* 
(6.21; 8.02) 
Rrs24 
(hPa.s.L-1) 
7.29 
(6.41; 8.19) 
7.22 
(6.46; 8.40) 
7.48 
(6.55; 8.32) 
7.35 
(6.09; 7.97) 
7.66 
(6.82; 8.54) 
6.98 
(5.99; 7.94) 
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Rrs26 
(hPa.s.L-1) 
7.14 
(6.33; 8.10) 
7.19 
(6.48; 8.27) 
7.29 
(6.50; 8.12) 
7.26 
(6.17; 7.95) 
7.60 
(6.70; 8.39) 
6.87 
(5.97; 7.88) 
       
C 
(hPa.s.ml-1) 
8.031 
(6.59;9.92) 
7.62 
(5.84;8.98) 
7.81 
(5.91;10.80) 
8.47 
(6.52;10.76) 
7.57 
(4.95;9.60) 
7.89 
(6.75;10.55) 
Xrs6 
(hPa.s.L-1) 
-2.92 
(-3.70;-2.35) 
-3.21 
(-4.10; -2.46) 
-3.14* 
(-4.06;-2.51) 
-3.24 
(-3.73;-2.11) 
-3.21 
(-4.70;-2.46) 
-2.83 
(-3.88;-2.30) 
Xrs8 
(hPa.s.L-1) 
-2.24 
(-2.88;-1.71) 
-2.46 
(-3.04;-1.83) 
-2.50* 
(-3.58;-1.89) 
-2.34 
(-3.20;-1.53) 
-2.62* 
(-3.86;-1.89) 
-2.20 
(-3.18;-1.59) 
Xrs10 
(hPa.s.L-1) 
-1.94 
(-2.60;-1.39) 
-2.25* 
(-2.98;-1.55) 
-2.22* 
(-3.33;-1.70) 
-1.96 
(-2.59;-1.20) 
-2.23 
(-3.41;-1.44) 
-1.87 
(-2.54;-1.10) 
Xrs12 
(hPa.s.L-1) 
-1.64 
(-2.20;-1.11) 
-1.89 
(-2.62;-1.22) 
-1.98* 
(-2.94;-1.42) 
-1.61 
(-2.28;--0.99) 
-1.68 
(-3.32;-1.17) 
-1.55 
(-2.18;-0.88) 
Xrs14 
(hPa.s.L-1) 
-1.45 
(-2.07;-0.84) 
-1.77 
(-2.32;-0.77) 
-1.88* 
(-2.86;-1.16) 
-1.60 
(-2.07;-0.88) 
-1.53 
(-2.79;-0.80) 
-1.28 
(-2.22;-0.78) 
Xrs16 
(hPa.s.L-1) 
-1.31 
(-1.92;-0.72) 
-1.63 
(-2.18;-0.60) 
-1.68* 
(-2.70;-0.97) 
-1.34 
(-2.14;-0.66) 
-1.63 
(-2.54;-0.72) 
-1.23* 
(-1.78;-0.68) 
Xrs18 
(hPa.s.L-1) 
-1.06 
(-1.63;-0.52) 
-1.31 
(-1.89;-0.45) 
-1.56* 
(-2.22;-0.76) 
-1.18 
(-1.84;-0.63) 
-1.31 
(-2.33;-0.39) 
-1.09 
(-1.78; -0.45) 
Xrs20 
(hPa.s.L-1) 
-0.80 
(-1.32;-0.23) 
-0.93 
(-1.60;-0.15) 
-1.33* 
(-2.06;-0.59) 
-0.93 
(-1.63;-0.49) 
-1.06 
(-2.00;-0.27) 
-0.79* 
(-1.45;-0.16) 
Xrs22 
(hPa.s.L-1) 
-0.49 
(-1.00;0.14) 
-0.41 
(-1.26;0.25) 
-0.83* 
(-1.63;-0.39) 
-0.59 
(1.12;-0.21) 
-0.77 
(-1.58;0.45) 
-0.57 
(-1.02;0.16) 
Xrs24 
(hPa.s.L-1) 
-0.16 
(-0.68;0.43) 
-0.16 
(-0.94;0.45) 
-0.52* 
(-1.18;-0.01) 
-0.52 
(-0.92;0.23) 
-0.55 
(-1.11;0.42) 
-0.24 
(-0.87;0.31) 
Xrs26 
(hPa.s.L-1) 
0.22 
(-0.36;0.72) 
0.15 
(-0.50;0.74) 
-0.31* 
(-0.74;0.36) 
-0.59 
(-0.66;0.55) 
-0.43 
(-0.74;0.80) 
0.02 
(-0.56;0.63) 
Raw data (respiratory resistance (Rrs) and reactance (Xrs)) between 6 and 26 Hz are presented as median (25; 75%). R, represents the frequency-
independent Newtonian resistance and C, the compliance of the respiratory system obtained from R-I-C model fitting. * p<0.05 for log transformed Zrs 
variables compared to healthy group. Preterm-birth (≤37-weeks) and none diagnosed with Bronchopulmonary Dysplasia. 
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Table S2- Regression analyses based on the conventional approach to defining healthy 
Transformed 
Zrs variable 
Covariate Regression 
coefficient 
p-value Overall SD 
R 
 (hPa.s.L-1) 
Height 
Constant 
-.00947   
3.11491 
<0.001 
<0.001 
0.174 
Rrs6  
(hPa.s.L-1) 
Height 
Constant 
-.01033  
      3.35013 
<0.001 
<0.001 
0.200 
Rrs8 
 (hPa.s.L-1) 
Height 
Constant 
-.01071 
3.35032 
<0.001 
<0.001 
0.193 
Rrs10  
(hPa.s.L-1) 
Height 
Constant 
-.01093 
3.33591 
<0.001 
<0.001 
0.180 
Rrs12 
 (hPa.s.L-1) 
Height 
Constant 
-.00991 
3.20757 
<0.001 
<0.001 
0.181 
Rrs14 
 (hPa.s.L-1) 
Height 
Constant 
-0.01067 
3.25900 
<0.001 
<0.001 
0.175 
Rrs16 
 (hPa.s.L-1) 
Height 
Constant 
-0.00920 
3.07681 
<0.001 
<0.001 
0.180 
Rrs18  
(hPa.s.L-1) 
Height 
Constant 
-0.00851 
2.95246 
<0.001 
<0.001 
0.183 
Rrs20 
 (hPa.s.L-1) 
Height 
Constant 
-0.00738 
2.81425 
<0.001 
<0.001 
0.182 
Rrs22 
 (hPa.s.L-1) 
Height 
Constant 
0.00145 
0.15515 
<0.001 
<0.001 
0.187 
Rrs24  
(hPa.s.L-1) 
Height 
Constant 
-0.00636 
2.66052 
<0.001 
<0.001 
0.180 
Rrs26 
 (hPa.s.L-1) 
Height 
Constant 
-0.00531 
2.52980 
<0.001 
<0.001 
0.181 
     
C  
(hPa.s.ml-1) 
Height 
Constant 
.020152 
-0.07249 
0.001 
0.780 
0.298 
Xrs6  
(hPa.s.L-1) 
Height 
Constant 
-.01928 
3.13134 
<0.001 
<0.001 
0.323 
Xrs8  Height -.02312 <0.001 0.415 
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(hPa.s.L-1) Constant 3.26307 <0.001 
Xrs10  
(hPa.s.L-1) 
Height 
Constant 
-.03071 
  3.89182 
<0.001 
<0.001 
0.534 
Xrs12 
 (hPa.s.L-1) 
Height 
Constant 
-0.037570 
4.39386 
<0.001 
<0.001 
0.738 
Xrs14  
(hPa.s.L-1) 
Height 
Constant 
-0.03389 
3.75885 
<0.001 
<0.001 
0.932 
Xrs16  
(hPa.s.L-1) 
Height 
Constant 
-0.04056 
4.35691 
<0.001 
<0.001 
0.921 
X18 
 (hPa.s.L-1) 
Height 
Constant 
-0.25729 
2.57203 
0.004 
0.007 
1.065 
Xrs20 
 (hPa.s.L-1) 
Height 
Constant 
-0.02193 
1.91267 
0.024 
0.064 
1.148 
Xrs22  
(hPa.s.L-1) 
Height 
Constant 
-0.00894 
0.31412 
0.347 
0.757 
1.126 
Xrs24  
(hPa.s.L-1) 
Height 
Constant 
-0.01366 
0.62777 
0.157 
0.541 
1.141 
Xrs26 
(hPa.s.L-1) 
Height 
Constant 
-0.01746 
1.09164 
0.048 
0.245 
1.044 
Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the 
frequency-independent Newtonian resistance and C, the compliance of the respiratory system 
obtained from the R-I-C model fitting. 
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Table S3- Supplemental Table S3: Regression analyses using the inclusive definition of healthy 
children. 
Transformed 
Zrs variable 
Covariate Regression 
coefficient 
p-value Overall SD 
R  
(hPa.s.L-1) 
Height 
Constant 
-.00989 
3.15919 
<0.001 
<0.001 
0.173 
Rrs6 
 (hPa.s.L-1) 
Height 
Constant 
-.01121 
3.44394 
<0.001 
<0.001 
0.197 
Rrs8 
 (hPa.s.L-1) 
Height 
Constant 
-.01085 
  3.36251   
<0.001 
<0.001  
0.190 
Rrs10  
(hPa.s.L-1) 
Height 
Constant 
-.01100 
3.34105 
<0.001 
<0.001 
0.178 
Rrs12 
 (hPa.s.L-1) 
Height 
Constant 
  -.010124 
3.22816 
<0.001 
<0.001 
0.178 
Rrs14  
(hPa.s.L-1) 
Height 
Constant 
  -.01066 
  3.25635 
<0.001 
<0.001 
0.174 
Rrs16 
 (hPa.s.L-1) 
Height 
Constant 
-.009956 
   3.15684 
<0.001 
<0.001 
0.179 
Rrs18 
 (hPa.s.L-1) 
Height 
Constant 
-.00923   
  3.03284 
<0.001 
<0.001 
0.182 
Rrs20 
 (hPa.s.L-1) 
Height 
Constant 
-.00818 
2.90156 
<0.001 
<0.001 
0.181 
Rrs22 
 (hPa.s.L-1) 
Height 
Constant 
-.00739 
2.78829 
<0.001 
<0.001 
0.186 
Rrs24 
 (hPa.s.L-1) 
Height 
Constant 
-.00717 
  2.75144   
<0.001 
<0.001 
0.180 
Rrs26 
 (hPa.s.L-1) 
Height 
Constant 
-.00636 
2.64685 
<0.001 
<0.001 
0.181 
     
C  
(hPa.s.ml-1) 
Height 
Constant 
.02106   
  -.17367 
<0.001 
0.459 
0.306 
Xrs6  
(hPa.s.L-1) 
Height 
Constant 
  -.02093   
3.31771 
<0.001 
<0.001 
0.333 
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Xrs8  
(hPa.s.L-1) 
Height 
Constant 
-.02525 
  3.50211 
<0.001 
<0.001 
0.416 
Xrs10  
(hPa.s.L-1) 
Height 
Constant 
-.03109   
3.94307 
<0.001 
<0.001 
0.519 
Xrs12  
(hPa.s.L-1) 
Height 
Constant 
-.02931   
3.55509   
<0.001 
<0.001 
0.627 
Xrs14  
(hPa.s.L-1) 
Height 
Constant 
-.03174 
3.63406   
<0.001 
<0.001 
0.781 
Xrs16 
 (hPa.s.L-1) 
Height 
Constant 
-.03624   
4.00148   
<0.001 
<0.001 
0.833 
Xrs18 
 (hPa.s.L-1) 
Height 
Constant 
-.03624 
4.00148 
<0.001 
<0.001 
0.833 
Xrs20 
 (hPa.s.L-1) 
Height 
Constant 
-.02172 
2.15665 
0.004 
0.008 
0.943 
Xrs22  
(hPa.s.L-1) 
Height 
Constant 
  -.02108 
  1.8677 
0.008 
0.026 
0.950 
Xrs24 
 (hPa.s.L-1) 
Height 
Constant 
-.03846   
3.48901   
<0.001 
<0.001 
0.994 
Xrs26 
 (hPa.s.L-1) 
Height 
Constant 
-.02527 
1.74426 
0.027 
0.149 
1.179 
Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 Hz and R, represents the 
frequency-independent Newtonian resistance and C, the compliance of the respiratory system 
obtained from the R-I-C model fitting. 
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Table S4- Mean (SD) z-scores calculated for each group using reference equations obtained based 
on the inclusive definition of healthy children to include those born preterm and those with early-
life wheeze. 
 Healthy Asthma Current wheeze Respiratory 
symptoms 
n 319 59 50 66 
R  
(hPa.s.L-1) 
0.00 
(1.00) 
0.26* 
(1.03) 
0.15 
(0.92) 
-0.35 
(1.11) 
Rrs6  
(hPa.s.L-1)   
-0.03 
(1.00) 
0.27* 
(1.09) 
0.25* 
(0.97) 
-0.30* 
(1.16) 
Rrs8   
(hPa.s.L-1) 
-0.02 
(1.00) 
0.27* 
(1.07) 
0.14 
(0.91) 
-0.38* 
(1.11) 
Rrs10   
(hPa.s.L-1) 
-0.01 
(1.00) 
0.29* 
(1.07) 
0.20 
(0.97) 
-0.36* 
(1.13) 
     
C  
(hPa.s.ml-1) 
0.03 
(1.00) 
-0.29* 
(1.16) 
-0.18 
(1.18) 
0.23 
(0.94) 
Xrs6 
(hPa.s.L-1) 
0.00 
(1.00) 
-0.22 
(1.35) 
-0.28 
(1.10) 
0.13 
(1.03) 
Xrs8  
(hPa.s.L-1) 
0.00 
(1.00) 
-0.19 
(1.17) 
-0.29* 
(1.00) 
0.12 
(1.01) 
Xrs10 
(hPa.s.L-1) 
0.04 
(1.04) 
-0.29* 
(1.06) 
-0.24* 
(1.04) 
0.32* 
(0.99) 
Data are presented as mean (SD). Respiratory resistance (Rrs) and reactance (Xrs) between 6 and 26 
Hz and R, represents the frequency-independent Newtonian resistance and C, the compliance of the 
respiratory system obtained from the R-I-C model fitting. *significantly different from healthy 
children, p<0.05.
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Appendix N 
Manuscript entitled ‘Intrabreath tracking of respiratory mechanics: normal values and application in 
young children”. Under review at the American Journal of Respiratory and Critical Care Medicine 
and discussed in Chapter 5 
Claire Shackleton1, Zoltan Hantos1,2, Stephanie Davis3, Peter Vuillermin4,5,6, Bence Radics2, Gergely 
Makan7, Charles C Clem3, Miriam Davis3, Robert S Ware8, Keith Grimwood8,9,10, Peter D Sly1, 
Dorottya Czovek1,11 
1Child Health Research Centre, University of Queensland, Brisbane, Australia; 2Department of 
Pulmonology, University of Szeged, Deszk, Hungary; 3Section of Pediatric Pulmonology, Allergy 
and Sleep Medicine, Department of Pediatrics, Riley Children’s Hospital, Indiana University School 
of Medicine, Indianapolis, Indiana, United States, 4Deakin University, Geelong, Victoria, Australia, 
5Barwon Health, Geelong, Victoria, Australia, 6Murdoch Children’s Research Institute, Parkville 
Victoria, Australia, 7Department of Technical Informatics, University of Szeged, Szeged, Hungary; 
8Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia, 9School of 
Medicine, Griffith University, Gold Coast, Australia, 10Department of Infectious Diseases and 
Paediatrics, Gold Coast Health, Gold Coast, Australia, 11Department of Paediatrics, Semmelweis 
University, Budapest, Hungary 
Authors’ contributions: PDS, ZH, DC and CS designed the study; ZH, PDS, DC, BR and GM 
designed the lung function test; PDS, SDD and PV were the lead investigators at the Brisbane, 
Indianapolis and Geelong sites, respectively; KG was the lead investigator of the ORChID study; CS, 
DC, CCC and MD recruited the children and collected the data; CS, DC, GM and BR analysed the 
lung function data; CS and RW did the statistical analysis, CS, DC, PDS and ZH drafted the 
manuscript. All authors have seen and approved the last version of the manuscript.    
Funding: These studies have been supported by The National Health and Medical Research 
Council of Australia (#1078600, #1082307 and #615700), the Hungarian Scientific Research Fund 
(#105403), the Australian Government Research Training Scholarship Program and the European 
Respiratory Society Clinical Research Collaboration Grant (#ERS-CRC-2013-2) 
Running title: Z-scores of intrabreath resistance and reactance 
Descriptor number: 14.4 
  
 
189 
 
Word count: 2979 
At a Glance Commentary: 
Scientific Knowledge on the Subject: Lung function testing is challenging in preschool-aged children. 
Most methods that are feasible in this age group are not sensitive or specific enough to detect lung 
function abnormalities in individuals. A new lung function method (the intrabreath tracking of 
respiratory impedance) is feasible and identifies airway obstruction in preschool-aged children with 
high sensitivity and specificity. 
What This Study Adds to the Field: This study shows the feasibility of this new method in three 
distinct research environments. The application guidelines and reference values established will 
facilitate the clinical utility and testing of this method in different respiratory conditions in young 
children with pulmonary disease.  
This article has an online data supplement, which is accessible from this issue's table of content 
online at www.atsjournals.org 
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ABSTRACT:  
Rationale: Lung function tests designed for preschool-aged children have limited clinical utility in 
individuals due to low specificity and sensitivity in detecting respiratory disease. However, the 
intrabreath tracking of respiratory impedance (Zrs) with the forced oscillation technique (T-FOT) has 
recently been reported to have a high diagnostic value in young children with airway obstruction. 
Objective: To establish the feasibility and normative values of intrabreath resistance (R) and 
reactance (X) measures in a multicenter study.  
Methods and Measurements: Children 3-6 years of age were recruited from three different sites and 
lung function was measured with T-FOT. The International Study of Asthma and Allergies in 
Childhood questionnaire data identified healthy children. Feasibility was assessed and z-scores 
created for the intrabreath measures of R and X. 
Main Results: T-FOT measurements were successfully obtained in 517 children (86.7%), of whom 
200 were deemed healthy. T-FOT outcome variables were significantly associated with height, 
whereas the volume dependence of R (∆R) and X (∆X) were not associated with height, weight, sex 
and age. An upper limit of normal of 1.96 hPa.s.L-1 for ΔR and the lower limit of normal of -0.54 
hPa.s.L-1 was defined for ΔX.  
Conclusions: T-FOT measurements are highly feasible in preschool-aged children in different 
research settings. Establishing normative reference values for this age improves the clinical 
application of the intrabreath measurement of Zrs and facilitates further investigations into its utility 
in different respiratory disease groups. 
Abstract word count: 232/250  
Key words: Lung function, reference values, forced oscillations, preschool age. 
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INTRODUCTION 
During the preschool years the respiratory system undergoes significant growth and development (1), 
making it susceptible to insults that may alter lung growth trajectory (2). However, measuring lung 
function in preschool aged children can be challenging. The forced oscillation technique (FOT), a 
measurement method of respiratory impedance (Zrs) is more feasible in preschool-aged children 
compared to other lung function tests (3-10). Despite this, the clinical utility of the commonly 
employed multi-frequency FOT is limited in clinical settings, and is based upon observations that 
FOT is more useful at detecting between-group differences rather than following disease progression 
in individuals (8, 11), especially in young children. This may be explained by the fact that respiratory 
resistance (R) and reactance (X) are calculated as an average value over several breathing cycles. 
This approach does not account for the well-established cyclical changes of R and X with flow and 
volume during tidal breathing (12, 13); therefore, significant physiological information related to 
intra-breath events is lost.  
Inspiratory R measured with the FOT was reported to have a stronger correlation with 
plethysmographic airway resistance compared to expiratory R (12, 14) and to be more sensitive to 
interventions (15-19). Our group recently reported that the clinical utility of FOT can be further 
improved by tracking the intrabreath changes of respiratory mechanics during tidal breathing as well 
as the established volume and flow-dependent R and X variables (20, 21). In addition, sensitive new 
measures of lung function that indicated airway obstruction in young children with acute and 
recurrent wheeze were identified (20). This novel lung function method, the intrabreath tracking FOT 
(T-FOT) has the potential to be incorporated into the clinical setting as it is easy to perform, cost and 
time effective and able to discriminate between healthy and wheezy children.  
To improve the clinical utility of T-FOT measurements in young children, normative reference values 
need to be established in the pre-schoolers, an age group that would particularly benefit from the low 
demand of cooperation of the FOT. These age-appropriate reference data will then facilitate 
employing this technique in different respiratory disease groups. The aims of this study are to i) assess 
the feasibility of T-FOT in a large population of preschool-aged children in different research settings, 
ii) develop guidelines for data collection and analysis, iii) characterize the intrabreath changes in R 
and X in healthy children between 3 and 6 years of age and iv) establish normal values for T-FOT 
outcome variables.   
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METHODS  
Participants and measurement environment 
Children 3-6 years of age were recruited from three centers; two in Australia and one in the United 
States. Within Australia, two community birth-cohort studies; the Observational Research in 
Childhood Infectious Diseases (ORChID) study (22) in Brisbane and the Barwon Infant Study (BIS) 
(23) in Geelong incorporated T-FOT measurements into the study protocol. Healthy children were 
recruited from the Riley Hospital for Children, Indianapolis, Indiana, United States. Participants were 
also recruited from kindergartens in Brisbane, Australia. At each site, parents signed a consent form 
and completed a questionnaire [modified International Study of Asthma and Allergies in Childhood 
(ISAAC) questionnaire] (24). Children’s lung function was measured at all sites and standing height 
and weight were measured without shoes and with light clothing only. The ISAAC questionnaire 
defined the respiratory health status of the participants. The study populations and the different 
recruitment strategies of participants are summarized in the Online Data Supplement (OLS).   
The feasibility of the T-FOT was assessed in different measurement settings: i) kindergartens, ii) lung 
function laboratories and iii) in clinical research study rooms. Children from the ORChID study were 
assessed annually up to four occasions, children from other sites were assessed on one occasion. 
The Children's Health Queensland (HREC/12/QRCH/23), The University of Queensland 
(2014000212), the Barwon Health (10/24) and the Indiana University School of Medicine 
(1506956908) ethics committees approved the studies. 
T-FOT Measurements and Data Analysis 
Respiratory mechanics was measured using a custom-made FOT device at all sites (20, 21). Briefly, 
a loudspeaker delivered a single 10 Hz small-amplitude (0.25 hPa) signal through a wave-tube (25) 
and Zrs was calculated as a load impedance on the wave-tube. A pneumotachograph recorded the 
tidal flow, and tidal volume (VT) was calculated via numerical integration of the tidal flow. T-FOT 
measurements were performed during tidal breathing over a 16-s period and repeated at least three 
times. A test epoch was accepted if a child had at least five artefact-free breathing cycles with a 
coefficient of variation (CV) of inspiratory resistance (R) <15%. Each artefact-free breathing cycle 
was analyzed separately and the medians calculated for the intrabreath-breath R and X variables 
described in Table 1 and Figure 1. Further details on lung function measurements are in the OLS. 
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Statistical Analysis 
Data were pooled from the three sites. Data were not normally distributed and are reported as median 
(25th; 75th percentile) values. R values were normalized using a natural logarithmic transformation 
and X values a log-modulus transformation (sign (T-FOT variable) × natural logarithm (absolute (T-
FOT variable) +1). Mixed-effects linear regression models investigated the relationship between 
height, weight, sex and age and T-FOT variables.  In all models, each individual was included as a 
random effect, to account for the probable dependence of observations from the same child. 
Prediction equations were generated for transformed intrabreath lung function variables, and z-scores 
calculated (Z= (measured - predicted)/ standard deviation) for the variables dependent on 
anthropometry. The upper limit of normal (ULN) corresponding to the 95th centile and the lower limit 
of normal (LLN) corresponding to the 5th centile were calculated for the variables independent of 
anthropometry (26-28). Mann-Whitney rank sum tests investigated the differences between median 
inspiratory and expiratory R and X outcome variables, and a p-value <0.05 was considered 
statistically significant. Data were analysed using Stata v13 for Windows (StataCorp, TX, USA). 
Further details on the mixed-effect linear regression and data analysis are described in the OLS.  
RESULTS 
Feasibility   
Of the 634 children enrolled, T-FOT measurements were not attempted in 38 as they were either 
absent the day of testing, had an incomplete questionnaire or the child did not cooperate in the 
measurement of height. In the remaining 596 children, a further 79 were excluded for reasons outlined 
in Figure 2. Acceptable T-FOT measurements were obtained in 517 children, corresponding to a 
feasibility of 86.7% (517/596), with the highest percentage of successful measurements (95%) 
achieved at the Indianapolis site. All children in the study were naïve to the T-FOT test. In the children 
with acceptable T-FOT measurements, 317 were excluded from the healthy dataset because they did 
not meet the criteria of ‘healthy’ based on the questionnaire. Overall, 200 healthy children (48.3% 
male) with a median age of 4.2 (range: 2.2-6.9) years and a median height of 105.7 (range: 86.0-
130.0) centimeters contributed 240 acceptable and repeatable T-FOT measurements. Successful T-
FOT measurements were obtained in 39 children from Indianapolis, 61 children from Geelong and 
100 children from Brisbane. In the children recruited for the ORChID study, 13 were measured twice, 
12 three times and one child contributed four annual sets of measurements (between 3 and 6 years of 
age). Anthropometric characteristics of healthy children with acceptable and repeatable T-FOT 
measurements are described in Table 2. The study population was >90% Caucasian.   
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Acceptable T-FOT measurements in healthy children 
A median of 12 (8; 17) (25th; 75th percentile) artefact-free cycles per child were included in the 
analysis with a median VT of 272 (229; 355) mL at a breathing frequency (Fbr) of 27 (23; 33) min
-1.  
There was no difference in the lung function outcome variables between the sites (data not shown). 
The highest R [10.35 (8.97; 11.91) hPa.s.L-1] corresponded to the maximum flow during expiration, 
whereas R at the end of inspiration represented the lowest R in the breathing cycle [7.15 (6.21; 8.33) 
hPa.s.L-1, Figures 3 and 5]. These changes were mirrored in X with the end of inspiration more 
negative (lower) than the end of expiration [-1.54 (-2.13; -1.05) vs -1.04 (-1.64; -0.51) hPa.s.L-1, 
Figures 4 and 5]).  Within-breath FOT studies traditionally report the mean R and X values for the 
inspiratory and expiratory phases of the breath cycle. In this cohort the mean expiratory R was 
significantly higher [8.75 (7.72; 10.07) hPa.s.L-1] than the mean inspiratory R [8.04 (7.08; 9.31) 
hPa.s.L-1, p<0.001, Figures. 3 and 5]. Whereas, the mean X during expiration [-1.82 (-2.68; -1.20) 
hPa.s.L-1] was slightly lower than the mean X in inspiration [-1.76 (-2.39; -1.25) hPa.s.L-1, p<0.28]. 
The differences in R and X at the end of expiration and the end of inspiration, ΔR [0.60 (0.12; 1.00) 
hPa.s.L-1] and ΔX [0.45 (0.11; 0.84) hPa.s.L-1] respectively are illustrated in Figure 6.   
 
Height was the only significant predictor of the transformed intrabreath tracking of the R and X 
variables, with weight, age and sex having no significant influence in multivariable models (Table 
E1 in the OLS). The raw values of the intrabreath lung function variables as functions of height are 
depicted in Figures 3 and 4. Height showed the strongest relationship with resistance at the end of 
expiration (ReE, p=<0.001, R2=0.1742) and with reactance at the end of inspiration (XeI, p=<0.001, 
R2=0.1511), measures that were independent of flow. Z-scores were established for all the relevant 
intrabreath measures using the prediction equations described in Table 3. None of the intrabreath 
tracking variables were outliers based on a z-score <-5.0 or >5.0 (29). There was no difference in the 
z-scores between the three sites (data not shown).  ΔR and ΔX were independent of height (Figure 
6), weight, age and sex. The ULN and LLN for ΔR and ΔX were defined as 1.96 hPa.s.L-1 and -0.54 
hPa.s.L-1, respectively. In the healthy dataset, 10.8% (26/240) of the measurements had a ΔR 
≥1.42hPa.s.L-1, the established cut-off value for the optimal detection of airway obstruction 
previously defined by our group (20). This value corresponded to the 89th percentile in the present 
data set and was slightly lower than the ULN. Additional data on the comparison of the ULN and the 
cut-off of ΔR are provided in the OLS.  
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DISCUSSION 
The findings presented in this multicenter study are the first description of reference values for the 
intrabreath measures of R and X in healthy preschool-aged children. Our data demonstrated that T-
FOT is a highly feasible technique in preschool-aged children naïve to lung function testing with a 
success rate of 86.7%. To increase the clinical utility of this novel lung function test, z-scores and the 
ULN and LLN were defined for the within-breath R and X variables.  
In accordance with the pioneering work of Davidson et al. (12) and previous studies in children (15-
17, 30) we found that R and X fluctuate significantly throughout the breathing cycle. R increases and 
X decreases with flow in both expiration and inspiration; therefore, the use of averages of R and X 
from several whole breathing cycles masks important information and over-simplifies the description 
of respiratory mechanics of children during tidal breathing. Previously, we have also demonstrated 
that the large fluctuations in resistance are related primarily to flow changes during tidal breathing, 
which may mask changes in the airway caliber (20). Consistent with this, the mean expiratory 
resistance has been shown to be only weakly related to the plethysmographic airway resistance (12) 
and to be influenced by the flow pattern and changes in the glottic aperture (30, 31). Although the 
within-breath FOT variables  that are flow dependent did not distinguish wheezy children from 
healthy ones (20), we report reference values for these measures in the present study to facilitate the 
clinical testing of T-FOT in various situations, where these measures of flow dependence may provide 
clinically relevant information (e.g. in vocal cord dysfunction). By measuring Zrs at the points of zero 
flow in the breathing cycle, i.e. end-expiration and end-inspiration, and calculating ∆R and ∆X, the 
effect of respiratory flow on R and X can be minimized. The diagnostic power of the FOT was 
improved in children with airway obstruction by using this approach (20).  
 
In accordance with our previous findings in a smaller population, ∆R and ∆X were independent of 
sex and anthropometry. Following the approach recommended by the Global Lung Initiative (29) we 
calculated the ULN for ΔR and the LLN for ΔX as the 95th centile and 5th centile, respectively. This 
gave higher values for ΔR and lower values for ΔX than what we had established previously as being 
indicative of airway obstruction (20). In the present study, ∆R was above the previously defined cut-
off in 10.8% of the healthy children. This is in line with the figure of 10.7% observed previously in a 
smaller population (20). In the present study, a ∆R of 1.42 hPa.s.L-1 corresponded to the 89th 
percentile of the data and was slightly lower than the ULN calculated for the same population. Whilst 
the introduction of the ULN minimizes the false positive cases and increases the specificity of ∆R, 
the cut-off value was established previously for a diseased population (20) and was calculated as the 
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best compromise between specificity and sensitivity. To investigate this further, using the lung 
function data previously published from acutely wheezing children (20) (data shown in the OLS) and 
the healthy population of the present study, the ULN of ∆R (1.96 hPa.s.L-1) corresponded to 95% 
specificity (as it was calculated as the 95th percentile), but the sensitivity of ∆R to detect airway 
obstruction decreased to 54%. The best compromise between sensitivity (92%) and specificity (89%) 
was 1.43 hPa.s.L-1, confirming the previously established cut-off value in a much larger population 
(Table E3). Therefore, we recommend using the cut-off value (1.42 hPa.s.L-1) that has a high positive 
and negative predictive value in wheezy children, while the clinical use of ULN in other disease 
groups requires further investigation.  The cut-off value of ∆X reported previously in wheezy children 
(-0.16 hPa.s.L-1) corresponds to the 86th percentile in the present population of healthy children.  
 
The findings of previous studies, where mean values of R and X were reported separately for 
expiration and inspiration in children are inconsistent. Some studies reported that mean inspiratory 
resistance is more useful to detect airway obstruction (17), while others could not confirm this finding 
(15, 30). We reported previously that the mean inspiratory and expiratory resistance values were less 
sensitive (65% and 58%, respectively) and specific (60% and 59%, respectively) to airway 
obstruction in children with acute wheeze than the intrabreath tracking FOT variables based on Zrs 
readings at zero flow (20). Our observations and the earlier inconsistent reports suggest that, 
compared to the average Zrs data for whole breathing periods, the improvement in clinical utility that 
can be expected from the separate estimation of mean expiratory and inspiratory resistance values is 
limited. Nevertheless, the present study is the first to report reference values for mean inspiratory and 
expiratory R and X values measured with the FOT to facilitate this application.   
 
The feasibility of the FOT in preschool aged children is well-established (8); indeed, only 3% of the 
data were excluded in the present study on the basis of T-FOT-specific criteria (i.e. poor quality 
measurement or user/equipment error). The most common reason for unacceptable measurements 
was the lack of cooperation from the child. The feasibility of T-FOT in the present study was similar 
to that reported in other lung function tests that require tidal breathing only. Measurements of specific 
airway resistance and interrupter resistance have good feasibility in preschool-aged children ranging 
from 61-83% (4, 32), to >88% (33, 34). In contrast, success rates in multiple breath washout 
measurements in preschool aged children are in the range of 50 - 73% (3, 6).  
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In this multicenter study, measurements were made across three sites with distinct environments 
(kindergartens, lung function laboratories, clinical research study rooms). Measurements from field 
work conducted in the kindergartens and in cohort study visits, and in the clinical environment of 
outpatient clinics were combined. When measuring lung function in field work time pressure may be 
a limiting factor in obtaining acceptable data, as most of the unsuccessful tests were from the 
kindergartens. In the more controlled environment of the clinical setting, the success rate was close 
to 100%. Overall, the high feasibility of the FOT measurements obtained across different settings 
enhances the FOT as a robust lung function method in preschool-aged children in both a busy 
outpatient setting and a research environment.  
 
Defining the eligibility criteria of the participants included in reference value datasets is imperative 
to the clinical interpretation of lung function data (35, 36). We used a modified ISAAC questionnaire 
to define the health status of all study participants (except for the Indianapolis site, where only healthy 
children were recruited, as detailed in the OLS). Although validated in children across different 
populations, the ISAAC questionnaire relies on parent recall over a 12 month period which has been 
reported to be unreliable (37, 38). The uncertainty in the area of early life respiratory events (as a 
well-known limitation of the questionnaires that rely on parent reports) may contribute to the 10% 
prevalence of high ΔR values in the present healthy population.  
 
The relationship between ethnicity and lung function is well established in adults, but remains 
uncertain in young children. The majority of published preschool-aged reference data have been 
collected in Caucasian children, making it difficult to compare between ethnicities. We report data in 
a mainly Caucasian population, although ethnicity was not consistently defined across study centers. 
Ethnicity was self-reported, which further limits the accuracy of this variable.  Nevertheless, the z-
scores were derived from children from diverse backgrounds across three different sites, enhancing 
the generalizability of our findings.  
 
The intrabreath tracking of respiratory resistance and reactance is a highly sensitive and specific 
method to detect airway obstruction in young children. In the present study, we confirmed the 
feasibility of T-FOT measurements in both clinical and research environments. The z-scores 
established for children between 3 and 6 years of age facilitate investigations into the utility of this 
method in respiratory diseases and supports the clinical application of this method in preschool aged 
children.  
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Figure 1. Temporal changes in resistance (R) and reactance (X) with the tidal flow (V’) and volume 
(V) in a representative 5-year old child. The dashed lines represent certain timepoints of the tidal 
breathing: A: end of inspiration, B: end of expiration, C: maximum expiratory flow, D: maximum 
inspiratory flow. R and X can also be displayed as a function of V and V’ (bottom panels), so called 
the resistance and reactance loops. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 2 4 6
R
 &
 X
 (
h
P
a
.s
.L
-1
)
-2
0
2
4
6
8
time (s)
0 2 4 6
V
' 
(L
.s
-1
) 
&
 V
 (
L
)
-0,6
-0,4
-0,2
0,0
0,2
0,4
0,6
0,8
Volume (L)
0,0 0,1 0,2 0,3
R
 &
 X
 (
h
P
a
.s
.L
-1
)
-2
0
2
4
6
8
Flow (L.s-1)
-0,6 -0,3 0,0 0,3 0,6
-2
0
2
4
6
8
  
 
203 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Participant flow chart 
Consent obtained n=634 
Excluded n=38  
- Absent on day of testing n=7 
- ISAAC questionnaire not completed n=18 
- Unable to measure height n= 13 
Acceptable T-FOT measurements n=517 
Healthy respiratory status n=200 
T-FOT testing observations n=240 
Excluded n=79 
- Participant unwilling to co-operate 
n=53 
- T-FOT measurements not acceptable 
n=22 
- Equipment/user error n=4 
Excluded due to respiratory status n= 317 
- Asthma n=60 
- Current wheeze n=64 
- Early-life wheeze n=90 
- Pre-term n=23 
- Respiratory symptoms n =80 
Testing attempted n=596 
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Figure 3. Resistance values (R) as a function of height in preschool-age children (n=240). The 
definitions of the tracking variables are in Table 1. Note the differences in the absolute values of R 
between the graphs. R was the highest at the maximum expiratory flow (Rmaxe) while it was the 
lowest at the end of inspiration (ReI). 
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Figure 4. Reactance values (X) as a function of height in preschool-age children (n=240). The 
definitions of the tracking variables are in Table 1. Note the differences in the X absolute absolute 
values between the graphs. X was the lowest at the maximum expiratory flow (XmaxE) while it 
reached its maximum at the end of inspiration (XeE). 
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Figure 5. Intrabreath values of resistance (R) and reactance (X) in healthy children (n=240). meanE: mean expiratory value; meanI: mean inspiratory 
value, maxE: value at the maximum expiratory flow, maxI: value at the maximum inspiratory flow, eE: value at the end of expiration, eI: value at the 
end of inspiration. 
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Figure 6. Volume dependence of resistance (ΔR) and reactance (ΔX) as a function of height in preschool-age children. Both ΔR and ΔX were 
independent of height. The solid lines represent the upper limit of normal in ΔR or the lower limit of normal in ΔX while the dashed lines represent the 
cut-off values defined earlier for the same variables (1).  
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Table 1: Definitions of variables measured from tracking the intrabreath changes of respiratory 
impedance using a 10 Hz signal 
 
 
 
 
 
 
 
 
 
 
 
 
Table modified from Czovek et al (1). 
 
Table 2: Demographic and anthropomorphic characteristics of healthy children from the three sites 
contributing acceptable and repeatable intrabreath FOT measurements. 
 Brisbane,  
Australia 
 
Geelong,  
Australia 
Indianapolis,  
United States of 
America 
n 100 61 39 
Observations 140 61 39 
Male (n) 66 28 22 
Age  
(years) 
4.3 
 (3.7;5.0) 
4.1 
(4.0;4.2) 
4.9 
( 3.8; 5.9) 
Height  
(cm) 
105.5 
(101.1;110.2) 
105.5  
(103.8; 108.3) 
110. 0  
(101.0; 120.0) 
Weight  
(Kg) 
17.6 
 (16.2;19.8) 
16.8  
(15.2; 17.9) 
19.0 
 (16.0; 23.0) 
Data are presented as median (25th; 75th percentile). 
Phase of the breathing 
cycles 
Resistance (R) Reactance (X) 
Mean during expiration RmeanE XmeanE 
Mean during inspiration RmeanI XmeanI 
at maximum expiratory flow 
(maxE) 
RmaxE XmaxE 
at maximum inspiratory flow 
(maxI) 
RmaxI XmaxI 
at end-expiration (eE) ReE XEe 
at end-inspiration (eI) ReI XEi 
Difference between eE and eI ΔR ΔX 
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Table 3: Prediction equations for the intrabreath changes in respiratory impedance in healthy 
preschool-aged children 
Intrabreath 
lung function 
variable 
Prediction Equation SD 
ReE 3.3296 + (-0.0120* height) 0.1927 
ReI 3.3264 + (-0.0127* height) 0.2021 
Rmax,E 
3.5136 + (-0.0110* height) 0.2072 
Rmin,E 3.2554 + (-0.0124 * height)  0.1978 
Rmax,I 3.3800 + (-0.0108* height) 0.1963 
Rmin,I 3.2550 + (-0.0126* height) 0.1964 
RmeanE 3.3567 + (-0.0111* height) 0.1980 
RmeanI 3.367 + (-0.0120 * height) 0.1899 
XeE -1.909 + (0.0114* height) 0.4483 
XeI -2.8220 + (0.0179 * height) 0.3231 
XmaxE -1.7375 + (0.0111* height) 0.4655 
XminE -2.5352 + (0.1112* height) 0.3653 
XmaxI -2.0392 + (0.0136* height) 0.4150 
XminI -2.8602+ (0.0152* height) 0.2955 
XmeanE -2.2220 + (0.0111* height) 0.3925 
XmeanI -2.6342 + (0.0154* height) 0.3242 
All R variables were transformed by natural logarithm and X variables underwent log modulus 
transformation (sign (T-FOT variable)* natural logarithm (absolute (T-FOT variable) +1. All units 
are hPa.s.L-1. 
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Online data supplement 
Intrabreath tracking of respiratory mechanics: normal values and application in young children 
Claire Shackleton1, Zoltan Hantos2, Stephanie Davis3, Peter Vuillermin4,5,6, Bence Radics2, Gergely 
Makan7, Charles C Clem3, Miriam Davis3, Robert S Ware8, Keith Grimwood8,9,10, Peter D Sly1, 
Dorottya Czovek1,11 
METHODS 
Subjects 
Children 3-6 years of age were recruited from three centers; two in Australia and one in the United 
States. Within Australia, two community birth cohort studies; the Observational Research in 
Childhood Infectious Diseases (ORChID) study in Brisbane and the Barwon Infant study (BIS) in 
Geelong incorporated FOT measurements into the study protocol.  The study design of both the 
ORChID and BIS studies has been published previously (E1, E2). Briefly, pregnant women were 
recruited from antenatal clinics and their healthy newborn infant was followed during early 
childhood. In both studies, information on respiratory symptoms and general health were collected 
from the parents using a daily diary in the first 2 years of life. In the ORChID study, lung function 
was measured at 3, 4, 5 and 6 years of age and the modified International Study of Asthma and Allergy 
in Childhood (ISAAC) questionnaire was completed annually.  In the BIS cohort, lung function was 
measured only at age 4 years.   
Participants were also recruited from local kindergartens in Brisbane, Australia. A consent form and 
a modified ISAAC questionnaire were sent to the families and returned prior to the study visit. All 
children from the BIS and ORChID studies and from the community with a signed consent form and 
returned questionnaire were eligible to participate in the study.  In comparison, healthy children only 
were recruited from the respiratory clinic at the Riley Hospital for Children, Indianapolis, Indiana, 
United States and were pre-screened using a questionnaire.  At this site, healthy children were defined 
as born at term (>37 weeks gestation), had no ventilator support during the neonatal period, had never 
been diagnosed with a chronic lung disease or congenital abnormality affecting their lung and/or body 
growth and development, had never wheezed or had a chronic cough (lasting >1 month).  On the day 
of the test, height and weight of the children were measured prior to the lung function test. All the 
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lung function data were analyzed by two researchers, who were blinded to the health status of the 
children.  
Following the analysis of the lung function data, the modified ISAAC questionnaire was used to 
define the respiratory status of the participants and children were excluded from the healthy dataset 
if; born pre-term (<37 weeks gestation) or birthweight <2500 g, diagnosed with a congenital 
abnormality affecting their lung and/or body growth and development, diagnosed by a doctor with 
asthma, had wheezed 12 months prior to the lung function test and if they had respiratory symptoms 
(from an upper or lower respiratory infections) 4 weeks prior to the study visit. The Children's Health 
Queensland (HREC/12/QRCH/23), The University of Queensland (2014000212), the Barwon Health 
(10/24) and the Indiana University School of Medicine (1506956908) ethics committees approved 
the studies. 
T-FOT Measurements and Analysis 
T-FOT was measured using a custom made FOT device. A loudspeaker delivered a single 10 Hz 
small-amplitude signal (0.25 hPa.s.L-1) to a wave-tube where two pressure transducers measured the 
inlet and outlet pressure along the wave-tube. Respiratory impedance (Zrs) was calculated as a load 
impedance on the wave tube, with the signal undergoing high-pass filtering to minimize the effect of 
spontaneous breathing on the measurement of Zrs. A screen pneumotachograph recorded the tidal 
flow and tidal volume (VT) was calculated via numerical integration of the tidal flow. T-FOT 
measurements were performed during tidal breathing over a 16-second period and repeated at least 
three times. A test epoch was accepted if a child had at least five artefact-free repeatable breathing 
cycles as defined by the coefficient of variation (CV) of inspiratory resistance (R) <15%. A breathing 
cycle was excluded if any of the following artefacts were detected; cough, leak, mouth movement, 
deep inspiration or sigh, glottal closure or audible noise. Each artefact-free breathing cycle was 
analyzed separately and the median calculated for the within-breath R and reactance (X) variables 
described in Table 1 and Figure 1 in the main text.  
Statistical Analysis 
Data were not normally distributed and are summarized as median (25th %; 75th %) values. R values 
were normalized using a natural logarithmic transformation and X values a log-modulus 
transformation (sign (T-FOT variable)* natural logarithm (absolute (T-FOT variable) +1). CV of 
inspiratory R was calculated as (SD/mean)*100 in each individual where SD represents the standard 
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deviation. Mixed-effect models were used to investigate the relationship between the anthropometric 
measures and the T-FOT variables.  Initially, successive univariate models with height, weight, age 
and sex were included as the main effects were constructed. Next, multivariate models were built 
using combinations of main effects, before the most parsimonious multivariable model was selected 
using the likelihood ratio test. In all models each child was included as a random effect, to account 
for the probable non-independence of observations from the same child. Z-scores were calculated for 
all T-FOT variables that were dependent on anthropometry using the equation: Z = (measured - 
predicted)/SD, where SD represents the overall SD of the model. While, the upper limit of normal 
(ULN) corresponding to the 95th centile and the lower limit of normal (LLN) corresponding to the 5th 
centile were calculated for the variables that were independent of anthropometry. To assess the 
differences between the three sites, z-scores calculated for the three sites were compared with Student 
t-test, using Brisbane as the reference site.  
RESULTS 
Table E1. The within-breath resistance (R) and reactance (X) variables studied (copied from the 
main text Table 1) 
Phase of the breathing 
cycles 
Resistance (R) Reactance (X) 
Mean during expiration RmeanE XmeanE 
Mean during inspiration RmeanI XmeanI 
at maximum expiratory flow 
(maxE) 
RmaxE XmaxE 
at maximum inspiratory flow 
(maxI) 
RmaxI XmaxI 
at end-expiration (eE) ReE XeE 
at end-inspiration (eI) ReI XeI 
Difference between eE and eI ΔR ΔX 
Table modified from Czovek et al (E3). 
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Table E2. Results of the univariable analysis  
TFOT  
variable 
Variable Coefficient p-value Constant 
Coefficient 
ReE 
(hPa.s.L-1) 
Height -.0114275   0.000* 3.261275 
 Age -.0745146 0.000* 2.36693 
 Sex .0131538 0.630 2.03646 
 Weight -.021869   0.000* 2.438648 
ReI 
(hPa.s.L-1) 
Height -.0119074 0.000* 3.234955 
 Age -.0866029 0.000* 2.342373 
 Sex .0136462   0.636 1.958731 
 Weight -.0224647 0.000* 2.371943 
Rmax,E 
(hPa.s.L-1) 
Height -.0101151 0.000* 3.411032 
 Age -.0659665 0.000* 2.619423 
 Sex .0130109 0.650 2.326173 
 Weight -.0181709 0.000* 2.661426 
Rmin,E 
(hPa.s.L-1) 
Height -.0115245 0.000* 3.158888 
 Age -.0823794 0.000* 2.288287 
 Sex .0153426 0.584 1.922603 
 Weight -.0217634 0.000*  2.324012 
Rmax,I 
(hPa.s.L-1) 
Height -.010388 0.000* 3.330943   
 Age -.0650416 0.000* 2.506172 
 Sex .0118499 0.666 2.217603 
 Weight -.020377 0.000* 2.592141 
Rmin,I 
(hPa.s.L-1) 
Height -.0116521 0.000* 3.153218 
 Age -.0825449   0.000* 2.269986 
 Sex .0177888   0.524 1.902063 
 Weight -.0221693 0.000* 2.312074 
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RmeanE 
(hPa.s.L-1) 
Height -.0102239 0.000* 3.26018 
 Age -.0677301 0.000* 2.464351 
 Sex .0200084   0.468 2.160115 
 Weight -.0187636 0.000* 2.509699 
RmeanI 
(hPa.s.L-1) 
Height -.0111365 0.000* 3.274422 
 Age -.0755656 0.000* 2.415875 
 Sex .0208238 0.440 2.076666 
 Weight -.0215271 0.000* 2.476635 
XeE 
(hPa.s.L-1) 
Height .0108335    0.005* -1.84422   
 Age .0572617 0.094 -.936282 
 Sex .0070191 0.906 -.6931362 
 Weight .015357 0.088 -.9671638 
XeI 
(hPa.s.L-1) 
Height .017731 0.000* -2.805098 
 Age .1148687 0.000* -1.416162   
 Sex -.087439 0.054 -.8700359 
 Weight .0321893 0.000* -1.497194 
Xmax,E 
(hPa.s.L-1) 
Height .0107081 0.007* -1.700412 
 Age .0521653   0.142 -.7832412 
 Sex -.0336124 0.584 -.5417098 
 Weight .0157419 0.092 -.843689 
Xmin,E 
(hPa.s.L-1) 
Height .0105272 0.001* -2.46439    
 Age .055957 0.045* -1.583741 
 Sex .021743    0.654 -1.353566 
 Weight .0155626 0.035* -1.623705 
Xmax,I 
(hPa.s.L-1) 
Height .0131982   0.000* -1.999452 
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 Age .074012    0.021* -.9140384 
 Sex -.0692661 0.211 -.5569142 
 Weight 0225831   0.007* -1.001005 
Xmin,I 
(hPa.s.L-1) 
Height .0149095 0.000* -2.835252    
 Age .0921238 0.000* -1.648381   
 Sex -.041032    0.317 -1.224897 
 Weight .0277365 0.000* -1.747573 
XmeanE 
(hPa.s.L-1) 
Height .0106672 0.001* -2.173206 
 Age .0498278 0.097 -1.250329 
 Sex -.0089339 0.863 -1.031611 
 Weight .0157522   0.046* -1.321026   
XmeanI 
(hPa.s.L-1) 
Height .0150598 0.000* -2.602014 
 Age .0914421 0.000* -1.396043 
 Sex -.0720778   0.105 -.9596018 
 Weight .0276859 0.000* -1.497404   
 
 
Testing the clinical utility of the upper limit of normal of the volume dependence of resistance (ΔR)  
Previously published lung function data from children with acute wheeze were used to test the clinical 
value of the ULN of ΔR defined in the present study as 1.96 hPa.s.L-1. Receiver operator characteristic 
analysis was conducted using ΔR data from wheezy children (n=26) and those from healthy children 
(n=240).  
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Figure E1. Receiver operator characteristic (ROC) curves constructed for the volume dependence of 
resistance (ΔR) in acutely wheezing children (lung function data previously published (E3)) and 
healthy children included in the present multicenter study (n=240, red curve) and for a smaller control 
population published previously (n=75, black curve). Area under the curves (AUCs) were 0.93 and 
0.95, respectively.    
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Table E3. Cut-off values of the volume dependence of respiratory resistance (ΔR) and the 
corresponding values of sensitivity and specificity with positive (LR+) and negative (LR-) likelihood 
ratios calculated for acutely wheezing children (n=26) and healthy children from the present study 
(n=240). The upper limit of normal (ULN=1.96 hPa.s.L-1) corresponded to 95% specificity and 54% 
sensitivity. The best compromise between specificity and sensitivity was at a ΔR of 1.43 hPa.s.L-1 
(89% specificity and 92% sensitivity). 
Test ΔR 
Cut-off  
value 
Sensitivity 
(%) 
95% CI Specificity 
(%) 
95% CI LR + LR - 
-2.27 100.0 86.77% - 
100.0% 
0.4 0.01068% 
- 2.328% 
1.00 0.00 
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-1.84 100.0 86.77% - 
100.0% 
0.8 0.1024% - 
3.015% 
1.01 0.00 
-1.45 100.0 86.77% - 
100.0% 
1.3 0.2618% - 
3.654% 
1.01 0.00 
-1.39 100.0 86.77% - 
100.0% 
1.7 0.4617% - 
4.265% 
1.02 0.00 
-1.36 100.0 86.77% - 
100.0% 
2.1 0.6885% - 
4.854% 
1.02 0.00 
-1.23 100.0 86.77% - 
100.0% 
2.5 0.9346% - 
5.429% 
1.03 0.00 
-1.10 100.0 86.77% - 
100.0% 
3.0 1.196% - 
5.991% 
1.03 0.00 
-1.05 100.0 86.77% - 
100.0% 
3.4 1.468% - 
6.543% 
1.03 0.00 
-0.99 100.0 86.77% - 
100.0% 
3.8 1.751% - 
7.086% 
1.04 0.00 
-0.95 100.0 86.77% - 
100.0% 
4.2 2.042% - 
7.623% 
1.04 0.00 
-0.92 100.0 86.77% - 
100.0% 
4.6 2.339% - 
8.153% 
1.05 0.00 
-0.90 100.0 86.77% - 
100.0% 
5.1 2.643% - 
8.677% 
1.05 0.00 
-0.89 100.0 86.77% - 
100.0% 
5.5 2.953% - 
9.197% 
1.06 0.00 
-0.88 100.0 86.77% - 
100.0% 
5.9 3.267% - 
9.713% 
1.06 0.00 
-0.85 100.0 86.77% - 
100.0% 
6.3 3.585% - 
10.22% 
1.07 0.00 
-0.77 100.0 86.77% - 
100.0% 
6.8 3.908% - 
10.73% 
1.07 0.00 
-0.68 100.0 86.77% - 
100.0% 
7.2 4.234% - 
11.24% 
1.08 0.00 
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-0.64 100.0 86.77% - 
100.0% 
7.6 4.563% - 
11.74% 
1.08 0.00 
-0.64 100.0 86.77% - 
100.0% 
8.0 4.896% - 
12.24% 
1.09 0.00 
-0.60 100.0 86.77% - 
100.0% 
8.4 5.231% - 
12.73% 
1.09 0.00 
-0.55 100.0 86.77% - 
100.0% 
8.9 5.569% - 
13.23% 
1.10 0.00 
-0.51 100.0 86.77% - 
100.0% 
9.3 5.909% - 
13.72% 
1.10 0.00 
-0.50 100.0 86.77% - 
100.0% 
9.7 6.252% - 
14.21% 
1.11 0.00 
-0.48 100.0 86.77% - 
100.0% 
10.1 6.597% - 
14.69% 
1.11 0.00 
-0.45 100.0 86.77% - 
100.0% 
10.6 6.944% - 
15.18% 
1.12 0.00 
-0.43 100.0 86.77% - 
100.0% 
11.0 7.293% - 
15.66% 
1.12 0.00 
-0.42 100.0 86.77% - 
100.0% 
11.4 7.643% - 
16.14% 
1.13 0.00 
-0.40 100.0 86.77% - 
100.0% 
11.8 7.996% - 
16.62% 
1.13 0.00 
-0.37 100.0 86.77% - 
100.0% 
12.2 8.350% - 
17.10% 
1.14 0.00 
-0.34 100.0 86.77% - 
100.0% 
12.7 8.706% - 
17.57% 
1.15 0.00 
-0.32 100.0 86.77% - 
100.0% 
13.1 9.063% - 
18.05% 
1.15 0.00 
-0.29 100.0 86.77% - 
100.0% 
13.5 9.422% - 
18.52% 
1.16 0.00 
-0.27 100.0 86.77% - 
100.0% 
13.9 9.782% - 
19.00% 
1.16 0.00 
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-0.25 100.0 86.77% - 
100.0% 
14.4 10.14% - 
19.47% 
1.17 0.00 
-0.23 100.0 86.77% - 
100.0% 
14.8 10.51% - 
19.94% 
1.17 0.00 
-0.20 100.0 86.77% - 
100.0% 
15.2 10.87% - 
20.40% 
1.18 0.00 
-0.19 100.0 86.77% - 
100.0% 
15.6 11.24% - 
20.87% 
1.19 0.00 
-0.18 100.0 86.77% - 
100.0% 
16.0 11.60% - 
21.34% 
1.19 0.00 
-0.18 100.0 86.77% - 
100.0% 
16.5 11.97% - 
21.80% 
1.20 0.00 
-0.18 100.0 86.77% - 
100.0% 
16.9 12.34% - 
22.27% 
1.20 0.00 
-0.17 100.0 86.77% - 
100.0% 
17.3 12.71% - 
22.73% 
1.21 0.00 
-0.15 100.0 86.77% - 
100.0% 
17.7 13.08% - 
23.19% 
1.22 0.00 
-0.13 100.0 86.77% - 
100.0% 
18.1 13.45% - 
23.65% 
1.22 0.00 
-0.11 100.0 86.77% - 
100.0% 
18.6 13.83% - 
24.11% 
1.23 0.00 
-0.10 100.0 86.77% - 
100.0% 
19.0 14.20% - 
24.57% 
1.23 0.00 
-0.08 100.0 86.77% - 
100.0% 
19.4 14.57% - 
25.03% 
1.24 0.00 
-0.07 100.0 86.77% - 
100.0% 
19.8 14.95% - 
25.48% 
1.25 0.00 
-0.06 100.0 86.77% - 
100.0% 
20.3 15.33% - 
25.94% 
1.25 0.00 
-0.05 100.0 86.77% - 
100.0% 
20.7 15.70% - 
26.40% 
1.26 0.00 
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-0.04 100.0 86.77% - 
100.0% 
21.1 16.08% - 
26.85% 
1.27 0.00 
-0.03 100.0 86.77% - 
100.0% 
21.5 16.46% - 
27.30% 
1.27 0.00 
-0.02 100.0 86.77% - 
100.0% 
21.9 16.84% - 
27.76% 
1.28 0.00 
-0.01 100.0 86.77% - 
100.0% 
22.4 17.22% - 
28.21% 
1.29 0.00 
0.00 100.0 86.77% - 
100.0% 
22.8 17.60% - 
28.66% 
1.30 0.00 
0.01 100.0 86.77% - 
100.0% 
23.2 17.99% - 
29.11% 
1.30 0.00 
0.03 100.0 86.77% - 
100.0% 
23.6 18.37% - 
29.56% 
1.31 0.00 
0.03 100.0 86.77% - 
100.0% 
24.1 18.75% - 
30.01% 
1.32 0.00 
0.04 100.0 86.77% - 
100.0% 
24.5 19.14% - 
30.46% 
1.32 0.00 
0.06 100.0 86.77% - 
100.0% 
24.9 19.52% - 
30.90% 
1.33 0.00 
0.08 100.0 86.77% - 
100.0% 
25.3 19.91% - 
31.35% 
1.34 0.00 
0.08 100.0 86.77% - 
100.0% 
25.7 20.30% - 
31.80% 
1.35 0.00 
0.10 100.0 86.77% - 
100.0% 
26.2 20.68% - 
32.24% 
1.35 0.00 
0.10 100.0 86.77% - 
100.0% 
26.6 21.07% - 
32.69% 
1.36 0.00 
0.11 100.0 86.77% - 
100.0% 
27.0 21.46% - 
33.13% 
1.37 0.00 
0.12 100.0 86.77% - 
100.0% 
27.4 21.85% - 
33.58% 
1.38 0.00 
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0.12 100.0 86.77% - 
100.0% 
27.9 22.24% - 
34.02% 
1.39 0.00 
0.13 100.0 86.77% - 
100.0% 
28.3 22.63% - 
34.46% 
1.39 0.00 
0.13 100.0 86.77% - 
100.0% 
28.7 23.02% - 
34.90% 
1.40 0.00 
0.14 100.0 86.77% - 
100.0% 
29.1 23.41% - 
35.35% 
1.41 0.00 
0.14 100.0 86.77% - 
100.0% 
29.5 23.81% - 
35.79% 
1.42 0.00 
0.15 100.0 86.77% - 
100.0% 
30.0 24.20% - 
36.23% 
1.43 0.00 
0.15 100.0 86.77% - 
100.0% 
30.4 24.59% - 
36.67% 
1.44 0.00 
0.17 100.0 86.77% - 
100.0% 
30.8 24.99% - 
37.10% 
1.45 0.00 
0.20 100.0 86.77% - 
100.0% 
31.2 25.38% - 
37.54% 
1.45 0.00 
0.21 100.0 86.77% - 
100.0% 
31.7 25.78% - 
37.98% 
1.46 0.00 
0.21 100.0 86.77% - 
100.0% 
32.1 26.17% - 
38.42% 
1.47 0.00 
0.22 100.0 86.77% - 
100.0% 
32.5 26.57% - 
38.85% 
1.48 0.00 
0.22 100.0 86.77% - 
100.0% 
32.9 26.97% - 
39.29% 
1.49 0.00 
0.23 100.0 86.77% - 
100.0% 
33.3 27.36% - 
39.73% 
1.50 0.00 
0.24 100.0 86.77% - 
100.0% 
33.8 27.76% - 
40.16% 
1.51 0.00 
0.26 100.0 86.77% - 
100.0% 
34.2 28.16% - 
40.60% 
1.52 0.00 
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0.28 100.0 86.77% - 
100.0% 
34.6 28.56% - 
41.03% 
1.53 0.00 
0.28 100.0 86.77% - 
100.0% 
35.0 28.96% - 
41.46% 
1.54 0.00 
0.29 100.0 86.77% - 
100.0% 
35.4 29.36% - 
41.90% 
1.55 0.00 
0.30 100.0 86.77% - 
100.0% 
35.9 29.76% - 
42.33% 
1.56 0.00 
0.30 100.0 86.77% - 
100.0% 
36.3 30.16% - 
42.76% 
1.57 0.00 
0.31 100.0 86.77% - 
100.0% 
36.7 30.56% - 
43.19% 
1.58 0.00 
0.31 100.0 86.77% - 
100.0% 
37.1 30.96% - 
43.62% 
1.59 0.00 
0.32 100.0 86.77% - 
100.0% 
37.5 31.37% - 
44.05% 
1.60 0.00 
0.33 100.0 86.77% - 
100.0% 
38.0 31.77% - 
44.48% 
1.61 0.00 
0.35 100.0 86.77% - 
100.0% 
38.4 32.17% - 
44.91% 
1.62 0.00 
0.36 100.0 86.77% - 
100.0% 
38.8 32.58% - 
45.34% 
1.63 0.00 
0.37 100.0 86.77% - 
100.0% 
39.2 32.98% - 
45.77% 
1.65 0.00 
0.38 100.0 86.77% - 
100.0% 
39.7 33.39% - 
46.20% 
1.66 0.00 
0.38 100.0 86.77% - 
100.0% 
40.1 33.79% - 
46.63% 
1.67 0.00 
0.39 100.0 86.77% - 
100.0% 
40.5 34.20% - 
47.05% 
1.68 0.00 
0.40 100.0 86.77% - 
100.0% 
40.9 34.61% - 
47.48% 
1.69 0.00 
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0.41 100.0 86.77% - 
100.0% 
41.3 35.01% - 
47.91% 
1.71 0.00 
0.41 100.0 86.77% - 
100.0% 
41.8 35.42% - 
48.33% 
1.72 0.00 
0.42 100.0 86.77% - 
100.0% 
42.2 35.83% - 
48.76% 
1.73 0.00 
0.43 100.0 86.77% - 
100.0% 
42.6 36.24% - 
49.18% 
1.74 0.00 
0.43 100.0 86.77% - 
100.0% 
43.0 36.65% - 
49.61% 
1.76 0.00 
0.44 100.0 86.77% - 
100.0% 
43.5 37.06% - 
50.03% 
1.77 0.00 
0.45 100.0 86.77% - 
100.0% 
43.9 37.46% - 
50.45% 
1.78 0.00 
0.47 100.0 86.77% - 
100.0% 
44.3 37.88% - 
50.88% 
1.80 0.00 
0.49 100.0 86.77% - 
100.0% 
44.7 38.29% - 
51.30% 
1.81 0.00 
0.50 100.0 86.77% - 
100.0% 
45.2 38.70% - 
51.72% 
1.82 0.00 
0.51 100.0 86.77% - 
100.0% 
45.6 39.11% - 
52.14% 
1.84 0.00 
0.52 100.0 86.77% - 
100.0% 
46.0 39.52% - 
52.56% 
1.85 0.00 
0.52 100.0 86.77% - 
100.0% 
46.4 39.93% - 
52.98% 
1.87 0.00 
0.53 100.0 86.77% - 
100.0% 
46.8 40.35% - 
53.40% 
1.88 0.00 
0.54 100.0 86.77% - 
100.0% 
47.3 40.76% - 
53.82% 
1.90 0.00 
0.56 100.0 86.77% - 
100.0% 
47.7 41.17% - 
54.24% 
1.91 0.00 
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0.56 100.0 86.77% - 
100.0% 
48.1 41.59% - 
54.66% 
1.93 0.00 
0.56 100.0 86.77% - 
100.0% 
48.5 42.00% - 
55.08% 
1.94 0.00 
0.56 100.0 86.77% - 
100.0% 
49.0 42.42% - 
55.50% 
1.96 0.00 
0.57 100.0 86.77% - 
100.0% 
49.4 42.83% - 
55.92% 
1.98 0.00 
0.57 100.0 86.77% - 
100.0% 
49.8 43.25% - 
56.33% 
1.99 0.00 
0.57 100.0 86.77% - 
100.0% 
50.2 43.67% - 
56.75% 
2.01 0.00 
0.58 100.0 86.77% - 
100.0% 
50.6 44.08% - 
57.17% 
2.03 0.00 
0.59 100.0 86.77% - 
100.0% 
51.1 44.50% - 
57.58% 
2.04 0.00 
0.60 100.0 86.77% - 
100.0% 
51.5 44.92% - 
58.00% 
2.06 0.00 
0.60 100.0 86.77% - 
100.0% 
51.9 45.34% - 
58.41% 
2.08 0.00 
0.61 100.0 86.77% - 
100.0% 
52.3 45.76% - 
58.83% 
2.10 0.00 
0.61 100.0 86.77% - 
100.0% 
52.7 46.18% - 
59.24% 
2.12 0.00 
0.62 100.0 86.77% - 
100.0% 
53.2 46.60% - 
59.65% 
2.13 0.00 
0.63 100.0 86.77% - 
100.0% 
53.6 47.02% - 
60.07% 
2.15 0.00 
0.64 96.2 80.36% - 
99.90% 
53.6 47.02% - 
60.07% 
2.07 0.07 
0.64 96.2 80.36% - 
99.90% 
54.0 47.44% - 
60.48% 
2.09 0.07 
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0.65 96.2 80.36% - 
99.90% 
54.4 47.86% - 
60.89% 
2.11 0.07 
0.65 96.2 80.36% - 
99.90% 
54.9 48.28% - 
61.30% 
2.13 0.07 
0.65 96.2 80.36% - 
99.90% 
55.3 48.70% - 
61.71% 
2.15 0.07 
0.65 96.2 80.36% - 
99.90% 
55.7 49.12% - 
62.12% 
2.17 0.07 
0.66 96.2 80.36% - 
99.90% 
56.1 49.55% - 
62.54% 
2.19 0.07 
0.66 96.2 80.36% - 
99.90% 
56.5 49.97% - 
62.94% 
2.21 0.07 
0.67 96.2 80.36% - 
99.90% 
57.0 50.39% - 
63.35% 
2.23 0.07 
0.67 96.2 80.36% - 
99.90% 
57.4 50.82% - 
63.76% 
2.26 0.07 
0.68 96.2 80.36% - 
99.90% 
57.8 51.24% - 
64.17% 
2.28 0.07 
0.70 96.2 80.36% - 
99.90% 
58.2 51.67% - 
64.58% 
2.30 0.07 
0.71 96.2 80.36% - 
99.90% 
58.7 52.09% - 
64.99% 
2.33 0.07 
0.72 96.2 80.36% - 
99.90% 
59.1 52.52% - 
65.39% 
2.35 0.07 
0.73 96.2 80.36% - 
99.90% 
59.5 52.95% - 
65.80% 
2.37 0.06 
0.73 96.2 80.36% - 
99.90% 
59.9 53.37% - 
66.21% 
2.40 0.06 
0.74 96.2 80.36% - 
99.90% 
60.3 53.80% - 
66.61% 
2.42 0.06 
0.74 96.2 80.36% - 
99.90% 
60.8 54.23% - 
67.02% 
2.45 0.06 
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0.74 96.2 80.36% - 
99.90% 
61.2 54.66% - 
67.42% 
2.48 0.06 
0.75 96.2 80.36% - 
99.90% 
61.6 55.09% - 
67.83% 
2.50 0.06 
0.75 96.2 80.36% - 
99.90% 
62.0 55.52% - 
68.23% 
2.53 0.06 
0.76 96.2 80.36% - 
99.90% 
62.5 55.95% - 
68.63% 
2.56 0.06 
0.76 96.2 80.36% - 
99.90% 
62.9 56.38% - 
69.04% 
2.59 0.06 
0.76 96.2 80.36% - 
99.90% 
63.3 56.81% - 
69.44% 
2.62 0.06 
0.76 96.2 80.36% - 
99.90% 
63.7 57.24% - 
69.84% 
2.65 0.06 
0.77 96.2 80.36% - 
99.90% 
64.1 57.67% - 
70.24% 
2.68 0.06 
0.77 96.2 80.36% - 
99.90% 
64.6 58.10% - 
70.64% 
2.71 0.06 
0.78 96.2 80.36% - 
99.90% 
65.0 58.54% - 
71.04% 
2.75 0.06 
0.78 96.2 80.36% - 
99.90% 
65.4 58.97% - 
71.44% 
2.78 0.06 
0.78 96.2 80.36% - 
99.90% 
65.8 59.40% - 
71.84% 
2.81 0.06 
0.79 96.2 80.36% - 
99.90% 
66.2 59.84% - 
72.24% 
2.85 0.06 
0.79 96.2 80.36% - 
99.90% 
66.7 60.27% - 
72.64% 
2.88 0.06 
0.80 96.2 80.36% - 
99.90% 
67.1 60.71% - 
73.03% 
2.92 0.06 
0.81 96.2 80.36% - 
99.90% 
67.5 61.15% - 
73.43% 
2.96 0.06 
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0.81 96.2 80.36% - 
99.90% 
67.9 61.58% - 
73.83% 
3.00 0.06 
0.82 96.2 80.36% - 
99.90% 
68.3 62.02% - 
74.22% 
3.04 0.06 
0.83 96.2 80.36% - 
99.90% 
68.8 62.46% - 
74.62% 
3.08 0.06 
0.83 96.2 80.36% - 
99.90% 
69.2 62.90% - 
75.01% 
3.12 0.06 
0.85 96.2 80.36% - 
99.90% 
69.6 63.33% - 
75.41% 
3.16 0.06 
0.86 96.2 80.36% - 
99.90% 
70.0 63.77% - 
75.80% 
3.21 0.06 
0.87 96.2 80.36% - 
99.90% 
70.5 64.21% - 
76.19% 
3.25 0.05 
0.89 96.2 80.36% - 
99.90% 
70.9 64.65% - 
76.59% 
3.30 0.05 
0.90 96.2 80.36% - 
99.90% 
71.3 65.10% - 
76.98% 
3.35 0.05 
0.91 96.2 80.36% - 
99.90% 
71.7 65.54% - 
77.37% 
3.40 0.05 
0.92 96.2 80.36% - 
99.90% 
72.2 65.98% - 
77.76% 
3.45 0.05 
0.94 96.2 80.36% - 
99.90% 
72.6 66.42% - 
78.15% 
3.51 0.05 
0.94 96.2 80.36% - 
99.90% 
73.0 66.87% - 
78.54% 
3.56 0.05 
0.95 96.2 80.36% - 
99.90% 
73.4 67.31% - 
78.93% 
3.62 0.05 
0.96 96.2 80.36% - 
99.90% 
73.8 67.76% - 
79.32% 
3.68 0.05 
0.96 96.2 80.36% - 
99.90% 
74.3 68.20% - 
79.70% 
3.74 0.05 
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0.97 96.2 80.36% - 
99.90% 
74.7 68.65% - 
80.09% 
3.80 0.05 
0.98 96.2 80.36% - 
99.90% 
75.1 69.10% - 
80.48% 
3.86 0.05 
0.99 96.2 80.36% - 
99.90% 
75.5 69.54% - 
80.86% 
3.93 0.05 
1.00 96.2 80.36% - 
99.90% 
75.9 69.99% - 
81.25% 
4.00 0.05 
1.01 96.2 80.36% - 
99.90% 
76.4 70.44% - 
81.63% 
4.07 0.05 
1.01 96.2 80.36% - 
99.90% 
76.8 70.89% - 
82.01% 
4.14 0.05 
1.02 96.2 80.36% - 
99.90% 
77.2 71.34% - 
82.40% 
4.22 0.05 
1.03 96.2 80.36% - 
99.90% 
77.6 71.79% - 
82.78% 
4.30 0.05 
1.04 96.2 80.36% - 
99.90% 
78.1 72.24% - 
83.16% 
4.38 0.05 
1.04 96.2 80.36% - 
99.90% 
78.5 72.70% - 
83.54% 
4.47 0.05 
1.05 96.2 80.36% - 
99.90% 
78.9 73.15% - 
83.92% 
4.56 0.05 
1.08 96.2 80.36% - 
99.90% 
79.3 73.60% - 
84.30% 
4.65 0.05 
1.11 96.2 80.36% - 
99.90% 
79.8 74.06% - 
84.67% 
4.75 0.05 
1.13 96.2 80.36% - 
99.90% 
80.2 74.52% - 
85.05% 
4.85 0.05 
1.15 92.3 74.87% - 
99.05% 
80.2 74.52% - 
85.05% 
4.66 0.10 
1.16 92.3 74.87% - 
99.05% 
80.6 74.97% - 
85.43% 
4.76 0.10 
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1.17 92.3 74.87% - 
99.05% 
81.0 75.43% - 
85.80% 
4.86 0.09 
1.18 92.3 74.87% - 
99.05% 
81.4 75.89% - 
86.17% 
4.97 0.09 
1.19 92.3 74.87% - 
99.05% 
81.9 76.35% - 
86.55% 
5.09 0.09 
1.21 92.3 74.87% - 
99.05% 
82.3 76.81% - 
86.92% 
5.21 0.09 
1.22 92.3 74.87% - 
99.05% 
82.7 77.27% - 
87.29% 
5.34 0.09 
1.22 92.3 74.87% - 
99.05% 
83.1 77.73% - 
87.66% 
5.47 0.09 
1.26 92.3 74.87% - 
99.05% 
83.5 78.20% - 
88.03% 
5.61 0.09 
1.30 92.3 74.87% - 
99.05% 
84.0 78.66% - 
88.40% 
5.76 0.09 
1.30 92.3 74.87% - 
99.05% 
84.4 79.13% - 
88.76% 
5.91 0.09 
1.31 92.3 74.87% - 
99.05% 
84.8 79.60% - 
89.13% 
6.08 0.09 
1.31 92.3 74.87% - 
99.05% 
85.2 80.06% - 
89.49% 
6.25 0.09 
1.32 92.3 74.87% - 
99.05% 
85.7 80.53% - 
89.86% 
6.43 0.09 
1.33 92.3 74.87% - 
99.05% 
86.1 81.00% - 
90.22% 
6.63 0.09 
1.33 92.3 74.87% - 
99.05% 
86.5 81.48% - 
90.58% 
6.84 0.09 
1.34 92.3 74.87% - 
99.05% 
86.9 81.95% - 
90.94% 
7.06 0.09 
1.36 92.3 74.87% - 
99.05% 
87.3 82.43% - 
91.29% 
7.29 0.09 
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1.38 92.3 74.87% - 
99.05% 
87.8 82.90% - 
91.65% 
7.54 0.09 
1.41 92.3 74.87% - 
99.05% 
88.2 83.38% - 
92.00% 
7.82 0.09 
1.41 92.3 74.87% - 
99.05% 
88.6 83.86% - 
92.36% 
8.10 0.09 
1.43 92.3 74.87% - 
99.05% 
89.0 84.34% - 
92.71% 
8.41 0.09 
1.45 88.5 69.85% - 
97.55% 
89.0 84.34% - 
92.71% 
8.06 0.13 
1.47 84.6 65.13% - 
95.64% 
89.0 84.34% - 
92.71% 
7.71 0.17 
1.50 84.6 65.13% - 
95.64% 
89.5 84.82% - 
93.06% 
8.02 0.17 
1.52 84.6 65.13% - 
95.64% 
89.9 85.31% - 
93.40% 
8.35 0.17 
1.52 80.8 60.65% - 
93.45% 
89.9 85.31% - 
93.40% 
7.97 0.21 
1.53 80.8 60.65% - 
93.45% 
90.3 85.79% - 
93.75% 
8.33 0.21 
1.53 80.8 60.65% - 
93.45% 
90.7 86.28% - 
94.09% 
8.70 0.21 
1.54 76.9 56.35% - 
91.03% 
90.7 86.28% - 
94.09% 
8.29 0.25 
1.56 76.9 56.35% - 
91.03% 
91.1 86.77% - 
94.43% 
8.68 0.25 
1.59 73.1 52.21% - 
88.43% 
91.1 86.77% - 
94.43% 
8.25 0.30 
1.62 73.1 52.21% - 
88.43% 
91.6 87.27% - 
94.77% 
8.66 0.29 
1.63 73.1 52.21% - 
88.43% 
92.0 87.76% - 
95.10% 
9.11 0.29 
  
 
232 
 
1.64 69.2 48.21% - 
85.67% 
92.0 87.76% - 
95.10% 
8.63 0.33 
1.64 69.2 48.21% - 
85.67% 
92.4 88.26% - 
95.44% 
9.12 0.33 
1.66 65.4 44.33% - 
82.79% 
92.4 88.26% - 
95.44% 
8.61 0.37 
1.67 61.5 40.57% - 
79.77% 
92.4 88.26% - 
95.44% 
8.11 0.42 
1.71 57.7 36.92% - 
76.65% 
92.4 88.26% - 
95.44% 
7.60 0.46 
1.75 57.7 36.92% - 
76.65% 
92.8 88.76% - 
95.77% 
8.05 0.46 
1.80 57.7 36.92% - 
76.65% 
93.3 89.27% - 
96.09% 
8.55 0.45 
1.84 57.7 36.92% - 
76.65% 
93.7 89.78% - 
96.41% 
9.11 0.45 
1.88 53.8 33.37% - 
73.41% 
93.7 89.78% - 
96.41% 
8.51 0.49 
1.93 53.8 33.37% - 
73.41% 
94.1 90.29% - 
96.73% 
9.11 0.49 
1.95 53.8 33.37% - 
73.41% 
94.5 90.80% - 
97.05% 
9.81 0.49 
1.97 53.8 33.37% - 
73.41% 
94.9 91.32% - 
97.36% 
10.64 0.49 
1.99 53.8 33.37% - 
73.41% 
95.4 91.85% - 
97.66% 
11.61 0.48 
2.05 53.8 33.37% - 
73.41% 
95.8 92.38% - 
97.96% 
12.76 0.48 
2.12 50.0 29.93% - 
70.07% 
95.8 92.38% - 
97.96% 
11.85 0.52 
2.16 46.2 26.59% - 
66.63% 
95.8 92.38% - 
97.96% 
10.94 0.56 
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2.27 46.2 26.59% - 
66.63% 
96.2 92.91% - 
98.25% 
12.14 0.56 
2.37 42.3 23.35% - 
63.08% 
96.2 92.91% - 
98.25% 
11.13 0.60 
2.39 42.3 23.35% - 
63.08% 
96.6 93.46% - 
98.53% 
12.52 0.60 
2.44 42.3 23.35% - 
63.08% 
97.1 94.01% - 
98.80% 
14.34 0.59 
2.49 38.5 20.23% - 
59.43% 
97.1 94.01% - 
98.80% 
13.04 0.63 
2.52 34.6 17.21% - 
55.67% 
97.1 94.01% - 
98.80% 
11.74 0.67 
2.56 34.6 17.21% - 
55.67% 
97.5 94.57% - 
99.07% 
13.68 0.67 
2.58 30.8 14.33% - 
51.79% 
97.5 94.57% - 
99.07% 
12.16 0.71 
2.63 30.8 14.33% - 
51.79% 
97.9 95.15% - 
99.31% 
14.58 0.71 
2.72 30.8 14.33% - 
51.79% 
98.3 95.74% - 
99.54% 
18.21 0.70 
2.77 30.8 14.33% - 
51.79% 
98.7 96.35% - 
99.74% 
24.23 0.70 
2.86 26.9 11.57% - 
47.79% 
98.7 96.35% - 
99.74% 
21.20 0.74 
2.95 26.9 11.57% - 
47.79% 
99.2 96.99% - 
99.90% 
32.05 0.74 
3.02 26.9 11.57% - 
47.79% 
99.6 97.67% - 
99.99% 
64.10 0.73 
3.21 23.1 8.974% - 
43.65% 
99.6 97.67% - 
99.99% 
54.95 0.77 
3.47 19.2 6.555% - 
39.35% 
99.6 97.67% - 
99.99% 
45.79 0.81 
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3.64 15.4 4.356% - 
34.87% 
99.6 97.67% - 
99.99% 
36.62 0.85 
3.70 11.5 2.446% - 
30.15% 
99.6 97.67% - 
99.99% 
27.48 0.89 
3.86 11.5 2.446% - 
30.15% 
100.0 98.46% - 
100.0% 
 
0.88 
4.10 7.7 0.9455% - 
25.13% 
100.0 98.46% - 
100.0% 
 
0.92 
5.54 3.8 0.09733% 
- 19.64% 
100.0 98.46% - 
100.0% 
 
0.96 
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What is the key question?: Can airway obstruction be detected in individual preschool-aged children 
with wheeze? 
What is the bottom line?: Unlike previous lung function techniques that are able to detect 
differences between groups of children our novel method detects airway obstruction in individual 
children with sensitivity of 92% and specificity of 89%. 
Why read on?: Measuring the volume dependence of resistance during tidal breathing using a 
modification of the forced oscillation technique has the potential to change the way asthma and 
other respiratory diseases are assessed in young children. 
 
 
ABSTRACT  
Rationale.  Individual assessment of airway obstruction in preschool-age children requires sensitive 
and specific lung function methods with low demand of cooperation. Although the forced 
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oscillation technique (FOT) is feasible in young children, conventional measurements of respiratory 
impedance (Zrs) have limited diagnostic power in individuals.  
 
Objective. To find descriptors of within-breath Zrs that are sensitive indicators of airway 
obstruction during tidal breathing in children.  
Methods.  Zrs was measured with (i) a standard multi-frequency FOT (4-26 Hz) to assess the mean 
values of resistance and reactance for whole breaths and (ii) a 10-Hz signal to track the within-
breath changes. Various Zrs measures obtained in healthy children (n=75) and those with acute 
wheeze (n=31) were investigated with Receiver Operator Characteristic (ROC) analysis. The cut-
off values obtained for airway obstruction were then tested in children with recurrent wheeze 
(n=20) before and after administration of salbutamol.  
 
Results. The largest area under the ROC curve (0.95) was observed for the tidal changes of 
resistance between the zero-flow values (ΔR). The ΔR cut-off value of 1.42 hPa.s.L-1 detected 
airway obstruction with sensitivity of 92% and specificity of 89% in children with acute wheeze 
and distinguished children with recurrent wheeze (16/20 above the cut-off value) from healthy 
children (22/23 below the cut-off value). Furthermore, ΔR significantly decreased after salbutamol 
in wheezy children but remained unchanged in healthy children.  
 
Conclusions. New lung function measure ΔR is able to detect airway obstruction with high 
sensitivity and specificity and is suitable for use in lung function testing in young children. 
 
 
INTRODUCTION  
Detection of acute pulmonary dysfunction in young children remains a challenge for physicians as 
there is no lung function method available in the routine clinical care that can be performed easily 
and reliably in sick young children.[1-3] This is particularly important considering that more than 
half the children hospitalized for wheeze or asthma exacerbation are under six years of age [4].  
Spirometry, the ‘gold standard’ lung function test, has many limitations in preschool-age children, 
especially when they are unwell. In addition to the high cooperation required for the respiratory 
manoeuvres, the technique is not applied consistently in children under six years of age, as different 
outcome measures and cut-off points have been suggested for the assessment of airway 
obstruction.[1,3.5-7] Alternative lung function methods have been developed in recent decades to 
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overcome these problems; however, these techniques are more frequently employed in research 
studies assessing differences in lung function between healthy and diseased study groups, and are 
not routinely used in clinical practice.[1,3] Objective measurements of lung function validated for 
detecting abnormalities in individual young children would present a significant advance. 
 
The forced oscillation technique (FOT) has been employed widely in paediatric lung function 
testing due to its non-invasive nature and the lack of special breathing manoeuvres required from 
the subject. Several reports have addressed the utility of the FOT in paediatrics,[1,3,8,9] and 
normative data are available;[10-13] however, FOT methodology and data interpretation differ 
between commercial devices. [1] In addition, current opinion suggests that FOT is more useful for 
showing differences between groups rather than following disease in individuals.[1,3] This may, in 
part be due to the large variance of normal data in preschool-age children.[10-13] 
 
Respiratory impedance (Zrs) is commonly determined at multiple oscillation frequencies and 
averaged over several breaths [8,14,15] with the tacit assumption of linearity, i.e. that the 
mechanical properties of the respiratory system do not change during quiet breathing. However, 
there is strong evidence that nonlinear phenomena (flow and volume dependence of impedance) 
result in marked within-breath changes in respiratory resistance (R).[16-19] Although the effect of 
the upper airways on R has not been fully established, previous research on the upper airway and 
vocal cord physiology demonstrated that the area of the glottic aperture achieved a minimum value 
in mid-expiration and thus elevates the mean R during expiration. This effect was greater in the 
presence of airway obstruction.[20,21] An important message from these studies was that the 
effects of flow and the geometry of the upper airways on R were significant in both health and 
disease, even during quiet breathing, and that the mean R values from total breaths or from whole 
inspiratory and expiratory phases separately are fundamentally dependent on the flow pattern.  
 
The present study aimed to examine within-breath changes in Zrs, in order to determine R in phases 
of the breathing cycle that are the least affected by the breathing pattern (i.e. airflow) and the 
rheology of the upper airways.  We hypothesised that the change in R with tidal volume (measured 
between the zero-flow points at end-expiration and end-inspiration) would be a sensitive indicator 
of airway calibre and hence the airway obstruction during tidal breathing in wheezy preschool-age 
children. 
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METHODS 
Subjects and study procedures 
Children with acute wheeze (Study I) 
Preschool-age children admitted with acute wheeze to the Emergency Department of the Royal 
Children’s Hospital, Brisbane, Australia were enrolled in the study between June 2014 and August 
2015. The relevant clinical information is shown in Table 1. Children were eligible to participate if 
they 1) had detectable wheeze on auscultation; 2) needed treatment with short acting β2 receptor 
agonist (SABA); and 3) did not require supplemental oxygen by the time of the lung function 
measurement. Lung function from children who had SABA 1 hour prior to the study visit were 
excluded from the analysis. Parents completed a modified ISAAC questionnaire (see Appendix) for 
their child, and lung function was then measured. Another group of children (n=75) was recruited 
from local kindergartens as healthy controls. The consent form and a questionnaire regarding the 
respiratory status of their child were mailed to the parents and the forms were collected on the day 
of the visit. Children were defined as healthy based on the following criteria assessed in the 
questionnaire: 1) ≥37 completed weeks of gestation, 2) no prior diagnosis of asthma or other 
respiratory disease, or known growth defects and 3) asymptomatic at least for 4 weeks prior to 
testing.  
 
Children with recurrent wheeze (Study II) 
Table 1. Clinical symptoms and treatment of wheezy children from Studies I and II.  
Clinical symptoms Acute wheeze (n=26) Recurrent wheeze (n=20) 
Doctor diagnosis of asthma  9 7 
≥1 hospital admission*  12 6 
No wheezy episode* 2 2 
1-3 wheezy episodes*  14 11 
4-12 wheezy episodes* 7 7 
>12 wheezy episodes* 3 0 
Medication#   
Daily treatment with ICS (+/- LTRA) 8 4 
Daily treatment with LTRA only 0 3 
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SABA only (prn) 13 4 
No treatment 5 9 
*:in the 12 months prior to the study visit; #:medication use prior to the study visit;  
ICS: inhaled corticosteroids; LTRA: leukotriene receptor antagonist; SABA: short-acting β2-
agonist 
 
 
Children with stable wheeze or asthma (i.e. more than 3 wheezy episodes after the first year of life 
and/or doctor diagnosis of asthma, Table 1; symptom-free for at least 4 weeks prior to the study 
visit, n=20) were recruited from Asthma Clinics at the Royal Children’s Hospital, Brisbane between 
April and November 2015. Informed consent was obtained and lung function measured before and 
after the administration of 400 µg inhaled salbutamol (Ventolin™, GlaxoSmithKline, Ermington, 
NSW, Australia) via a spacer (Aerochamber*, Trudell Medical International, London, Ontario, 
Canada). Bronchodilator response was also assessed in a subgroup of the healthy children (n=23). 
Both studies were approved by the Children’s Health Services Human Research Ethics Committee, 
Brisbane, Australia. 
Impedance measurements 
Custom-made FOT equipment, consisting of a loudspeaker and a wave tube was used to measure 
Zrs.[22] A pneumotachograph was employed to record changes in flow and volume during tidal 
breathing (Fig. 1). Two types of FOT measurements were performed in each subject during tidal 
breathing. First, Zrs was measured with a multiple-frequency pseudorandom signal between 4 and 
26 Hz for 16 s; these measurements were repeated until 3 reproducible Zrs spectra were obtained 
and these spectra were ensemble averaged. Second, the within-breath changes in Zrs were tracked 
with a single 10-Hz sinusoid, and all regular breathing periods from 3 recordings were selected for 
analysis. Details of the Zrs measurements are given in the Appendix.    
 
Table 2. Definitions of the within-breath impedance measures obtained from the 10 Hz recordings.   
Phases of the breathing cycle Resistance (R) Reactance (X) 
Whole expiration (meanE) RmeanE XmeanE 
Whole inspiration (meanI) RmeanI XmeanI 
Difference between meanE and meanI ΔRmean ΔXmean 
  
 
240 
 
End expiration (eE) ReE XeE 
End inspiration (eI) ReI XeI 
Difference between eE and eI  ΔR ΔX 
Maximum expiratory flow (maxE) RV’maxE XV’maxE 
Maximum inspiratory flow (maxI) RV’maxI XV’maxI 
Area within the resistance vs flow loops ARV’ - 
 
Data analysis 
Mean values of R and X at each measured frequency were determined from the averaged Zrs 
spectra and those at 6, 8, and 10 Hz (R6, R8, R10, X6, X8 and X10) are reported. From the temporal 
recordings, R and X were obtained at every 0.1 s from all the artefact-free breathing cycles and their 
values were calculated at specific time points (Fig. and Table 2). The temporal variables are 
summarized in Table 2. Tidal volume (VT), tidal inspiratory (V’maxI) and expiratory flows (V’maxE), 
breathing frequency (fbr), and the expiratory time relative to the total breathing period (TE/Ttot) were 
obtained from the tidal flow signal. 
 
Statistical analysis 
Summary statistics for continuous variables are presented as either mean±standard deviation (SD) 
or median (25% percentile;75% percentile) as appropriate. The differences in Zrs and tidal 
breathing variables between the groups in Study I were assessed with the Wilcoxon rank sum tests. 
A p-value of <0.05 was considered statistically significant. The sensitivity and specificity, negative 
and positive predicted values (NPV and PPV, respectively) and likelihood ratios of the variables to 
detect airway obstruction were determined using receiver operator characteristic (ROC) analysis. 
Cut-off value for each of the variables was defined as the best relationship between sensitivity and 
specificity. The effect of salbutamol was analysed using the two-way repeated measures of 
ANOVA.  
 
RESULTS 
Children with acute wheeze (Study I)  
Three obstructed children who received SABA less than 1 h prior to the FOT measurements were 
excluded from the analysis while two children were not able to perform lung function testing. (Fig. 
3). The demographic characteristics of the children in the two groups are summarized in Table 3. 
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Table 3. Anthropometric and tidal breathing data of children (Study I). Data are presented as 
median (25th percentile;75th percentile).  
 Healthy  (n=75) Acute wheeze (n=26) p-value 
Age (year) 4.8 (4.3;5.2) 4.8 (3.9;6.0) 0.93 
Height (cm) 108.3 (105.9;116.9) 110.6 (102.1;118.5) 0.24 
Weight (kg) 19.0 (16.2;21.1) 20.7 (17.7;23.6) 0.46 
Tidal volume (ml) 289 (232;378) 337 (270;428) 0.15 
Fbr (breath/min) 28 (23;32) 26 (22;34) 0.30 
Te/Ttot 0.54 (0.52;0.57) 0.57 (0.55;0.59) 0.002* 
V’maxE/V’maxI 0.88 (0.81;0.97) 0.81 (0.72;0.92) 0.014* 
Fbr: breathing frequency, Te: time of expiration, Ttot: total time of a breathing cycle, V’maxE: 
maximum expiratory flow, VmaxI: maximum inspiratory flow. *statistically significant difference  
Respiratory function 
 Zrs data collected with the pseudorandom signal are shown in Fig. 4. The conventional FOT 
variables (R6, R8, R10, X6, X8 and X10) did not differ between the two groups (p=0.54, 0.88, 0.60, 
0.72, 0.16 and 0.37, respectively). The expiration was proportionally longer and V’maxE was reduced 
in children with acute airway obstruction (Table 3); however, minute ventilation was similar in the 
two groups (p=0.42). The mean values of R during inspiration (RmeanI) and expiration (RmeanE) did 
not distinguish between the two groups whereas the inspiratory and expiratory mean reactances 
(XmeanI and XmeanE, respectively) were significantly lower in children with acute airway obstruction. 
The differences between the corresponding inspiratory and expiratory mean values (ΔRmean and 
ΔXmean) did not differ between the groups (Table 4).  
 
 
 
 
 
 
Table 4. Impedance measures calculated for expiration (RmeanE, XmeanE) and inspiration (RmeanI, 
XmeanI) and their differences (ΔRmean, ΔXmean) in the two groups of children (Study I). Data are 
presented as median (25th percentile;75th percentile).  
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Impedance measures 
(hPa.s.L-1) 
Healthy (n=75) Acute wheeze (n=26) p-value 
RmeanE 8.63 (7.48;10.13) 9.23 (7.82;10.90) 0.12 
RmeanI 7.74 (6.73;8.66) 8.26 (7.17;9.25) 0.14 
ΔRmean 0.97 (0.60;1.41) 1.14 (0.36,1.83) 0.30 
XmeanE -1.83 (-2.96; -1.16)  -2.70 (-4.17;-1.70) 0.026* 
XmeanI -1.75 (-2.41; -1.01) -2.22 (-3.24;-1.81) 0.014* 
ΔXmean -0.19 (-0.50;0.29) 0.05 (-0.67;0.29) 0.66 
*statistically significant difference 
The changes in the group mean values of R and X during tidal breathing are illustrated in Fig. 5. At 
the end of expiration, R was significantly higher in children with acute airway obstruction 
compared to healthy subjects (p<0.001) and remained elevated at V’maxI (p=0.007). By the end of 
inspiration, R decreased, with the difference in R between the groups disappearing (p=0.51). The 
onset of expiratory flow resulted in a fast rise in R in both groups; however, in children with acute 
airway obstruction R was higher (p=0.02) and remained elevated at the end of expiration. The 
changes in X during tidal breathing mirrored the changes in R, with statistically significant 
differences between the two groups at end-expiration (p<0.001), at V’maxI (p<0.001) and V’maxE 
(p=0.005).  
The most significant differences between the two groups were the changes in R and X between the 
beginning and the end of inspiration, as illustrated by typical R and X vs volume and flow loops in 
Fig. 6. Children with acute airway obstruction exhibited a significantly increased difference in R 
between end-expiration and end-inspiration (ΔR, Fig. 6B) compared to healthy children (Fig. 6A; 
2.42±1.31 vs 0.61±0.66 hPa.s.L-1, p<0.001), and this difference remained unchanged when ΔR was 
corrected for VT (7.73±5.83 vs 1.87±2.63 hPa.s.L
-2, p<0.001). Furthermore, ΔR exhibited no 
relationship with the height-corrected tidal volume (cVT; r
2=0.02, p=0.25) while both ReE and ReI 
were negatively related to cVT (r
2=0.06 and r2=0.42, respectively, both p<0.001,). . There was a 
weak (although statistically significant) relationship between TE/Ttot and ΔR (r2=0.06, p=0.013); 
however, when height was included as a co-variable in the regression, the significance disappeared 
(p=0.055). We note here that there was no relationship between VT, TE/Ttot and the conventional 
measures of respiratory resistance and reactance, i.e. mean R and X at different frequencies (data 
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not shown). The tidal change in X (ΔX) was similar in magnitude in the two groups but opposite in 
sign (0.29±1.08 vs -0.40±0.54 hPa.s.L-1, p<0.001).  
Diagnostic value of impedance measures for detecting airway obstruction 
The ROC curves for RmeanE, RmeanI, XmeanE, XmeanI, ΔR and ΔX are presented in Fig. 7. The largest 
area under the curve (AUC) was observed for ΔR (0.95) and ΔX (0.79), corresponding to higher 
values of sensitivity and specificity to detect airway obstruction than that of the mean inspiratory or 
mean expiratory Zrs variables (RmeanE: 0.60; RmeanI: 0.60; XmeanE: 0.65 and XmeanI: 0.70; all p<0.0001 
vs ΔR). Optimal detection of airway obstruction was established with a ΔR of ≥1.42 hPa.s.L-1, 
which corresponded to a sensitivity of 92% (75 to 99) and a specificity of 89% (57 to 89) with NPV 
and PPV of 97% (90 to 99) and 75  (57 to 89), respectively, calculated for the prevalence of wheeze 
in the study population (25.7%; 26/101 children). This prevalence is comparable with the expected 
proportion of preschool-age children with recurrent wheeze who go on to develop persistent asthma 
(30%).The cut-off values for potential outcome measures with values of sensitivity and specificity, 
NPV, PPV, positive and negative likelihood ratios are shown in the Appendix.  
 
Children with recurrent wheeze (Study II) 
Bronchodilator response 
Baseline lung function was measured in 20 children with recurrent wheeze (age: 4.04 ± 0.55 yr, 
height: 101.3 ± 7.4 cm) and 23 healthy children (age: 4.29 ± 0.51 yr, height: 99.6 ± 5.3 cm). Three 
wheezy children were not able to repeat the lung function test after administration of salbutamol. 
Bronchodilator response in Zrs measured with the multiple-frequency signal is illustrated in Fig. 8.  
There was no significant difference between the groups either at baseline or in their responses to 
salbutamol. Despite the lack of differences in the conventional FOT variables, ΔR and RmeanI were 
significantly increased at baseline in the wheezy children compared to the healthy children (Table 
5). Sixteen of the 20 wheezy children had a baseline ΔR higher than the cut-off value defined for 
airway obstruction in Study I, while ΔR was below the cut-off in 96% of the healthy children (22 
out of the 23). The difference in ΔR between the groups disappeared after the administration of 
salbutamol (Fig 9, p=0.38). 
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Table 5. Resistance (R) and reactance (X) measures calculated at 6 Hz (R6 and X6), separately for expiration (RmeanE and XmeanE), inspiration (RmeanI 
and XmeanI) and the volume dependence (ΔR and ΔX) in two groups of children pre and post salbutamol (Study II). Data are presented as mean ± SD 
 Healthy (n=23) Recurrent wheeze (n=17) p-value§ 
Lung function variables pre post p-value# pre post p-value#  
Tidal volume (mL) 244 ± 193 220 ± 183  0.29 211 ± 156 209 ± 144 0.12 0.151 
Fbr (breath/min) 27 ± 4 26 ± 4 0.41 25 ± 5 26 ± 4 0.25 0.331 
TE/Ttot 0.54 ± 0.04 0.55 ± 0.05 0.19 0.58 ± 0.04 0.56 ± 0.04 0.14 0.186 
R6 (hPa.s.L
-1) 9.61 ± 1.74 7.95 ± 1.56 <0.001* 9.83 ± 2.41 7.57 ± 1.58 <0.001* 0.398 
RmeanE (hPa.s.L
-1) 9.25 ± 1.28 7.96 ± 1.84 <0.001* 9.27 ± 2.53 6.79 ± 1.23 <0.001* 0.054 
RmeanI (hPa.s.L
-1) 8.32 ± 1.02 7.06 ±1.78 <0.001* 8.56 ± 2.00 6.00 ± 1.06 <0.001* 0.023* 
X6 (hPa.s.L
-1) -3.16 ± 0.93 -2.61 ± 1.01 <0.001* -3.65 ± 1.72 -2.38 ± 1.02 <0.001* 0.107 
XmeanE (hPa.s.L
-1) -2.27 ± 1.14 -1.36 ± 0.91 <0.001* -2.28 ± 1.57 -0.95 ± 0.91 <0.001* 0.237 
XmeanI (hPa.s.L
-1) -2.08 ± 0.88 -1.16 ± 0.73 <0.001* -2.21 ± 1.08 -0.91 ± 0.61 <0.001* 0.178 
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ΔR (hPa.s.L-1) 0.67 ± 0.58 0.26 ± 0.82 0.065 2.00 ± 1.21 0.52 ± 0.46 <0.001* <0.001* 
ΔX (hPa.s.L-1) -0.36 ± 0.51 -0.69 ± 0.38 0.002* -0.08 ± 1.02 -0.65 ± 0.51 0.02* 0.089 
Fbr: breathing frequency, Te: time of expiration, Ttot: total time of a breathing cycle; #: p-value vs pre salbutamol; §: p-value vs healthy. *: significant 
difference 
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DISCUSSION 
 
The results from the present study demonstrate that the change of respiratory resistance during 
normal breathing is a highly specific and sensitive measure of airway obstruction in young children, 
whereas the conventional averaged estimates of respiratory resistance fail to discriminate between 
the wheezing and healthy preschool-age children. Together with the known feasibility of the FOT in 
young children and the achievable high success rate the extension of this technique to the within-
breath analysis of respiratory mechanics has the potential to reveal physiologically and clinically 
important alterations in airway function.  
 
Respiratory resistance is assumed to reflect airway calibre; therefore, FOT measurements have been 
employed widely in paediatric studies in various groups of patients with respiratory disease.[23-28] 
While some of these studies suggested that, similarly to other methods, such as spirometry [5,7] and 
multiple breath washout [29,30] the FOT was able to distinguish between healthy and diseased 
subject groups,[25,28,31-33] others raised concerns about the diagnostic value of the Zrs data, 
especially in young children.[23,24,26,27,34] The controversies surrounding the FOT not only arise 
from the diversity of Zrs measures reported from the various studies but also from the wide range of 
the normal values in the paediatric population for any given age or height.[10-13] The large 
variability of the Zrs in healthy preschool-age children can be explained, in part, by the unstable 
end-expiratory lung volume level and the variable breathing patterns adopted by young 
children.[35] In agreement with the body of the literature we did not find a difference between 
healthy and wheezy children when using conventional mean values of Zrs measures from whole 
breathing cycles or considering only the inspiratory phase as proposed recently.[19,32,36]   
 
Previous investigations suggested that R measured during spontaneous breathing not only reflects 
the overall airway calibre but is also determined by the airflow through the upper airways and larger 
conducting airways.[37] In agreement with earlier findings,[16-19] our within-breath Zrs data 
demonstrated that R increases with expiratory flow reaching its peak at the maximum flow that can 
be related to the vocal cord movements during tidal breathing (i.e. during expiration, the glottic 
aperture narrows and reaches its smallest diameter at mid-expiration).[20,21] It is important to note 
that, the glottic aperture resumes its original area at the end of expiration in healthy adults. Since 
there are no data available on vocal cord movements in airway obstruction in children, we cannot 
exclude the possibility that, contrary to the findings in adults,[20,21] the relatively narrow glottic 
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aperture during expiration does not completely return to its original size by the time inspiration 
begins, possibly affecting R at the end-expiration, and hence ∆R. Although further investigations 
are required to localise the airway obstruction (i.e. intra- vs extrapulmonary), our data suggest that 
independently of the exact location, ΔR is a sensitive and specific indicator of the airway 
obstruction in young children. These findings support our hypothesis that by the identification of 
the zero-flow resistance points we can minimize the effect of the nonlinear, flow-dependent 
behaviour of the upper airways on R.  
 
Although flow dependence of R is also significant in inspiration, the mean values of the inspiratory 
R have been suggested as a surrogate measure of airway resistance.[16] In the present study, the 
diagnostic value of RmeanI was weak, which suggests that flow-dependent contributions to R during 
inspiration did not differ between groups. The flow dependence of R, present in both inspiratory 
and expiratory phases, is primarily related to the breathing pattern and not to the degree of 
obstruction, and this may exert a masking effect on the assessment of airway calibre. This finding 
may explain why the average R obtained with the conventional FOT is poor in separating normal 
and diseased subject groups. Indeed, significant improvements in sensitivity and specificity were 
attained in the present study when the influence of flow on R was eliminated by examining the 
change in R between the zero-flow, i.e. end-inspiratory and end-expiratory points (∆R). The 
diagnostic power of ∆R reported in the present study is much greater than that of any lung function 
index, including that of the FOT, reported previously in the preschool-age group.[27,33] 
 
The mechanisms by which ∆R differs between healthy children and those with acute airway 
obstruction are likely to be complex, and their clarification needs further investigation. 
Nevertheless, the fact that the difference in R at end-expiration between the two groups diminishes 
during inspiration suggests that the airways of children with acute obstruction demonstrate an 
increased baseline constrictor tone before inspiration begins (i.e. at functional residual capacity) that 
is reduced by a normal tidal expansion of the lungs but then re-established during expiration. This 
finding is consistent with the observation in precision-cut human lung slices where the 
acetylcholine-induced smooth muscle constriction of the individual intra-parenchymal airways was 
reversed with the tidal expansion.[38] It is also possible that inhomogeneity in the resistance of the 
distal airways at end-expiration is higher in children with obstruction; this is indicated by both a 
higher R and an increase in apparent elasticity of the lungs [39,40] as reflected by the more negative 
X values that also return to a normal level at end-inspiration. The inhomogeneity of peripheral 
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resistance might reach the degree of cyclic closure and reopening of some peripheral lung units, 
which would also be consistent with the observed changes in R and X. The coupling of the resistive 
and elastic parameters during the breathing cycle is also supported by the second highest value of 
the AUC (0.80) observed in the ROC analysis for ∆X.  
 
Analysis of R as a bilinear function of flow and volume has proved useful in characterizing the 
volume dependence before and after methacholine provocation [18,37] and subsequent 
bronchodilatation in children with a history of cough or asthma.[19] In the present study, expiratory 
flow limitation was present (and the ratio V’maxE/V’maxI reduced) in acute airway obstruction 
compared to that in healthy children. However, detailed analysis of our data suggests that changes 
in R with tidal volume are more specific for airway obstruction than the changes in the flow profile 
(data are not shown). On the basis of the cut-off value of ∆R established in children with acute 
airway obstruction, 80% of the children with recurrent wheeze were identified as having airway 
obstruction in our test population and 96% of the healthy children were properly classified as not 
having airway obstruction before the administration of salbutamol. Furthermore, all variables we 
studied changed in both groups significantly and uniformly in response to salbutamol, whereas ΔR 
only decreased in asthmatics and was thus able to differentiate between the groups. This finding 
suggests that although these children with well-controlled stable asthma exhibit conventional lung 
function measures apparently very similar to that of the healthy children (this may partly be due to 
the relatively low contribution of the small airways to the total resistance of the respiratory system), 
a sensitive technique is able to reveal the alterations in their airway function. Further investigations 
are needed to establish whether the lack of a high ΔR and response to salbutamol in some of our 
wheezy children reflects a well-controlled and/or early stage of disease without ongoing 
inflammation and airway remodelling, or it is associated with structural alterations of the airway 
wall that result in a decreased airway distensibility which cannot be eliminated by the 
administration of bronchodilator agonist.  
 
Since the influences of height and age on ∆R and ∆X were not significant in the present study, the 
cut-off values established for children between 3 and 7 years of age can be applied safely to other 
populations of young children with similar demographics. However, it is important to note that the 
potential of ∆R as a descriptor of airway dynamics in children with paediatric respiratory conditions 
other than asthma, such as those associated with peripheral abnormalities (cystic fibrosis, interstitial 
lung disease, etc.) needs to be further investigated. Additionally, although the primary aim of this 
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study was the comparison of the within-breath approach with conventional FOT, assessment of 
agreement with other techniques commonly employed in the preschool age (multiple breath 
washout, forced spirometry) would be informative. We nevertheless think that the present results 
document a methodological advance worthy of further investigation in larger and longitudinal 
studies. 
 
In conclusion, the assessment of the tidal and flow-independent changes in forced oscillatory 
resistance in the present study has resulted in a significant improvement in the sensitivity and 
specificity attained previously with the FOT and other lung function tests in the differentiation 
between healthy preschool-age children and those with acute bronchial obstruction. The cut-off 
value of ∆R used in a test population properly separated wheezy and healthy children. Our results 
demonstrate the potential of the within-breath approach of the FOT in the assessment of lung 
disease in individual patients.   
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FIGURES 
 
Figure 1. Forced oscillation technique device. P1 and P2 are two identical pressure transducers to 
measure the inlet and outlet pressures of the wave-tube.  
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Figure 2. Tidal changes in resistance (R) and reactance (X) with the flow and volume traces. Dashed 
lines indicate time points of end expiration (eE), end inspiration (eI), maximum inspiratory flow 
(V’maxI) and maximum expiratory flow (V’maxE). 
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Figure 3. Flow chart of participants in Study I.
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Figure 4. Impedance (Zrs) spectra between 6 and 26 Hz obtained in children with acute wheeze (open 
circles) and that in healthy subjects (closed circles). Bars represent standard deviation. 
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Figure 5. Mean values of resistance (R, top) and reactance (X, bottom) in children with (open circles) 
and without acute airway obstruction (closed circles) at the end of expiration (eE), maximum 
inspiratory flow (maxI), end of inspiration (eI) and maximum expiratory flow (maxE). Bars represent 
SEM values; *: statistically significant difference between groups.
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Figure 6. Tidal changes with volume (panels A and B) and flow (panels D and C) in resistance (R, 
top) and reactance (X, bottom) during inspiration (open circles) and expiration (closed circles) in a 
healthy subject (panels A and C) and in a child with acute airway obstruction (panels B and D). 
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Figure 7. Receiver operator characteristic (ROC) curves for within-breath resistance (panel A) and 
reactance measures (panel B). The open squares represent the difference between the end-expiratory 
and end-inspiratory resistance (ΔR) or reactance (ΔX) values; open circles and triangles indicate the 
mean values of the resistance and reactance in expiration (RmeanE, XmeanE) and inspiration (RmeanI, 
XmeanI), respectively. 
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Figure 8. Respiratory impedance (Zrs) between 6 and 26 Hz in healthy (panel A) and children with 
recurrent wheeze (panel B) before (closed circles) and after administration of salbutamol (open 
circles). Bars represent standard deviation.
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Figure 9. Individual changes in volume-dependence of resistance (ΔR) pre and post administration 
of salbutamol. Symbols and lines represent data in healthy children (panel A) and children with 
recurrent wheeze (panel B). The horizontal dashed line shows the cut-off value of ΔR for airway 
obstruction (1.42 hPa.s.L-1).
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APPENDIX 
 
APPENDIX 1 (METHODS) 
DEATAILS ON IMPEDANCE MEASUREMENTS 
The custom-made FOT setup consisted of a computer-controlled loudspeaker-in-box system 
delivering the forced oscillatory signal and a wave-tube (length: 17 cm, internal diameter: 1.4 cm) 
employed for the estimation of Zrs.[1] Model 26PCAFA6D pressure sensors (Honeywell S&C, New 
Jersey, USA) were used for the measurements of the inlet (P1) and outlet (P2) pressures of the wave 
tube and the pressure difference across the pneumotachograph. Tidal flow (V’) was recorded with a 
screen pneumotachograph and volume (V) was obtained via numerical integration of V’.  
Two types of FOT measurements were performed in each subject during 16-s intervals of tidal 
breathing. First, Zrs was measured with a pseudorandom signal with a peak-to-peak size of <1.5 
hPa.s.L-1, containing 12 frequency components between 4 and 26 Hz. The signals P1 and P2 were 
high-pass filtered at 3 Hz to suppress the influence of spontaneous breathing signal components on 
the estimation of Zrs. These measurements were repeated until 3 reproducible Zrs spectra (i.e. where 
the magnitude of Zrs was within the 20% range at all frequencies) were obtained, and these spectra 
were ensemble averaged. Second, the temporal changes in Zrs were tracked with a single small-
amplitude (<0.25 hPa.s.L-1) 10-Hz sinusoid and the signals P1 and P2 were band-passed around 10 Hz 
to reduce the influence of the higher harmonics of breathing. The values of resistance (R) and 
reactance (X) were calculated for every oscillation cycle (0.1 s). The exact time points of end-
expiration and end-inspiration, as well as the corresponding R and X values, were obtained by linear 
interpolation between the data neighbouring the zero crossing of V’.  
 
ANALYSIS OF ZRS RECORDINGS 
Zrs recordings (i.e. multi or single frequency recordings) were analysed in a random order by the 
same assessors who performed the lung function tests. International guidelines were always followed 
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in the analysis of the multi-frequency data and the within-breath analysis was also standardized by 
selecting all regular breathing periods for analysis. Although the assessors were aware of the health 
status of the subjects involved in both studies, the statistical analysis of the Zrs data and their 
relationships with health status was performed once the final dataset was assembled.  
 
STATISTICAL ANALYSIS  
Summary statistics for continuous variables are presented as either mean±standard deviation (SD) or 
median (25% percentile;75% percentile) as appropriate. The differences in Zrs and tidal breathing 
variables between the groups in Study I were assessed with the Wilcoxon rank sum tests. Tidal 
breathing and FOT variables were also expressed as standardised residuals to assess the comparative 
effect sizes of the main outcome variables (Table E1).   A p-value of <0.05 was considered statistically 
significant. The areas under the receiver operator characteristic (ROC) curves (the AUCs) were 
calculated.[2] An optimal cut-off value for each of the variables was determined as the value that 
gave the best compromise between sensitivity and specificity. Diagnostic statistics, including 
sensitivity, specificity, predictive values and likelihood ratios, of the variables to detect airway 
obstruction were calculated. Negative and positive predicted values and likelihood ratios were 
calculated as following:    
NPV= 
Specificity x (1-Prevalence (P)) 
Specificity x (1-P) + (1-Sensitivity) x P 
 
PPV= 
Sensitivity x P 
Sensitivity x P + (1-Specificity) x (1-P) 
 
NLR= 
Probability of a negative test given the presence of disease  
Probability of a negative test given the absence of disease 
 
PLR= 
Probability of a positive test given the presence of disease  
Probability of a positive test given the absence of disease 
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PPV and NPV have been calculated for a prevalence of 25.7% (prevalence of wheeze in the present 
study) and for an extremely low (10%) and high (60%) prevalence.  
The effects of salbuterol were analysed using two-way repeated measures ANOVA with the Holm-
Sidak post-hoc test. Analyses were undertaken using SigmastatTM (SPSS Inc., Chicago, IL, USA) and 
Stata statistical software v11.2 (StataCorp, College Station, TX, USA). 
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APPENDIX 2 (RESULTS) 
Table E1. Association between participants’ health status (acute wheeze/healthy) and lung function 
variables. Standardised residuals were calculated using univariable linear regression. 
Lung function measures Standardised residuals  
Tidal volume (ml) 0.11 
Fbr (breath/min) 0.03 
Te/Ttot 0.31 
V’maxE/V’maxI 0.28 
ΔR 0.65 
ΔX 0.07 
RmeanE (hPa.s.L
-1) 0.04 
RmeanI (hPa.s.L
-1) 0.01 
ΔRmean (hPa.s.L-1) 0.11 
XmeanE (hPa.s.L
-1) 0.04 
XmeanI (hPa.s.L
-1) 0.05 
ΔXmean (hPa.s.L-1) 0.01 
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Tables E2 and E3. Results of the receiver operator characteristic (ROC) analysis for the impedance variables. Data are presented as value (95% 
Confidence Interval). Results are reported for 26 children with airway obstruction and 75 healthy children.  
Impedance 
variable 
(hPa.s.L-1) 
Area under the 
curve 
Cut-off value 
(hPa.s.L-1) 
Number of cases above 
cut-off value (obstructive, 
healthy) 
Sensitivity 
(%) 
Specificity 
(%) 
Positive 
likelihood 
ratio 
Negative 
likelihood 
ratio 
ΔR 
0.95 (0.90 to 
0.99) 
1.42 24, 8 92 (75 to 99) 89 (80 to 95) 
8.7 (4.5 to 
16.8) 
0.1 (0.02 to 
0.3) 
ΔX 
0.82 (0.71 to 
0.92) 
-0.16 20, 20 77 (56 to 91) 73 (62 to 83) 
2.63 (1.68 to 
4.11) 
0.28 (0.12 to 
0.62) 
RmeanE 
0.60 (0.47 to 
0.73) 
9.07 15, 31 58 (37 to 77) 59 (47 to 70) 
1.4 (0.9 to 2.1) 0.7 (0.4 to 1.2) 
RmeanI 
0.60 (0.47 to 
0.72) 
7.98 17, 30 65 (44 to 83) 60 (48 to 71) 
1.6 (1.1 to 2.4) 0.6 (0.3 to 1.0) 
XmeanE 
0.65 (0.53 to 
0.78) 
-1.99 16, 33 62 (41 to 78) 56 (44 to 68) 
1.4 (0.9 to 2.1) 0.7 (0.4 to 1.2) 
XmeanI 
0.70 (059 to 
0.81 
-2.07 16, 30 62 (41 to 80) 60 (48 to 71) 
1.5 (1.0 to 2.3) 0.6 (0.4 to 1.1) 
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Pair 
Difference in the 
area 
Standard error 95% COI ChiSquare, DF=1 P-value 
ΔR, RmeanE 0.35 0.0670 0.21 to 0.48 26.3 < 0.0001 
ΔR, RmeanI 0.35 0.0664 0.22 to 0.48 27.7 < 0.0001 
ΔR, XmeanE 0.29 0.0657 0.17 to 0.42 20.1 < 0.0001 
ΔR,  XmeanI 0.25 0.0591 0.13 to 0.37 18.0 < 0.001 
ΔR, ΔX 0.15 0.0559 0.05 to 0.26 7.7 0.005 
ΔX, XmeanE 0.14 0.0677 0.01 to 0.27 4.2 0.039 
ΔX, XmeanI 0.10 0.0610 0.02 to 0.21 2.4 0.118 
ΔX, RmeanE 0.19 0.0798 0.03 to 0.34 5.6 0.018 
ΔX, RmeanI 0.19 0.0764 0.04 to 0.34 6.4 0.011 
RmeanE,  RmeanI 0.01 0.022 -0.04 to 0.05 0.1 0.795 
XmeanE, RmeanE 0.05 0.0523 0.03 to 0.22 0.9 0.351 
XmeanE, RmeanI 0.05 0.0487 0.04 to 0.15 0.3 0.263 
XmeanE, XmeanI -0.04 0.0364 -0.11 to 0.03 1.5 0.224 
XmeanI, RmeanE 0.09 0.0622 0.03 to 0.22 2.2 0.135 
XmeanI, RmeanI 0.10 0.0552 0.01 to 0.21 3.2 0.074 
  
 
265 
 
Table E4. Predictive values calculated after the receiver operator characteristic (ROC) analysis for the impedance variables. Data are presented as value 
(95% Confidence Interval). Predicted values are calculated assuming prevalence of disease of 10%, 25.7% and 60%, respectively.  
 Prevalence = 10% Prevalence = 25.7% Prevalence = 60% 
 PPV NPV PPV NPV PPV NPV 
ΔR 43 (30 to 57) 99 (97 to 100) 75 (57 to 89) 97 (90 to 99) 92 (75 to 99) 88 (64 to 99) 
ΔX 19 (12 to 28) 96 (92 to 99) 50 (34 to 66) 90 (80 to 96) 77 (56 to 91) 65 (38 to 86) 
RmeanE 33 (20 to 48) 95 (91 to 97) 33 (20 to 48) 80 (67 to 90) 68 (45 to 86) 50 (28 to 72) 
RmeanI 18 (11 to 27) 95 (90 to 97) 36 (23 to 51) 83 (71 to 92) 74 (52 to 90) 57 (34 to 78) 
XmeanE 24 (15 to 36) 95 (91 to 98) 33 (20 to 48) 81 (67 to 90) 80 (56 to 94) 57 (34 to 77) 
XmeanI 17 (10 to 26) 94 (89 to 97) 35 (21 to 50) 82 (69 to 91) 73 (50 to 89) 52 (30 to 74) 
  
 
266 
 
APPENDIX 3 MODIFIED ISAAC QUESTIONNAIRE 
 
INTERNATIONAL STUDY OF ASTHMA AND ALLERGIES IN 
CHILDHOOD ASTHMA (ISAAC) QUESTIONNAIRE 
 
Core questions for asthma 
1 Has your child ever had wheezing or whistling in the chest? 
 Yes – go to question 2 
 No – skip to question 7 
 
2 At what age was your child’s first wheezing episode? 
 _____  years | months (please circle) 
 
3 Has your child had wheezing or whistling in the chest in the past 12 months? 
 Yes – go to question 4 
 No – skip to question 7 
 
4 How many attacks of wheezing has your child had in the past 12 months? 
 None 
 1 - 3 
 4 - 12 
 More than 12 
 
5 
In the past 12 months, how often, on average, has your child’s sleep been disturbed due 
to wheezing? 
 Never woken with wheezing 
 Less than one night per week 
 One or more night per week 
 
6 
In the past 12 months, has wheezing ever been severe enough to limit your child’s 
speech to only one or two words at a time between breaths? 
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 Yes 
 No 
 
7 Has your child ever had asthma? 
 Yes – go to question 8 
 No – skip to question 15 
  
8 At what age was your child first diagnosed by a doctor with asthma? 
 _____  years | months (please circle) 
 
9 In the past 12 months, has your child’s chest sounded wheezy during or after exercise? 
 Yes  
 No  
 
10 
In the past 12 months, has your child had a dry cough at night, apart from a cough 
associated with a cold or chest infection?  
 Yes  
 No  
 
11 Has your child’s asthma ever been treated with medication?  
 Yes – go to question 12 
 No – skip to question 15 
 
12 Asthma medication Child’s age when medication was first commenced 
  _____  years | months (please circle) 
  _____  years | months (please circle) 
  _____  years | months (please circle) 
  _____  years | months (please circle) 
  _____  years | months (please circle) 
  _____  years | months (please circle) 
  
 
268 
 
 
 
13 In the past 12 months, has your child taken medication for their asthma?  
 Yes – go to question 14 
 No – skip to question 15 
 
14 
Medication and dose taken in the  
past 12 months 
Month and year when medication was first 
commenced 
   
   
   
   
   
   
 
15 Has your child ever been hospitalised for a respiratory condition?  
 Yes – go to question 16 
 No – skip to the core questions for rhinitis section 
 
16 Date of admission Age of child Reason for hospitalisation 
 
                     month | year      
(please circle)     
_____  years | months  
            (please circle) 
 
 
 
 
                     month | year 
(please circle) 
_____  years | months  
            (please circle) 
 
 
 
 
                     month | year 
(please circle) 
_____  years | months  
            (please circle) 
 
 
 
 
                     month | year    
(please circle) 
_____  years | months  
            (please circle) 
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Core questions for rhinitis 
All questions are about problems which occur when you DO NOT have a cold or the flu. 
1 
Has your child ever had a problem with sneezing, or a runny blocked nose when they did 
not have a cold or flu? 
 Yes – go to question 2 
 No – skip to question 6 
 
2 
In the past 12 months, has your child had a problem with sneezing, or a runny blocked 
nose when they did not have a cold or flu? 
 Yes – go to question 3 
 No – skip to question 6 
 
3 In the past 12 months, has this nose problem been accompanied by itchy watery eyes? 
 Yes – go to question 4 
 No – skip to question 6 
 
4 In which, of the past 12 months did this nose problem occur (please tick any which apply). 
 
5 
In the past 12 months, how much did this nose problem interfere with your child’s daily 
activities? 
 Not at all 
 A little 
 January  May  September 
 
 
February 
 
 
June 
 
 
  October 
 
 
March 
 
 
July 
 
 
November 
 
 
April 
 
 
August 
 
 
December 
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 A moderate amount 
 A lot 
 
6 Has your child ever had hayfever?  
 Yes  
 No  
 
Core questions for eczema 
1 Has your child ever had an itchy rash which was coming and going for at least 6 months? 
 Yes – go to question 2 
 No – skip to question  
 
2 Has your child had this itchy rash at anytime in the past 12 months? 
 Yes – go to question 3 
 No – skip to question 6 
 
3 
Has this itchy rash at anytime affected any of the following places: the folds of the elbows, 
behind the knees, in front of the ankles, under or around the neck, ears or eyes? 
 Yes  
 No  
 
4 Has this rash cleared completely at anytime during the past 12 months? 
 Yes  
 No  
 
5 
In the past 12 months, how often, on average, has your child been kept awake at night 
with an itchy rash? 
 Never in the past 12 months 
 Less than one night per week 
 One or more nights per week 
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6 Has your child ever had eczema? 
 Yes  
 No  
 
 
 
